Menu
Search Results
You searched for "breast cancer". We found 2 journal(s).
Breast Cancer: Targets and Therapy
International Journal of Women's Health
You searched for "breast cancer". We found 1000 paper(s).
SEPT3 as a Potential Molecular Target of Triple-Negative Breast Cancer
Yang LH, Wang GZ, Gao C
International Journal of General Medicine 2024, 17:1605-1613
Correlation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC)
Sui X, Feng P, Sun X, Liang P, Liu Y, Zhang G
Breast Cancer: Targets and Therapy 2024, 16:245-252
Expression and Significance of LINC02418 in Breast Cancer
Zhou YH, Huang JY
Breast Cancer: Targets and Therapy 2024, 16:233-243
Unveiling Intricacies of DIEP Breast Reconstruction Post Early Breast Cancer: A Deep Dive into a Case of Unforeseen Complications
Xie L, Kong X, Gao J
Cancer Management and Research 2024, 16:337-345
Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis [Retraction]
Zhang M, Zhu W, Haeryfar M, Jiang S, Jiang X, Chen W, Li J
OncoTargets and Therapy 2024, 17:361-362
Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells [Retraction]
Ren F, Shrestha C, Shi H, Sun F, Zhang M, Cao Y, Li G
OncoTargets and Therapy 2024, 17:359-360
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Chen Y, Li WX, Wu JH, Chen GH, Yang CM, Lu H, Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Hong RX, Jiang KK, Zhong YY, Zhang G, Tienchaiananda P, Oikawa M, Yuan ZY, Chen QJ
Breast Cancer: Targets and Therapy 2024, 16:223-231
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer
Ma S, Hao R, Lu YW, Wang HP, Hu J, Qi YX
Breast Cancer: Targets and Therapy 2024, 16:199-219
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]
Syahruddin FI, Prihantono, Muis M
Breast Cancer: Targets and Therapy 2024, 16:221-222
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
Ye M, Xu H, Ding J, Jiang L
Breast Cancer: Targets and Therapy 2024, 16:181-197
Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer
Fan T, Huang Y, Liu Z, Huang J, Ke B, Rong Y, Qiu H, Zhang B
Drug Design, Development and Therapy 2024, 18:1115-1131
Spiritual Needs and Influencing Factors of Postoperative Breast Cancer Women Undergoing Chemotherapy: A Cross-Sectional Study
Cheng SL, Yusuf A, He YY, Tang WZ, Solihin Sulaiman NA
Risk Management and Healthcare Policy 2024, 17:843-853
Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials
Yeo W, Ngai NTY, Yip CCH, Mo FKF, Yeo VA, Ko JWH, Li LV, Lau TKH, Lai KT, Pang E, Yip CH, Yeo HL, Kwok CCH, Ko SWY, Molassiotis A
Cancer Management and Research 2024, 16:283-297
Antitumor Effect of Triptolide in T-Cell Lymphoblastic Lymphoma by Inhibiting Cell Viability, Invasion, and Epithelial–Mesenchymal Transition via Regulating the PI3K/AKT/mTOR Pathway [Retraction]
Huang Y, Wu S, Zhang Y, Wang L, Guo Y
OncoTargets and Therapy 2024, 17:303-304
MicroRNA-155-3p Promotes Breast Cancer Progression Through Down-Regulating CADM1 [Retraction]
Zhang G, Zhong L, Luo H, Wang S
OncoTargets and Therapy 2024, 17:301-302
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients
Wang S, Chen Y, Li W, Hao C, Zhang L, Zhao W, Shi Y, Tong Z
Breast Cancer: Targets and Therapy 2024, 16:163-179
TNFα Promotes Glioblastoma A172 Cell Mitochondrial Apoptosis via Augmenting Mitochondrial Fission and Repression of MAPK–ERK–YAP Signaling Pathways [Retraction]
Lu C, Chen X, Wang Q, Xu X, Xu B
OncoTargets and Therapy 2024, 17:297-298
Overexpression of Mst1 Reduces Gastric Cancer Cell Viability by Repressing the AMPK-Sirt3 Pathway and Activating Mitochondrial Fission [Retraction]
Yao S, Yan W
OncoTargets and Therapy 2024, 17:281-282
Effects of Metformin on JNK Signaling Pathway and PD-L1 Expression in Triple Negative Breast Cancer
Wang R, Zhao Y
Cancer Management and Research 2024, 16:259-268
Innovative Surgical Approaches That Improve Individual Outcomes in Advanced Breast Cancer
Luțenco V, Rebegea L, Beznea A, Tocu G, Moraru M, Mihailov OM, Ciuntu BM, Luțenco V, Stanculea FC, Mihailov R
International Journal of Women's Health 2024, 16:555-560
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer
Ubowski MM, VanSice R, Marriott M, Yacobucci MJ, Chablani L
Breast Cancer: Targets and Therapy 2024, 16:149-162
HER2 Low Expression in Primary Male Breast Cancer
Nobbe K, Erices-Leclercq M, Foerster F, Förster R, Baldus SE, Rudlowski C, Schröder L, Lubig S
Breast Cancer: Targets and Therapy 2024, 16:141-148
The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer
Liu L, Xiao W, Zhang C, Fan P, Zeng J, Yi J
International Journal of General Medicine 2024, 17:1233-1251
Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants
Valsalakumari R, Pandya AD, Prasmickaite L, Kvalvaag A, Myrann AG, Åslund AKO, Kjos MS, Fontecha-Cuenca C, Haroon HB, Ribeiro ARS, Horejs-Hoeck J, Moghimi SM, Mørch Ý, Skotland T, Sandvig K, Mælandsmo GM, Iversen TG
International Journal of Nanomedicine 2024, 19:3009-3029
Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
Wang C, Xiang J, Zhang Q, Li J, Liu Y, Liu J
Drug Design, Development and Therapy 2024, 18:909-917
Towards Agility in Breast Cancer Treatment Principles as Adopted from Agile Software Engineering
Odeh Y, Al-Balas M
Journal of Multidisciplinary Healthcare 2024, 17:1315-1341
Factors Influencing Breast Cancer Awareness in Rural Southwest China: A Cross-Sectional Study
Zhu L, Zhou Q, Huang Z, Yang Y, Yang Y, Du Y, Zhao Y, Yu X, Li T, Chen W
International Journal of Women's Health 2024, 16:509-518
Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy
Hong C, Wang A, Xia J, Liang J, Zhu Y, Wang D, Zhan H, Feng C, Jiang X, Pan J, Wang J
International Journal of Nanomedicine 2024, 19:2879-2888
Prognostic Value of CRP–Albumin–Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer
Zhuang J, Wang S, Wang Y, Wu Y, Hu R
International Journal of General Medicine 2024, 17:997-1005
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer
Rangel N, Sánchez IL, Valbuena DS, Rondón-Lagos M
Breast Cancer: Targets and Therapy 2024, 16:127-139
SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer
Ning L, Xie N
Cancer Management and Research 2024, 16:137-150
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients
Ma Q, Liu YB, She T, Liu XL
Breast Cancer: Targets and Therapy 2024, 16:117-126
Glutathione Depletion-Induced ROS/NO Generation for Cascade Breast Cancer Therapy and Enhanced Anti-Tumor Immune Response
Wang J, Sang Y, Chen W, Cheng L, Du W, Zhang H, Zheng B, Song L, Hu Y, Ma X
International Journal of Nanomedicine 2024, 19:2301-2315
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
Sharman Moser S, Apter L, Livnat I, Ginsburg R, Yarden A, Drori M, Drizon A, Chodick G, Siegelmann-Danieli N
Breast Cancer: Targets and Therapy 2024, 16:105-116
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery
Li Q, Gao C, Zhao X, Li J, Shen Q, Chen L
Breast Cancer: Targets and Therapy 2024, 16:91-103
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer
Zhou Y, Xue W, Meng X, Bhandari A, Zeng H, KC R, Hirachan S, Xia E
Breast Cancer: Targets and Therapy 2024, 16:71-89
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads
Monteiro MR, Nunes NCC, Junior AADS, Fêde ABDS, Bretas GDO, Souza CDP, Mano M, da Silva JL
Breast Cancer: Targets and Therapy 2024, 16:51-70
Anti-Cancer Potency of Copper-Doped Carbon Quantum Dots Against Breast Cancer Progression
Wang M, Lan S, Zhang W, Jin Q, Du H, Sun X, He L, Meng X, Su L, Liu G
International Journal of Nanomedicine 2024, 19:1985-2004
Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges
Yu X, Zhu L
International Journal of Nanomedicine 2024, 19:1867-1886
Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model
Hu Y, Wang D, Zhang T, Lei M, Luo Y, Chen Z, Li Y, Duan D, Zhang L, Zhu Y
International Journal of Nanomedicine 2024, 19:1809-1825
Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis
Li C, Wang Z, Zhang Y, Zhu Y, Xu M, Lei H, Zhang D
International Journal of Nanomedicine 2024, 19:1749-1766
Coronin 3 Promotes the Development of Oncogenic Properties in Glioma Through the Wnt/β-Catenin Signaling Pathway [Retraction]
Wang M, Li Q, Yu S, Zhang Z, Qiu P, Zhang Y, Yang W, Xu G, Xu T
OncoTargets and Therapy 2024, 17:145-146
Platelet Membrane Biomimetic Manganese Carbonate Nanoparticles Promote Breast Cancer Stem Cell Clearance for Sensitized Radiotherapy
Jiang Y, Liao X, Tang W, Huang C, Pan Y, Ning S
International Journal of Nanomedicine 2024, 19:1699-1707
Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study
Bhimani F, Lin S, McEvoy M, Cavalli A, Obaid L, Chen Y, Gupta A, Pastoriza J, Shihabi A, Feldman S
Breast Cancer: Targets and Therapy 2024, 16:41-50
Nanofabrications of Erythrocyte Membrane-Coated Telmisartan Delivery System Effective for Radiosensitivity of Tumor Cells in Mice Model
Chen S, Wang C, Meng Y, Li P, Pan Y, He M, Ni X
International Journal of Nanomedicine 2024, 19:1487-1508
Mst1-Hippo Pathway Triggers Breast Cancer Apoptosis via Inducing Mitochondrial Fragmentation in a Manner Dependent on JNK–Drp1 Axis [Retraction]
Ouyang H, Zhou E, Wang H
OncoTargets and Therapy 2024, 17:109-110
Thyroid Metastases from Triple-Negative Breast Cancer with High PD-L1 Expression – A Rare Presentation
Meng W, Guo Q, Tang G, Han G, Ma G, Zhang Q, Li R, Liu S, Yu G
OncoTargets and Therapy 2024, 17:103-107
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study
Chen L, Liu Q, Tan C, Wu T, Wu M, Tan X, Liu J, Wang J
ImmunoTargets and Therapy 2024, 13:75-94
Prevalence and Factors Contributing to Fear of Recurrence in Breast Cancer Patients and Their Partners: A Cross-Sectional Study
Tong L, Wang Y, Xu D, Wu Y, Chen L
International Journal of Women's Health 2024, 16:229-236
Time Trends in Male Breast Cancer Incidence, Mortality, and Survival in Austria (1983–2017)
Ilic L, Simon J, Hackl M, Haidinger G
Clinical Epidemiology 2024, 16:57-69
Long Non-Coding RNA LINC01089 Enhances the Development of Gastric Cancer by Sponging miR-145-5p to Mediate SOX9 Expression [Retraction]
Wang F, Yang Q
OncoTargets and Therapy 2024, 17:35-36
LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression [Retraction]
Meng D, Shao H, Feng C
OncoTargets and Therapy 2024, 17:37-38
Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment
Zhang Z, Luo X, Xue X, Pang M, Wang X, Yu L, Qian J, Li X, Tian M, Lu A, Lu C, Liu Y
International Journal of Nanomedicine 2024, 19:743-758
Long-Noncoding RNA CASC9 Promotes Progression of Non-Small Cell Lung Cancer by Promoting the Expression of CDC6 Through Binding to HuR [Retraction]
Zhang X, Lian T, Fan W, Zhang G, Chen Z, Gou X, Jha RK
Cancer Management and Research 2024, 16:69-70
LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis [Retraction]
Chen T, Gao F, Yang T, Li H, Li Y, Ren H, Chen M
Cancer Management and Research 2024, 16:65-66
LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g/CHI3L1 Axis [Retraction]
Liu W, Yang YJ, An Q
Cancer Management and Research 2024, 16:63-64
Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer
Hu C, Liu Y, Cao W, Li N, Gao S, Wang Z, Gu F
International Journal of Nanomedicine 2024, 19:507-526
Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer
Chen CC, Tang WH, Wu CC, Lee TL, Tsai IT, Hsuan CF, Wang CP, Chung FM, Lee YJ, Yu TH, Wei CT
Breast Cancer: Targets and Therapy 2024, 16:23-39
Copper-Based Single-Atom Nanozyme System Mimicking Platelet Cells for Enhancing the Outcome of Radioimmunotherapy
Chen C, Chen N, Qi Y, Lyu M, Wu C, Xie C, Yu H
International Journal of Nanomedicine 2024, 19:403-414
Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery
Guo X, Han L, Chen W, He H, Zhang W, Huang C, Wang X
International Journal of Nanomedicine 2024, 19:247-261
Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer
Zhou X, Li Z, Chen H, Jiao M, Zhou C, Li H
BRCA2, PALB2, RECQL4 Germline Pathogenic Variants, and Somatic TP53 Mutation in Triple Metachronous Malignancies: A Case Report and Literature Review
Liu Y, Yang H, Fu X, Zhong L, Xu P, Fang F, Liu Y, Li Q, Yan Y, Wei S, Wang J, Zhang C
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer
Jin J, Li J, Liu Y, Shi Q, Zhang B, Ji Y, Hu P
Breast Cancer: Targets and Therapy 2024, 16:15-22
Comparison of Cytokine RANTES/CCL5 Inflammation in Apical Periodontitis and in Jawbone Cavitations – Retrospective Clinical Study
Vasconcelos e Cruz J, Notter F, Schick F, Lechner J
Journal of Inflammation Research 2024, 17:67-80
The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors
Ekemen S, Bilir E, Soultan HEA, Zafar S, Demir F, Tabandeh B, Toprak S, Yapicier O, Coban C
Breast Cancer: Targets and Therapy 2024, 16:1-13
Resumption of Intravenous Anti-Cancer Therapy in Breast Cancer: A Real-World Experience During the SARS-CoV-2 Pandemic
Yang F, Li C, Qiu Y, Chen X, Zheng K, Kang D, Zhang Y, Liu B, Yao Y, Xie L
Cancer Management and Research 2024, 16:1-9
CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1
Zhu X, Yu J, Ai F, Wang Y, Lv W, Yu G, Cao X, Lin J
Breast Cancer: Targets and Therapy 2023, 15:967-984
Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand
Yeo HY, Wong JHY, Chan SJ, Latu ATF, Han CH, Anwar M, Marra CA
Patient Preference and Adherence 2023, 17:3525-3537
Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy
Kim JY, Yang DW, Kim S, Choi JG
Breast Cancer: Targets and Therapy 2023, 15:955-966
Predictive Models of Psychological Distress, Quality of Life, and Adherence to Medication in Breast Cancer Patients: A Scoping Review
Pezzolato M, Spada GE, Fragale E, Cutica I, Masiero M, Marzorati C, Pravettoni G
Patient Preference and Adherence 2023, 17:3461-3473
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]
Wardoyo S, Fadillah MA, Hamtini
Breast Cancer: Targets and Therapy 2023, 15:953-954
Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2)
Hagberg KW, Vasilakis-Scaramozza C, Persson R, Neasham D, Kafatos G, Jick S
Clinical Epidemiology 2023, 15:1193-1206
Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1)
Hagberg KW, Vasilakis-Scaramozza C, Persson R, Neasham D, Kafatos G, Jick S
Clinical Epidemiology 2023, 15:1183-1192
Immunotherapy: Constructive Approach for Breast Cancer Treatment
Anayyat U, Ahad F, Muluh TA, Zaidi SAA, Usmani F, Yang H, Li M, Hassan HA, Wang X
Breast Cancer: Targets and Therapy 2023, 15:925-951
ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer [Retraction]
Cheng J, Wang R, Zhong G, Chen X, Cheng Y, Li W, Yang Y
OncoTargets and Therapy 2023, 16:1053-1054
Gadolinium Oxide Nanoparticles Reinforce the Fractionated Radiotherapy-Induced Immune Response in Tri-Negative Breast Cancer via cGAS-STING Pathway
Yu B, Lu X, Feng X, Zhao T, Li J, Lu Y, Ye F, Liu X, Zheng X, Shen Z, Jin X, Chen W, Li Q
International Journal of Nanomedicine 2023, 18:7713-7728
Cell Line-Dependent Adhesion and Inhibition of Proliferation on Carbon-Based Nanofilms
Wójcik B, Zawadzka K, Sawosz E, Sosnowska M, Ostrowska A, Wierzbicki M
Nanotechnology, Science and Applications 2023, 16:41-57
Breast Cancer Awareness Among Women in Saudi Arabia: A Systematic Review
AlRajhi B, Aljadani FF, Almarwan SR, Alzahrani AA, Sindi MHM, Kano A, Alzahrani RS, Baaqeel R
Breast Cancer: Targets and Therapy 2023, 15:913-924
Green Nanotechnology of Yucca filamentosa- Phytochemicals-Functionalized Gold Nanoparticles—Antitumor Efficacy Against Prostate and Breast Cancers
Thipe VC, Jatar A, Raphael Karikachery A, Katti KK, Katti KV
Nanotechnology, Science and Applications 2023, 16:19-40
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models
Hu W, Wang L, Luo J, Zhang J, Li N
Breast Cancer: Targets and Therapy 2023, 15:899-912
Evaluation of Cytotoxicity of the Methanolic Extract of Red Sea Marine Sponge Xestospongia Testudinaria and Its Related Compounds Against MCF-7 Human Breast Cancer Cells
Alkhilaiwi FA, Fadil SA, Aljoud FA, Yonbawi AR, Ashi A, Hareeri RH, Bakhashab S, Alamri AM, Albikairi AY, Shaala LA, El-Gamal AA, Youssef DT
Breast Cancer: Targets and Therapy 2023, 15:879-890
Accuracy Rate of Methylene Blue Injection in Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Patients: A Prospective Observational Study
Aziz HK, Azhar Y, Widarda IR, Abdurahman M, Erdiansyah Z, Nugraha P, Lukman K
Breast Cancer: Targets and Therapy 2023, 15:891-897
Solasodine, Isolated from Solanum Sisymbriifolium Fruits, Has a Potent Anti-Tumor Activity Against Pancreatic Cancer [Retraction]
Fan Y, Li Z, Wu L, Lin F, Shao J, Ma X, Yao Y, Zhuang W, Wang Y
Drug Design, Development and Therapy 2023, 17:3685-3686
Current Perspectives and Trend of Acupuncture in Breast Cancer-Related Symptoms: A Bibliometric Study
Wang H, Qu S, Zhou T, Hu Q, Zhao X, Yang Q, Chi H, Luo S, Li X, Ke H, He X, Zhao H
Journal of Pain Research 2023, 16:4165-4180
Hsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p [Retraction]
Zhang L, Ding F
OncoTargets and Therapy 2023, 16:1021-1022
LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction]
Li H, Yao G, Zhai J, Hu D, Fan Y
OncoTargets and Therapy 2023, 16:1013-1014
Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells
Caputo TM, Barisciano G, Mulè C, Cusano AM, Aliberti A, Muccillo L, Colantuoni V, Sabatino L, Cusano A
International Journal of Nanomedicine 2023, 18:6999-7020
Regulatory Effect of miR497-5p–CCNE1 Axis in Triple-Negative Breast Cancer Cells and Its Predictive Value for Early Diagnosis [Retraction]
Liu WW, Li WD, Zhang YJ, Zhang ML
Cancer Management and Research 2023, 15:1339-1340
Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker
North WG
OncoTargets and Therapy 2023, 16:973-982
A Case of ALK-Positive Anaplastic Large Cell Lymphoma of the Male Breast
Wang X, Jia Z, Li J, Yang H, Sun X, Liu Y
International Medical Case Reports Journal 2023, 16:747-755
Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody–Drug Conjugate Therapy
Goyal RK, Zhang J, Davis KL, Sluga-O'Callaghan M, Kaufman PA
Breast Cancer: Targets and Therapy 2023, 15:855-865
Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases
Huang J, Zhu W, Duan Q, Zhu C, Shi X, Zhao H, Cai P, Li D
Breast Cancer: Targets and Therapy 2023, 15:841-853
The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications
Li J, He D, Bi Y, Liu S
Breast Cancer: Targets and Therapy 2023, 15:825-840
Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study
Zhou Y, Guo X, Shen L, Liu K, Sun Q, Wang Y, Wang H, Fu W, Yao Y, Wu S, Chen H, Qiu J, Pan T, Deng Y
OncoTargets and Therapy 2023, 16:939-960
Enhancing Ezetimibe Anticancer Activity Through Development of Drug Nano-Micelles Formulations: A Promising Strategy Supported by Molecular Docking
Ahmed TA, Ali EM, Omar AM, Almehmady AM, El‐Say KM
International Journal of Nanomedicine 2023, 18:6689-6703
Psychometric Properties and Factorial Analysis of the Arabic McGill-QoL Questionnaire in Breast Cancer
Omar MTA, Alnahdi AH
Breast Cancer: Targets and Therapy 2023, 15:813-824
ABCB1 Regulates Immune Genes in Breast Cancer
Chen HK, Chen YL, Wang CY, Chung WP, Fang JH, Lai MD, Hsu HP
Breast Cancer: Targets and Therapy 2023, 15:801-811
Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability Treatment Weighting Analysis
Zhao J, Hao S, Li Y, Liu X, Liu Z, Zheng C, Han D
ImmunoTargets and Therapy 2023, 12:113-133
miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction]
Wang J, Wang L, Zhang C
OncoTargets and Therapy 2023, 16:937-938
LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction]
Han X, Liu J, Liu Y, Mou L, Li C
Cancer Management and Research 2023, 15:1267-1268
Eleven Years of Oncogenetic Consultations in a Swiss Center: Patient and Testing Characteristics
Grandjean B, Scherz A, Rabaglio M
The Application of Clinical Genetics 2023, 16:205-213
Tarin-Loaded Nanoliposomes Activate Apoptosis and Autophagy and Inhibit the Migration of Human Mammary Adenocarcinoma Cells
Cardoso RV, Pereira PR, Freitas CS, Mattos EBA, De Freitas Silva AV, Midlej VDV, Vericimo MA, Conte-Júnior CA, Paschoalin VMF
International Journal of Nanomedicine 2023, 18:6393-6408
Synergetic Photodynamic-Photothermal-Chemotherapy Dual Targeting Nanoplatform Effective Against Breast Cancer in-Mice Model
Li N, Jiang X, Zhang W, Xiao W, Wu Z, Wang H, He F
International Journal of Nanomedicine 2023, 18:6349-6365
Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
Dakroub R, Huard S, Hajj-Younes Y, Suresh S, Badran B, Fayyad-Kazan H, Dubois T
Breast Cancer: Targets and Therapy 2023, 15:785-799
Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study
Onwusah DO, Ojewole EB, Manyangadze T, Chimbari MJ
Patient Preference and Adherence 2023, 17:2821-2839
Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
Gorenšek R, Kresnik M, Takač I, Rojko T, Sobočan M
Breast Cancer: Targets and Therapy 2023, 15:773-783
Study on the Relationship Between PTPRO Methylation in Plasma and Efficacy Neoadjuvant Chemotherapy in Patients with Early Breast Cancer
Liu XW, Hong MJ, Qu YY
International Journal of Women's Health 2023, 15:1673-1680
Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review
Zhu Z, Zhou N, Yu S, Gao X, Cheng X, Wang Y, Bai C
OncoTargets and Therapy 2023, 16:905-911
Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review
Yeo HY, Liew AC, Chan SJ, Anwar M, Han CHW, Marra CA
Patient Preference and Adherence 2023, 17:2679-2706
Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
Chen L, Meng Z, Zhou Z, Li X, Zhao L, Jia Z, Chen J, Tian Y, Meng Q, Liu Y
OncoTargets and Therapy 2023, 16:885-890
A Review on the Management of Peripheral Neuropathic Pain Following Breast Cancer
Avila F, Torres-Guzman R, Maita K, Garcia JP, De Sario GD, Borna S, Ho OA, Forte AJ
Breast Cancer: Targets and Therapy 2023, 15:761-772
Temperature-Sensitive Nanocarbon Hydrogel for Photothermal Therapy of Tumors
Tan W, Chen S, Xu Y, Chen M, Liao H, Niu C
International Journal of Nanomedicine 2023, 18:6137-6151
Traditional Chinese Medicine for Breast Cancer: A Review
Feng RQ, Li DH, Liu XK, Zhao XH, Wen QE, Yang Y
Breast Cancer: Targets and Therapy 2023, 15:747-759
PDL1-Based Nomogram May Be of Potential Clinical Utility for Predicting Survival Outcome in Stage III Breast Cancer
Zhang X, Li R, Wang G
Breast Cancer: Targets and Therapy 2023, 15:731-746
A Progressively Disassembled DNA Repair Inhibitors Nanosystem for the Treatment of BRCA Wild-Type Triple-Negative Breast Cancer
Fang W, Wang J, Ma X, Shao N, Ye K, Zhang D, Shi C, Luo L
International Journal of Nanomedicine 2023, 18:6001-6019
Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis [Retraction]
Cao MD, Song YC, Yang ZM, Wang DW, Lin YM, Lu HD
OncoTargets and Therapy 2023, 16:839-840
Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives
Wang J, Wu SG
Breast Cancer: Targets and Therapy 2023, 15:721-730
A Comprehensive Model Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging Can Better Predict the Preoperative Histological Grade of Breast Cancer Than a Radiomics Model
Wu Y, Pan W, Wang L, Pan W, Zhang H, Jin S, Wu X, Liu A, Xin E, Ji W
Breast Cancer: Targets and Therapy 2023, 15:709-720
Hsa_circ_0007823 Overexpression Suppresses the Progression of Triple-Negative Breast Cancer via Regulating miR-182-5p-FOXO1 Axis
Yu J, Wang H, Shen W, Zhou Y, Cui J, Li H, Gao B
Breast Cancer: Targets and Therapy 2023, 15:695-708
The Impact of Deep Inspiration Breath Hold (DIBH) Implementation on the Hybrid Technique in Left-Sided Whole Breast Irradiation: A Dosimetric Characteristic Study of 3D-CRT Hybrid VMAT in DIBH and Free Breathing Conditions, and VMAT in Free Breathing Conditions
Yeh HL, Lin JF
Breast Cancer: Targets and Therapy 2023, 15:683-693
Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer
Abduh MS
International Journal of Nanomedicine 2023, 18:5713-5732
The Therapeutic Effects of MUC1-C shRNA@Fe3O4 Magnetic Nanoparticles in Alternating Magnetic Fields on Triple-Negative Breast Cancer
Li Z, Guo T, Zhao S, Lin M
International Journal of Nanomedicine 2023, 18:5651-5670
Biofabrication of Silver Nanoparticles Using Nostoc muscorum Lukesova 2/91: Optimization, Characterization, and Biological Applications
Hamida RS, Ali MA, Sharif FT, Sonbol H, Bin-Meferij MM
International Journal of Nanomedicine 2023, 18:5625-5649
Adaptation and Implementation of Pictorial Conversation Aids for Early-Stage Breast Cancer Surgery and Reconstruction: A Quality Improvement Study
Durand MA, Bannier M, Aim MA, Mancini J
Patient Preference and Adherence 2023, 17:2463-2474
c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights
Abdellateif MS, Bayoumi AK, Mohammed MA
OncoTargets and Therapy 2023, 16:785-799
Aggressiveness of Cancer Care at End of Life in Patients with Metastatic Breast Cancer in Jordan
Abunasser M, Abu-Fares H, Abdel-Razeq S, Shamieh O, Salama O, Ashouri K, Al Qudah A, Taqash A, Abu-Jaish H, Saadah SS, Abdel-Razeq H
Journal of Multidisciplinary Healthcare 2023, 16:2873-2881
Severe Untreated Scoliosis and Early Onset Breast Cancer in a Patient with Neurofibromatosis Associated with a Nonsense Variant of NF1 Gene
Reinhold V, Saarinen A, Suominen E, Syrjänen S, Kankuri-Tammilehto M
Orthopedic Research and Reviews 2023, 15:183-189
The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications
Guo Q, Liu XL, Zhai K, Chen C, Ke XX, Zhang J, Xu G
International Journal of General Medicine 2023, 16:4321-4328
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
Zhang Z, Zhang R, Li D
Biologics: Targets and Therapy 2023, 17:113-128
Establishment and Validation of a Predictive Model for Post-Treatment Anxiety Based on Patient Attributes and Pre-Treatment Anxiety Scores
Sun W, Shen J, Sun R, Zhou D, Li H
Psychology Research and Behavior Management 2023, 16:3883-3894
SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway
Wang GZ, Yang LH, Gao C
International Journal of General Medicine 2023, 16:4155-4164
Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer
Liu WL, Zhang YQ, Luo XJ, Zhu YY, Song L, Ming ZH, Zhang LX, Li MJ, Lv RC, Zhang GJ, Chen M
International Journal of Nanomedicine 2023, 18:5141-5157
microRNA-130a is an Oncomir Suppressing the Expression of CRMP4 in Gastric Cancer [Retraction]
Zhou Y, Li R, Yu H, Wang R, Shen Z
OncoTargets and Therapy 2023, 16:723-724
Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction]
Wang Y, Liu Y, Du X, Ma H, Yao J
OncoTargets and Therapy 2023, 16:725-726
Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study
Chen X, Qian X, Xiao M, Zhang P
Breast Cancer: Targets and Therapy 2023, 15:671-682
How National Health Insurance Coverage Policy Affected the Use of Trastuzumab and Rituximab in China: A Bicentric Retrospective Study
Shang L, Lin Y, Fang W, Liu Y, Bao Y, Li X, Zhang Y
Risk Management and Healthcare Policy 2023, 16:1739-1753
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T, Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V
Breast Cancer: Targets and Therapy 2023, 15:659-669
Combined Dextran-Graft-Polyacrylamide/Zinc Oxide Nanocarrier for Effective Anticancer Therapy in vitro
Chumachenko V, Virych P, Nie G, Virych P, Yeshchenko O, Khort P, Tkachenko A, Prokopiuk V, Lukianova N, Zadvornyi T, Rawiso M, Ding L, Kutsevol N
International Journal of Nanomedicine 2023, 18:4821-4838
Effect of Dexmedetomidine and Two Different Doses of Esketamine Combined Infusion on the Quality of Recovery in Patients Undergoing Modified Radical Mastectomy for Breast Cancer - A Randomised Controlled Study
Huang Z, Liu N, Hu S, Ju X, Xu S, Wang S
Drug Design, Development and Therapy 2023, 17:2613-2621
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
Tong L, Yu X, Wang S, Chen L, Wu Y
Breast Cancer: Targets and Therapy 2023, 15:647-658
ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban
Kim H, Song TJ, Yee J, Kim DH, Park J, Gwak HS
Drug Design, Development and Therapy 2023, 17:2513-2522
Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients
He Y, Li YH, Geng YN, Liu A, Gao FY, Ji C, Liu Y, Wang M, Li XM, Wang Y, Wu YM
International Journal of General Medicine 2023, 16:3677-3687
KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy
Huang X, Li S, Gao W, Shi J, Cheng M, Mi Y, Liu Y, Sang M, Li Z, Geng C
International Journal of General Medicine 2023, 16:3623-3635
Critical Response to Article “Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer” [Letter]
Dany F, Nikmah UA, Lienggonegoro LA
Drug Design, Development and Therapy 2023, 17:2455-2456
Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan
Haque R, Chen LH, Oestreicher N, Lalla D, Chlebowski RT
Breast Cancer: Targets and Therapy 2023, 15:637-645
ABVS-Based Radiomics for Early Predicting the Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancers
Jiang W, Deng X, Zhu T, Fang J, Li J
Breast Cancer: Targets and Therapy 2023, 15:625-636
The Circular RNA circFGFR4 Facilitates Resistance to Anti-PD-1 of Triple-Negative Breast Cancer by Targeting the miR-185-5p/CXCR4 Axis
Wang F, Lu Q, Yu H, Zhang XM
Cancer Management and Research 2023, 15:825-835
Diagnostic Value of a Combined Serum α-Hydroxybutyrate Dehydrogenase, Carcinoembryonic Antigen and Glycoantigen 125 Test for Early-Stage Breast Cancer
Zhan CH, Liu GJ
Breast Cancer: Targets and Therapy 2023, 15:617-623
HER2-Low Breast Cancer: Current Landscape and Future Prospects
Shirman Y, Lubovsky S, Shai A
Breast Cancer: Targets and Therapy 2023, 15:605-616
Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer
Sun X, Yuan Z, Zhang L, Ren M, Yang J, Xu Y, Hao J
Journal of Inflammation Research 2023, 16:3381-3398
The Progress of Platelets in Breast Cancer
Wang L, Zhang K, Feng J, Wang D, Liu J
Cancer Management and Research 2023, 15:811-821
Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy
Fan J, Tang Y, Wang K, Yang S, Ma B
Breast Cancer: Targets and Therapy 2023, 15:591-604
Popularity of Traditional Chinese Medicine Use Among Breast Cancer Patients in North China: A Cross-Sectional Study
Zhao R, Zhang J, Gou Q, Gao J
Breast Cancer: Targets and Therapy 2023, 15:577-589
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, Ding J
Pharmacogenomics and Personalized Medicine 2023, 16:747-758
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy
Cucinella L, Tiranini L, Cassani C, Martella S, Nappi RE
International Journal of Women's Health 2023, 15:1261-1282
An Intraoperative Sub-Anesthetic Dose of Esketamine on Postoperative Depressive Symptoms in Perimenopausal Women with Breast Cancer Undergoing Modified Radical Mastectomy: Protocol for a Randomized, Triple-Blinded, Controlled Trial
Liu LL, Hu JH, Pan JJ, Liu H, Ji FH, Peng K
International Journal of General Medicine 2023, 16:3373-3381
Nonpharmacological Interventions for Management of the Pain-Fatigue-Sleep Disturbance Symptom Cluster in Breast Cancer Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
He CC, Lin DM, Liu HZ, Wang FF, Guo XF, Zhang XB, Ai YQ, Meng LM
Journal of Pain Research 2023, 16:2713-2728
Nano Uncaria gambir as Chemopreventive Agent Against Breast Cancer
Wardana AP, Aminah NS, Kristanti AN, Fahmi MZ, Zahrah HI, Widiyastuti W, Ajiz HA, Zubaidah U, Wiratama PA, Takaya Y
International Journal of Nanomedicine 2023, 18:4471-4484
Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing
Bai Q, Lv H, Bao L, Yang Y, Zhang X, Chang H, Xue T, Ren M, Zhu X, Zhou X, Yang W
Breast Cancer: Targets and Therapy 2023, 15:563-575
Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]
Dang W, Xing B, Jia X, Zhang Y, Jia B, Yu C, He J, Li Z, Li H, Liu Z
International Journal of Nanomedicine 2023, 18:4447-4448
Histone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis [Retraction]
Liu J, Li D, Zhang X, Li Y, Ou J
OncoTargets and Therapy 2023, 16:655-656
Early but Quality Diagnosis: On Breast Cancer and Its Risk Factors [Letter]
Zehra SS, Turabee Z, Rawalia MA
Breast Cancer: Targets and Therapy 2023, 15:549-550
Metabolic Profile and Negatively Association Between Insulin Resistance and Metastatic Incidence in Indonesian Primary Invasive Breast Cancer: A Cross-Sectional Study
Rachman A, Fiantoro ZH, Sutandyo N, Priantono D, Romadhon PZ, Jonlean R
International Journal of General Medicine 2023, 16:3257-3265
Clinicopathological Risk Factors of Unfavorable Outcomes in Vietnamese Women with Primary Invasive Breast Cancer: A Retrospective Cohort Study
Huynh CG, Huynh NX, Truong BHT, Thai TT, Doan PTT
Breast Cancer: Targets and Therapy 2023, 15:551-561
Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
Zhang Y, Han X, Wang K, Liu D, Ding X, Hu Z, Wang J
International Journal of Nanomedicine 2023, 18:4329-4346
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
Huang M, Zhai BT, Fan Y, Sun J, Shi YJ, Zhang XF, Zou JB, Wang JW, Guo DY
International Journal of Nanomedicine 2023, 18:4275-4311
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
Höller A, Nguyen-Sträuli BD, Frauchiger-Heuer H, Ring A
Breast Cancer: Targets and Therapy 2023, 15:525-540
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib
Sharaf B, Abu-Fares H, Tamimi F, Al-Sawajneh S, Salama O, Daoud R, Alhajahjeh A, Al-Lababidi S, Abdel-Razeq H
Breast Cancer: Targets and Therapy 2023, 15:541-548
Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression
Purwanto I, Leo B, Hutajulu SH, Kurnianda J, Taroeno-Hariadi KW, Hardianti MS, Satiti AD, Dwianingsih EK, Heriyanto DS, Widodo I, Aryandono T
Breast Cancer: Targets and Therapy 2023, 15:515-524
The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
Wang Z, Zhong Y, Zhou Y, Mao F, Zhang X, Wang C, Sun Q
Clinical Interventions in Aging 2023, 18:1163-1174
Perceived Barriers and Facilitators to Breast Cancer Screening Among Women in Saudi Arabia
AlAbdulKader A, Gari D, Al yousif G, Alghamdi A, AlKaltham S, AlDamigh F, AlEisawi Y, AlGhamdi A, Al-Hayek O, AlMudhi A
Breast Cancer: Targets and Therapy 2023, 15:505-513
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery
Ni Y, Deng F, Yu S, Zhang J, Zhang X, Huang D, Zhou H
Breast Cancer: Targets and Therapy 2023, 15:495-504
Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer
Wang Z, Qin Y, Wang X, Zhang T, Hu Y, Wang D, Zhang L, Zhu Y
International Journal of Nanomedicine 2023, 18:4023-4042
LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p [Retraction]
Yu H, Dong L, Wang H, Zhang Y, Wang Z, Wang C, Xia H, Bao H
Cancer Management and Research 2023, 15:739-740
PRO Hair Safe Study: The Patient’s Perspective on the Effects of Scalp Cooling on Hair Preservation
Brunner C, Egle D, Ritter M, Kofler R, Giesinger JM, Schneitter L, Sztankay M, Emmelheinz M, Abdel Azim S, Wieser V, Oberguggenberger A
Breast Cancer: Targets and Therapy 2023, 15:485-494
Molecular Mechanisms Behind Vascular Mimicry as the Target for Improved Breast Cancer Management
Wei Y, Jiao Z, Sun T, Lai Z, Wang X
International Journal of Women's Health 2023, 15:1027-1038
Methodological and Cellular Factors Affecting the Magnitude of Breast Cancer and Normal Cell Radiosensitization Using Gold Nanoparticles
Musielak M, Boś-Liedke A, Piwocka O, Kowalska K, Markiewicz R, Lorenz A, Bakun P, Suchorska W
International Journal of Nanomedicine 2023, 18:3825-3850
Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
Huang Y, Guo Y, Xiao Q, Liang S, Yu Q, Qian L, Zhou J, Le J, Pei Y, Wang L, Chang C, Chen S, Zhou S
Breast Cancer: Targets and Therapy 2023, 15:461-472
Ultrasound Triggered Tumor Metabolism Suppressor Induces Tumor Starvation for Enhanced Sonodynamic Immunotherapy of Breast Cancer
Qiao K, Luo C, Huang R, Xiang J, Pan Y, Zhang S, Jiang C, Ding S, Yang H, Huang Y, Ning S
International Journal of Nanomedicine 2023, 18:3801-3811
A Cross-Sectional Evaluation of Knowledge About Breast Cancer and Perceived Barriers to the Uptake of Mammogram Screening Among Northern Saudi Women: A Population-Based Study
Alanazi MF, Thirunavukkarasu A, Alrowily M, Alaqel N, Alaqel A, Alruwaili M, Alazmi NNM, Alhassan O, Aljarallah MFM, Altaymani AM
Breast Cancer: Targets and Therapy 2023, 15:451-460
Promoter Methylation-Regulated Differentially Expressed Genes in Breast Cancer
Sindi S, Hamdi N, Hassan S, Ganash M, Alharbi M, Alburae N, Azhari S, Alkhayyat S, Linjawi A, Alkhatabi H, Elaimi A, Alrefaei G, Alsubhi N, Alrafiah A, Alhazmi S
Breast Cancer: Targets and Therapy 2023, 15:435-450
CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
Motyka J, Gacuta E, Kicman A, Kulesza M, Malinowski P, Ławicki S
Cancer Management and Research 2023, 15:573-589
Effect of ABC Theory Model on Negative Emotion of Young Patients with Breast Cancer During Treatment
He R, He X, Su Y, Wang Y, Liang T, Cui Z, Zhang L
Journal of Multidisciplinary Healthcare 2023, 16:1883-1888
Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
Dong H, Gao M, Lu L, Gui R, Fu Y
International Journal of Nanomedicine 2023, 18:3577-3593
A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases
Shen F, Huang J, Yang K, Sun C
OncoTargets and Therapy 2023, 16:485-495
Informatics on Drug Repurposing for Breast Cancer
Zhou H, Liu H, Yu Y, Yuan X, Xiao L
Drug Design, Development and Therapy 2023, 17:1933-1943
The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Retraction]
Xia C, Jiang H, Ye F, Zhuang Z
OncoTargets and Therapy 2023, 16:483-484
Research Status and Prospects of Acupuncture in Perioperative Medicine Over the Past Decade: A Bibliometric Analysis
Zhang J, Liu L, Zhu M, Zheng X, Liang Y, Zhong Y, Xu J, Yang J
Journal of Pain Research 2023, 16:2189-2204
Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical Approach
Zhang B, Shi H, Wang H
Journal of Multidisciplinary Healthcare 2023, 16:1779-1791
Pregnancy Associated Invasive Apocrine Carcinoma of the Breast: Case Report from Ethiopia
Alemu HK, Hammad N, Tola MA, Vanderpuye V
Breast Cancer: Targets and Therapy 2023, 15:429-433
Multi-Site Attack, Neutrophil Membrane-Camouflaged Nanomedicine with High Drug Loading for Enhanced Cancer Therapy and Metastasis Inhibition
Huang R, Fan D, Cheng H, Huo J, Wang S, He H, Zhang G
International Journal of Nanomedicine 2023, 18:3359-3375
MicroRNA 628 Suppresses Migration and Invasion of Breast Cancer Stem Cells through Targeting SOS1 [Retraction]
Lin C, Gao B, Yan X, Lei Z, Chen K, Li Y, Zeng Q, Chen Z, Li H
OncoTargets and Therapy 2023, 16:421-422
Detecting the Frequency of c.5946delT Pathogenic Variant in the BRCA2 Gene and Associated Risk Factors Among Breast Cancer Patients Visiting Felege Hiwot Referral Hospital and University of Gondar Comprehensive Specialized Hospital
Berhane N, Chekol Z, Seid A
Breast Cancer: Targets and Therapy 2023, 15:421-427
Expression and Clinical Significance of TIGIT in Primary Breast Cancer
Tang L, Sha M, Guo T, Lu H, Qian J, Shao Q, Ye J
International Journal of General Medicine 2023, 16:2405-2417
Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis
Zhu H, Yang K, Yao H, Chen X, Yan S, He Y, Cao Y, Luo J, Wang D
International Journal of Nanomedicine 2023, 18:3109-3124
Dietary Behavior and Its Association with Nutrition Literacy and Dietary Attitude Among Breast Cancer Patients Treated with Chemotherapy: A Multicenter Survey of Hospitals in China
Tang H, Wang R, Yan P, Zhang W, Yang F, Guo S, Li T, Yi L, Bai X, Lin S, Zhang Y, Shang L
Patient Preference and Adherence 2023, 17:1407-1419
MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK [Retraction]
Zhang W, Liao K, Liu D
Cancer Management and Research 2023, 15:487-488
Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer
Dang W, Xing B, Jia X, Zhang Y, Jia B, Yu C, He J, Li Z, Li H, Liu Z
International Journal of Nanomedicine 2023, 18:3047-3068
Perioperative Administration of Pregabalin and Esketamine to Prevent Chronic Pain After Breast Cancer Surgery: A Randomized Controlled Trial
Wang M, Xiong HP, Sheng K, Sun XB, Zhao XQ, Liu QR
Drug Design, Development and Therapy 2023, 17:1699-1706
High Levels of SII and PIV are the Risk Factors of Axillary Lymph Node Metastases in Breast Cancer: A Retrospective Study
Tong L, Wang S, Zhang R, Wu Y, Xu D, Chen L
International Journal of General Medicine 2023, 16:2211-2218
Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis
Liu Y, Tang J, Qiu X, Teng LA, Sriwastva MK, Han X, Li Z, Liu M, Liu S, Da D, Li Z, Zhen L, Ren Y
Breast Cancer: Targets and Therapy 2023, 15:403-419
Transcriptome Profiling Analysis of Breast Cancer Cell MCF-7 Treated by Sesamol
Wu J, Luo D, Xu J
Breast Cancer: Targets and Therapy 2023, 15:391-401
Thinkful of Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway [Response to Letter]
Gao S, Zhang X, Liu J, Lv Y, Shi W
Drug Design, Development and Therapy 2023, 17:1611-1612
Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography
Ma Q, Shen C, Gao Y, Duan Y, Li W, Lu G, Qin X, Zhang C, Wang J
Breast Cancer: Targets and Therapy 2023, 15:381-390
Pulse Wave Morphology Changes in Aortic Valve Stenosis Detected with Cardio-Ankle Vascular Index
Plunde O, Franco-Cereceda A, Bäck M
Vascular Health and Risk Management 2023, 19:325-328
ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion
Ahmad SMS, Nazar H, Rahman MM, Rusyniak RS, Ouhtit A
Breast Cancer: Targets and Therapy 2023, 15:373-380
Association of Body Composition and Handgrip Strength with Interleukin-6 (IL-6) and Vitamin D Level in Cancer Patients
Sutandyo N, Cintakaweni DMW, Setiawan L, Hariani R, Utami N
International Journal of General Medicine 2023, 16:1995-2001
New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells
Długosz-Pokorska A, Perlikowska R, Janecki T, Janecka A
Biologics: Targets and Therapy 2023, 17:69-83
Depths of Malignancy: On the Prognosis of Breast Cancer [Response to Letter]
He J, Tong L, Wu P, Wu Y, Shi W, Chen L
International Journal of General Medicine 2023, 16:1807-1808
The Ratio of Monocyte to Apolipoprotein A1 is an Independent Predictor of Breast Cancer: A Retrospective Study
Lin Z, Luo C, Yuan Y
Cancer Management and Research 2023, 15:423-432
Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line
Kostrzewa T, Nowak I, Feliczak-Guzik A, Drzeżdżon J, Jacewicz D, Górska-Ponikowska M, Kuban-Jankowska A
International Journal of Nanomedicine 2023, 18:2507-2523
A New de novo BRCA1 Mutation in a Young Breast Cancer Patient: A Case Report
Scherz A, Stoll S, Rothlisberger B, Rabaglio M
The Application of Clinical Genetics 2023, 16:83-87
A Novel Clinical Prognostic Model for Breast Cancer Patients with Malignant Pleural Effusion: Avoiding Chemotherapy in Low-Risk Groups?
Wang Y, Zhou T, Zhao S, Li N, Sun S, Li M
Cancer Management and Research 2023, 15:409-422
Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
Dubrava AL, Kyaw PSP, Newman J, Pringle J, Westhuyzen J, La Hera Fuentes G, Shakespeare TP, Sakalkale R, Aherne NJ
Breast Cancer: Targets and Therapy 2023, 15:359-371
Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review
Alghamdi MAA, Esam Mahmood S
Breast Cancer: Targets and Therapy 2023, 15:349-358
ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy
Wang J, Chen W, Du W, Zhang H, Ilmer M, Song L, Hu Y, Ma X
International Journal of Nanomedicine 2023, 18:2389-2409
KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction]
Yang GH, Ren ZX, Yang X, Zhang YG
OncoTargets and Therapy 2023, 16:309-310
Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications
da Silva JL, Carvalho GDS, Zanetti de Albuquerque L, Rodrigues FR, Fernandes PV, Kischinhevsky D, de Melo AC
Breast Cancer: Targets and Therapy 2023, 15:337-347
Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data
Izci H, Macq G, Tambuyzer T, De Schutter H, Wildiers H, Duhoux FP, de Azambuja E, Taylor D, Staelens G, Orye G, Hlavata Z, Hellemans H, De Rop C, Neven P, Verdoodt F
Clinical Epidemiology 2023, 15:559-568
Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
Percik R, Oedegaard Smith C, Leibovici A, Shai A
Biologics: Targets and Therapy 2023, 17:61-67
The Use of Chatbots in Oncological Care: A Narrative Review
Wang A, Qian Z, Briggs L, Cole AP, Reis LO, Trinh QD
International Journal of General Medicine 2023, 16:1591-1602
Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses
Jin Y, Lan A, Dai Y, Jiang L, Liu S
Breast Cancer: Targets and Therapy 2023, 15:327-335
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O
Breast Cancer: Targets and Therapy 2023, 15:311-325
Prognostic and Immunological Roles of CES2 in Breast Cancer and Potential Application of CES2-Targeted Fluorescent Probe DDAB in Breast Surgery
Qu W, Yao Y, Liu Y, Jo H, Zhang Q, Zhao H
International Journal of General Medicine 2023, 16:1567-1580
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
Shen J, Yan H, Yang C, Lin H, Li F, Zhou J
Breast Cancer: Targets and Therapy 2023, 15:295-310
The Validity of a New Procedure-Based Definition of Cancer Status in Patients with Breast-, Lung- and Colorectal Cancer in the Danish National Patient Registry
Nielsen SK, Nouhravesh N, Jensen MH, Jensen RFG, Klein MF, Saghir Z, Nielsen D, Schou M, Lamberts M
Clinical Epidemiology 2023, 15:483-491
Thinkful of Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway [Letter]
Mariya SS, Rinendyaputri R, Nikmah UA
Drug Design, Development and Therapy 2023, 17:1245-1246
Beneficial Effect of Toxoplasma gondii Infection on the Prognosis of Breast Cancer Was Modified by Cytokines
Ye HM, Lu MJ, Liu Q, Lin Y, Tang LY, Ren ZF
Clinical Epidemiology 2023, 15:469-481
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review
Wang J, Liao D, Zhang X, Miao C, Chen K
Breast Cancer: Targets and Therapy 2023, 15:281-294
Ultrasound-Targeted Microbubble Disruption with Key Nanodroplets for Effective Ferroptosis in Triple-Negative Breast Cancer Using Animal Model
Liu R, Shi D, Guo L, Xiao S, Shang M, Sun X, Meng D, Zhao Y, Wang X, Li J
International Journal of Nanomedicine 2023, 18:2037-2052
Advances in Prepectoral Breast Reconstruction
Xie J, Yan W, Zhu Z, Wang M, Shi J
Therapeutics and Clinical Risk Management 2023, 19:361-368
The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas
Rodriguez-Rojas LX, Candelo E, Pachajoa H, Garcia-Robledo JE, Nastasi-Catanese JA, Olave-Rodriguez JA, Zambrano AR
The Application of Clinical Genetics 2023, 16:53-62
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer
Engel-Nitz NM, Johnson MG, Johnson MP, Cha-Silva AS, Kurosky SK, Liu X
Patient Preference and Adherence 2023, 17:1049-1062
Breast Cancer Awareness Among Medical Students, University of Bisha, Saudi Arabia
Miskeen E, Al-Shahrani AM
Breast Cancer: Targets and Therapy 2023, 15:271-279
Psychosocial Problems of Rural Indian Women Practising Breast Self-Examination – a Community-Based Study from Southern India
Balaiah Mehanathan P, Arthur Edwards Dennison A, Vikramathithan Panchapooranam A, Kandasamy S, Subbiah P, Velappan L, Kalyanaraman S
Breast Cancer: Targets and Therapy 2023, 15:263-270
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study
Koo DH, Lee KS, Sim SH, Chae H, Lee EG, Han JH, Jung SY, Lee S, Kang HS, Lee ES, Park CY, Oh SW
Breast Cancer: Targets and Therapy 2023, 15:251-261
Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration
Yin L, Ding Y, Wang Y, Wang C, Sun K, Wang L
International Journal of General Medicine 2023, 16:1279-1294
131I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer
Zhao L, Gong J, Qi Q, Liu C, Su H, Xing Y, Zhao J
International Journal of Nanomedicine 2023, 18:1915-1925
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
Stella S, Martorana F, Massimino M, Vitale SR, Manzella L, Vigneri P
OncoTargets and Therapy 2023, 16:235-247
Cellulose Nanofiber-Coated Perfluoropentane Droplets: Fabrication and Biocompatibility Study
Loskutova K, Torras M, Zhao Y, Svagan AJ, Grishenkov D
International Journal of Nanomedicine 2023, 18:1835-1847
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
Badiginchala R, Dattatreya PS, Suresh AVS, Nirni SS, Andra VV, Bunger D, Chaturvedi A
OncoTargets and Therapy 2023, 16:215-225
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
Colombo GL, Valentino MC, Fabi A, Dieci MV, Caruggi M, Bruno GM, Lombardi G, Di Matteo S
Therapeutics and Clinical Risk Management 2023, 19:301-312
Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study
Sherwani M, Vohra L, Ali D, Soomro R, Adnan S, Idrees R
Breast Cancer: Targets and Therapy 2023, 15:237-250
Depths of Malignancy: On the Prognosis of Breast Cancer [Letter]
Zehra SS, Ali A, Zafar SA
International Journal of General Medicine 2023, 16:1111-1112
Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date
Varella L, Cristofanilli M
OncoTargets and Therapy 2023, 16:189-196
The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer
Karadag I, Karakaya S, Akkan T, Demir B, Alkurt EG, Dogan M
Cancer Management and Research 2023, 15:311-317
Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer
Zhao M, Fu L, Xu P, Wang T, Li P
Drug Design, Development and Therapy 2023, 17:901-917
ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy
Zhou J, Li K, Zang X, Xie Y, Song J, Chen X
International Journal of Nanomedicine 2023, 18:1381-1397
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
Satish S, Moore JF, Littlefield JM, Bishop IJ, Rojas KE
Breast Cancer: Targets and Therapy 2023, 15:227-235
Predictive Model of Functional Exercise Compliance of Patients with Breast Cancer Based on Decision Tree
Luo Z, Luo B, Wang P, Wu J, Chen C, Guo Z, Wang Y
International Journal of Women's Health 2023, 15:397-410
Effects of Mind-Regulation Acupuncture Therapy on Serum Ghrelin, Gastric Inhibitory Polypeptide, Leptin, and Insulin Levels in Breast Cancer Survivors with Cancer-Related Fatigue: A Randomized Controlled Trial
Li J, Xie J, Guo X, Fu R, Wang Y, Guan X
International Journal of General Medicine 2023, 16:1017-1027
Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway
Gao S, Zhang X, Liu J, Ji F, Zhang Z, Meng Q, Zhang Q, Han X, Wu H, Yin Y, Lv Y, Shi W
Drug Design, Development and Therapy 2023, 17:821-836
Bibliometric Analysis of Acupuncture Therapy for Cancer Pain Over the Past 10 Years
Ling F, Qi W, Li X, Zhou J, Xiong J, Zhao Y, Zheng Q, Liang F
Journal of Pain Research 2023, 16:985-1003
Single-Dose of Postoperative Ketamine for Postoperative Pain After Mastectomy: A Pilot Randomized Controlled Trial
Doan LV, Li A, Brake L, Ok D, Jee HJ, Park H, Cuevas R, Calvino S, Guth A, Schnabel F, Hiotis K, Axelrod D, Wang J
Journal of Pain Research 2023, 16:881-892
Lumbar Spine Infection with Eikenella corrodens Presented as Abdominal Pain: A Case Report and Literature Review
Cheng H, Tan N, Lu Y, Wu H, Liu Z, Zhang D, Xu Z, Li C
Infection and Drug Resistance 2023, 16:1407-1417
A Novel Nanoemulsion Formula for an Improved Delivery of a Thalidomide Analogue to Triple-Negative Breast Cancer; Synthesis, Formulation, Characterization and Molecular Studies
Tawfik NM, Teiama MS, Iskandar SS, Osman A, Hammad SF
International Journal of Nanomedicine 2023, 18:1219-1243
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis
Huo Q, Ning L, Xie N
Breast Cancer: Targets and Therapy 2023, 15:213-226
Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
Castellanos G, Valbuena DS, Pérez E, Villegas VE, Rondón-Lagos M
Breast Cancer: Targets and Therapy 2023, 15:189-211
Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis
Cao Q, Ai XQ, Mushajiang M
Breast Cancer: Targets and Therapy 2023, 15:175-188
Ethnobotanical Survey of Medicinal Plants Used in Breast Cancer Treatment by Traditional Health Practitioners in Central Uganda
Lutoti S, Kaggwa B, Kamba PF, Mukonzo J, Sesaazi CD, Katuura E
Journal of Multidisciplinary Healthcare 2023, 16:635-651
Streamlining the Multi-Disciplinary Team Meeting: The Introduction of Robust Pre-Preparation Methods and Its Effect on the Length of Case Discussions
Merker L, Conroy S, El-Wakeel H, Laurence N
Journal of Multidisciplinary Healthcare 2023, 16:613-622
Active Hydrophilic Graphene Oxide Nanocomposites Delivery Mediated by Adipose-Derived Stem Cell for Elevated Photothermal Therapy of Breast Cancer
Peng Z, Chang Q, Xing M, Lu F
International Journal of Nanomedicine 2023, 18:971-986
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
Emiroglu S, Özkurt E, Cabıoglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M, Tukenmez M
Breast Cancer: Targets and Therapy 2023, 15:163-173
A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX
Zhu J, Li G, Zhang Z, Wang Y
ImmunoTargets and Therapy 2023, 12:17-23
A Multifunctional, Highly Biocompatible, and Double-Triggering Caramelized Nanotheranostic System Loaded with Fe3O4 and DOX for Combined Chemo-Photothermal Therapy and Real-Time Magnetic Resonance Imaging Monitoring of Triple Negative Breast Cancer
Wang F, Li N, Wang W, Ma L, Sun Y, Wang H, Zhan J, Yu D
International Journal of Nanomedicine 2023, 18:881-897
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks
Mandó P, Waisberg F, Pasquinelli R, Rivero S, Ostinelli A, Perazzo F
OncoTargets and Therapy 2023, 16:115-132
Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy
Lu W, Liu W, Hu A, Shen J, Yi H, Cheng Z
International Journal of Nanomedicine 2023, 18:861-879
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?
Jongbloed EM, Blommestein HM, van Schoubroeck HM, Martens JW, Wilting SM, Uyl-de Groot CA, Jager A
Breast Cancer: Targets and Therapy 2023, 15:147-161
Misconceptions About Female Cancers Contributing to Late Presentation to Health Facilities in Ethiopia: A Qualitative Study
Solomon K, Tamire M, Solomon N, Bililign N, Kaba M
International Journal of Women's Health 2023, 15:299-309
The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis
Liao Y, Liao Y, Li J, Li Y, Fan Y
Breast Cancer: Targets and Therapy 2023, 15:135-146
Shared-Decision-Making Experiences in Breast Cancer Care with and without Patient Participation in Multidisciplinary Tumor Conferences: A Mixed-Methods-Study
Heuser C, Schellenberger B, Ernstmann N, Diekmann A, Krüger E, Schreiber L, Scholl I, Ansmann L
Journal of Multidisciplinary Healthcare 2023, 16:397-409
Smart Chondroitin Sulfate Micelles for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Metastasis
Yu J, Xie X, Wang L, Liu W, Xu H, Lu X, Li X, Ren J, Li W
International Journal of Nanomedicine 2023, 18:663-677
Dual Sensitization Anti-Resistant Nanoparticles for Treating Refractory Breast Cancers via Apoptosis-Inducing
Ju R, Wu F, Tian Y, Chu J, Peng X, Wang X
Drug Design, Development and Therapy 2023, 17:403-418
Computational Study of Bis-(1-(Benzoyl)-3-Methyl Thiourea) Platinum (II) Complex Derivatives as Anticancer Candidates
Ruswanto R, Mardianingrum R, Nofianti T, Fizriani R, Siswandono S
Advances and Applications in Bioinformatics and Chemistry 2023, 16:15-36
Prognostic Significance of Preoperative Lactate Dehydrogenase to Albumin Ratio in Breast Cancer: A Retrospective Study
He J, Tong L, Wu P, Wu Y, Shi W, Chen L
International Journal of General Medicine 2023, 16:507-514
The Practice and Willingness of Women Towards Opportunistic Screening for Breast and Cervical Cancers in Sichuan Province, China: A Cross-Sectional Study
Li H, Huang M, Yang Y, Tang J, Ye Y
Risk Management and Healthcare Policy 2023, 16:169-183
Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage
Shi YY, Chen XL, Chen QX, Yang YZ, Zhou M, Ren YX, Tang LY, Ren ZF
Journal of Inflammation Research 2023, 16:493-503
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Response to Letter]
AlSumai TS, Alhefdhi A
Breast Cancer: Targets and Therapy 2023, 15:133-134
Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer
Li N, Song C, Huang X, Zhang H, Su J, Yang L, He J, Cui G
Breast Cancer: Targets and Therapy 2023, 15:121-132
An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
Zhang M, Bao S, Qiu G, Liang J, Wang Q, Zhu X, Qin G, Liu J, Zhao C
Breast Cancer: Targets and Therapy 2023, 15:101-119
Assessment of Knowledge and Awareness About Breast Self-Examination Among University Female Students in Saudi Arabia
Albeshan S, Shubayr N, Alashban Y
Breast Cancer: Targets and Therapy 2023, 15:91-99
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications
Prodhan ASU, Islam DZ, Khandker SS, Jamiruddin MR, Abdullah A, Godman B, Opanga S, Kumar S, Sharma P, Adnan N, Pisana A, Haque M
Breast Cancer: Targets and Therapy 2023, 15:51-89
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus
Zhang F, de Bock GH, Denig P, Landman GW, Zhang Q, Sidorenkov G
Clinical Epidemiology 2023, 15:109-121
Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review
Badran O, Abu Amna M, Turgeman I, Bar-Sela G
Breast Cancer: Targets and Therapy 2023, 15:47-50
Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques
Zhang Q, Zeng Y, Peng Y, Yu H, Zhang S, Wu S
Breast Cancer: Targets and Therapy 2023, 15:25-38
10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling
Liang Y, Wu G, Luo T, Xie H, Zuo Q, Huang P, Li H, Chen L, Lu H, Chen Q
Drug Design, Development and Therapy 2023, 17:129-142
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening
Chlebowicz J, Akella R, Humphreys JM, He H, Kannangara AR, Wei S, Posner B, Goldsmith EJ
Drug Design, Development and Therapy 2023, 17:93-105
Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review
Wu J, Jin Y, Liu M, Zhu N, Jing Z, Zeng X
Breast Cancer: Targets and Therapy 2023, 15:39-45
The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer
Cai W, Lv W, Meng L, Duan Y, Zhang L
International Journal of Nanomedicine 2023, 18:339-351
Multifunctional Nanoparticles Codelivering Doxorubicin and Amorphous Calcium Carbonate Preloaded with Indocyanine Green for Enhanced Chemo-Photothermal Cancer Therapy
Yu J, Wang L, Xie X, Zhu W, Lei Z, Lv L, Yu H, Xu J, Ren J
International Journal of Nanomedicine 2023, 18:323-337
A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review
Li D, Liu X, Cui S, Yang D, Zhu Y, Pan E, Yang P, Dai Z
OncoTargets and Therapy 2023, 16:17-22
Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
Ma J, Dong C, Cao YZ, Ma BL
Breast Cancer: Targets and Therapy 2023, 15:11-24
Improvements in Survival and Early Retirement Rates – Real-World Evidence on Danish Breast Cancer Patients 2004–2018
Khan H, Rudolfsen JH, Olsen J, Borgquist S, Poulsen PB
Cancer Management and Research 2023, 15:43-53
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer
Abdel-Razeq H, Abujamous L, Al-Azzam K, Abu-Fares H, Bani Hani H, Alkyam M, Sharaf B, Elemian S, Tamimi F, Abuhijla F, Edaily S, Salama O, Abdulelah H, Daoud R, Abubaker M, Al-Atary A
Breast Cancer: Targets and Therapy 2023, 15:1-10
CD169+ Macrophages Residing in the Draining Lymph Nodes and Infiltrating the Tumor Play Opposite Roles in the Pathogenesis of Bladder Cancer
Nagata M, Ishizaka K, Asano T
Research and Reports in Urology 2023, 15:1-7
Quantum Dot-Based Immunofluorescent Imaging of Ki67 and Identification of Prognostic Value in HER2-Positive (Non-Luminal) Breast Cancer [Erratum]
Sun J, Chen C, Jiang G, Tian W, Li Y, Sun S
International Journal of Nanomedicine 2023, 18:207-208
Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation
Tian H, Zhao T, Li Y, Sun N, Ma D, Shi Q, Zhang G, Chen Q, Zhang K, Chen C, Zhang Y, Qi X
Breast Cancer: Targets and Therapy 2022, 14:515-535
A Dosimetric Study Comparing Different Radiotherapy Planning Techniques With and Without Deep Inspiratory Breath Hold for Breast Cancer
S Nair S, Devi VNM, Sharan K, Nagesh J, Nallapati B, Kotian S
Cancer Management and Research 2022, 14:3581-3587
Whole Genome Sequencing of Single-Circulating Tumor Cell Ameliorates Unraveling Breast Cancer Heterogeneity
Li Y, Jiang X, Zhong M, Yu B, Yuan H
Breast Cancer: Targets and Therapy 2022, 14:505-513
Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis
Liu J, Sun X, Du Q, Yao J, Dai M, Cheng Q, Xu H, Li Y, Liu X, Zhang M, Zhou Y, Yang Y
Breast Cancer: Targets and Therapy 2022, 14:491-504
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Letter]
Zhang JY, Xu BH
Breast Cancer: Targets and Therapy 2022, 14:489-490
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
Zheng YZ, Li JY, Ning LW, Xie N
Breast Cancer: Targets and Therapy 2022, 14:475-487
Multifunctional Graphene Oxide Nanodelivery Platform for Breast Cancer Treatment
Mo Y, Liu W, Liu P, Liu Q, Yuan Z, Wang Q, Yuan D, Chen XJ, Chen T
International Journal of Nanomedicine 2022, 17:6413-6425
Advice from One Patient to Another: Qualitative Analysis of Patients’ Perspectives About Chemotherapy Initiation
Malinowski C, Paredes E, Housten AJ, Chavez-MacGregor M
Patient Preference and Adherence 2022, 16:3283-3289
Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer
Li M, Yan T, Wang M, Cai Y, Wei Y
Breast Cancer: Targets and Therapy 2022, 14:465-474
Dual-Channel Detection of Breast Cancer Biomarkers CA15-3 and CEA in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor
Li H, Wang S, Li X, Cheng C, Shen X, Wang T
International Journal of Nanomedicine 2022, 17:6289-6299
In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment
Ahmadi S, Seraj M, Chiani M, Hosseini S, Bazzazan S, Akbarzadeh I, Saffar S, Mostafavi E
International Journal of Nanomedicine 2022, 17:6233-6255
Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer
Yu Y, Wang J, Liao D, Zhang D, Li X, Jia Y, Kong F
Breast Cancer: Targets and Therapy 2022, 14:417-432
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment
Wu AH, Vigen C, Tseng C, Garcia AA, Spicer D
Breast Cancer: Targets and Therapy 2022, 14:433-451
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States
Lang Y, Wu B, Liu X
Breast Cancer: Targets and Therapy 2022, 14:453-463
Biosynthesis and Characterization of Gold and Copper Nanoparticles from Salvadora persica Fruit Extracts and Their Biological Properties
ELhabal SF, Elwy HM, Hassanin S, El-Rashedy AA, Hamza AA, Khasawneh MA
International Journal of Nanomedicine 2022, 17:6095-6112
Circular RNA PVT1 Promotes the Invasion and Epithelial–Mesenchymal Transition of Breast Cancer Cells through Serving as a Competing Endogenous RNA for miR-204-5p [Retraction]
Bian Q
OncoTargets and Therapy 2022, 15:1505-1506
Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer
Li Y, Ma X, Zhao Z, Li L, Gao C, Liu D, Li B, Zhao B
Breast Cancer: Targets and Therapy 2022, 14:405-415
Identification of CISD1 as a Prognostic Biomarker for Breast Cancer
Liu X, Cui Q
International Journal of General Medicine 2022, 15:8451-8465
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer
Wang R, Li Y, Zhao Y, Shi F, Zhou Q, Wu J, Lyu S, Song Q
Breast Cancer: Targets and Therapy 2022, 14:391-403
Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer
Shen J, Wang M, Li F, Yan H, Wang R, Zhou J
Breast Cancer: Targets and Therapy 2022, 14:375-389
Combined Self-Assembled iRGD Polymersomes for Effective Targeted siRNA Anti-Tumor Therapy
Li D, Li J, Wang S, Teng W, Wang Q
International Journal of Nanomedicine 2022, 17:5679-5696
ICAM1-Targeting Theranostic Nanoparticles for Magnetic Resonance Imaging and Therapy of Triple-Negative Breast Cancer
Chen J, Lv M, Su X, Wang S, Wang Y, Fan Z, Zhang L, Tang G
International Journal of Nanomedicine 2022, 17:5605-5619
Multi-Layered PLGA-PEI Nanoparticles Functionalized with TKD Peptide for Targeted Delivery of Pep5 to Breast Tumor Cells and Spheroids
Mohan AK, M M, Kumar TRS, Kumar GSV
International Journal of Nanomedicine 2022, 17:5581-5600
Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer
Huang C, Li C, Cai J, Chen J, Wang B, Li M, Zhou W, Wang J, Zhang P, Zhang JV
International Journal of Nanomedicine 2022, 17:5547-5563
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer
Cheng WJ, Lin SY, Chuang KH, Chen M, Ho HO, Chen LC, Hsieh CM, Sheu MT
International Journal of Nanomedicine 2022, 17:5353-5374
Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment
Kong C, Xu B, Qiu G, Wei M, Zhang M, Bao S, Tang J, Li L, Liu J
International Journal of Nanomedicine 2022, 17:5391-5411
Dose Adjustment of Poly (ADP‑Ribose) Polymerase Inhibitors in Patients with Hepatic or Renal Impairment
Zhao D, Long X, Wang J
Drug Design, Development and Therapy 2022, 16:3947-3955
Novel Curcumin Derivative-Decorated Ultralong-Circulating Paclitaxel Nanoparticles: A Novel Delivery System with Superior Anticancer Efficacy and Safety
Wei Y, Zeng M, Pi C, Shen H, Yuan J, Zuo Y, Wen J, Guo P, Zhao W, Li K, Su Z, Song X, Fu S, Lee RJ, Zhao L
International Journal of Nanomedicine 2022, 17:5265-5286
Predicting Response to Radiotherapy in Breast Cancer-Induced Bone Pain: Relationship Between Pain and Serum Cytokine Expression Levels After Radiotherapy
Lou Y, Cao H, Wang R, Chen Y, Zhang H
Journal of Pain Research 2022, 15:3555-3562
Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
Liu S, Li J, Gu L, Wu K, Xing H
International Journal of Nanomedicine 2022, 17:5209-5227
Comparative Assessment of the Apoptotic Potential of Silver Nanoparticles Synthesized by Bacillus Tequilensis and Calocybe Indica in MDA-MB-231 Human Breast Cancer Cells: Targeting p53 for Anticancer Therapy [Corrigendum]
Gurunathan S, Park JH, Han JW, Kim J
International Journal of Nanomedicine 2022, 17:5207-5208
Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens [Retraction]
Xu F, Wang D, Cui J, Li J, Jiang H
Cancer Management and Research 2022, 14:3119-3120
Effectiveness of Mammography Screening on Breast Cancer Mortality – A Study Protocol for Emulation of Target Trials Using German Health Claims Data
Braitmaier M, Kollhorst B, Heinig M, Langner I, Czwikla J, Heinze F, Buschmann L, Minnerup H, García-Albéniz X, Hense HW, Karch A, Zeeb H, Haug U, Didelez V
Clinical Epidemiology 2022, 14:1293-1303
Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group
Dal Maso L, Santoro A, Iannelli E, De Paoli P, Minoia C, Pinto M, Bertuzzi AF, Serraino D, De Angelis R, Trama A, Haupt R, Pravettoni G, Perrone M, De Lorenzo F, Tralongo P
Cancer Management and Research 2022, 14:3105-3118
Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction]
Dong Y, Chang C, Liu J, Qiang J
OncoTargets and Therapy 2022, 15:1317-1318
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer
Almasri H, Erjan A, Abudawaba H, Ashouri K, Mheid S, Alnsour A, Abdel-Razeq H
Breast Cancer: Targets and Therapy 2022, 14:363-373
Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge
Leung M, Rodrigues P, Roitman D
OncoTargets and Therapy 2022, 15:1309-1315
Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines [Corrigendum]
Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M
OncoTargets and Therapy 2022, 15:1289-1290
Mapping Current Organizational Structure and Improvement Points of Breast Cancer Multidisciplinary Team Meetings – An Interview Study
Kočo L, Siebers CCN, Schlooz M, Meeuwis C, Oldenburg HSA, Prokop M, Mann RM
Journal of Multidisciplinary Healthcare 2022, 15:2421-2430
Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial
Caputo R, Fabi A, Romagnoli E, Baldini E, Grasso D, Fenderico N, Michelotti A
Breast Cancer: Targets and Therapy 2022, 14:351-362
Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials
Davey MG, Kerin MJ
Breast Cancer: Targets and Therapy 2022, 14:343-350
Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer
Wang S, Wei Y, Li Z, Xu J, Zhou Y
Breast Cancer: Targets and Therapy 2022, 14:335-342
A Review of Herbal Medicine-Based Phytochemical of Garcinia as Molecular Therapy for Breast Cancer
Triyasa KS, Diantini A, Barliana MI
Drug Design, Development and Therapy 2022, 16:3573-3588
Differences and Similarities in Spontaneous Activity Between Animal Models of Cancer-Induced Pain and Neuropathic Pain
Zhu YF, Kan P, Singh G
Journal of Pain Research 2022, 15:3179-3187
Effects of Esketamine Combined with Ultrasound-Guided Pectoral Nerve Block Type II on the Quality of Early Postoperative Recovery in Patients Undergoing a Modified Radical Mastectomy for Breast Cancer: A Randomized Controlled Trial
Yu L, Zhou Q, Li W, Zhang Q, Cui X, Chang Y, Wang Q
Journal of Pain Research 2022, 15:3157-3169
Effect of Alcohol Intake on Inflammatory Status and Prognosis in Cancer Patients
Liu X, Zhang W, Ji W, Zheng K, Zhao Y, He Y, Cui J, Li W
Journal of Inflammation Research 2022, 15:5815-5826
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer
Alsumai TS, Alhazzaa N, Alshamrani A, Assiri S, Alhefdhi A
Breast Cancer: Targets and Therapy 2022, 14:323-334
The Involvement of Insulin-Like Growth Factor 2 Messenger Ribonucleic Acid-Binding Protein 2 in the Regulation of the Expression of Breast Cancer-Related Genes
Gao C, Li L, Jin X, Song X, Li H, Xu X, Dong C, Ma B
Breast Cancer: Targets and Therapy 2022, 14:311-322
Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation
Merola D, Young J, Schrag D, Lin KJ, Robert N, Schneeweiss S
Clinical Epidemiology 2022, 14:1135-1144
Development of the Breast Cancer Survivors Symptom Checklist for Use in Follow-Up Multidisciplinary Appointments
Schou-Bredal I, Sørensen EM, Kraglund KH, Jensen VS, Drageset S
Patient Related Outcome Measures 2022, 13:199-208
Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects
Abdel-Razeq H, Abu Rous F, Abuhijla F, Abdel-Razeq N, Edaily S
Clinical Interventions in Aging 2022, 17:1445-1460
Efficacy and Safety of Pyrotinib in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Multicenter, Retrospective, Real-World Study
Zhang X, Li Z, Han L, Lv Z, Teng Y, Cui X, Zhou C, Wu H, Fang W, Xu L, Zhao S, Song C, Zheng Y, Gao T, Li M
OncoTargets and Therapy 2022, 15:1067-1078
Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancer
Kosaka Y, Saeki T, Takano T, Aruga T, Yamashita T, Masuda N, Koibuchi Y, Osaki A, Watanabe J, Suzuki R
International Journal of Nanomedicine 2022, 17:4567-4578
The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer
Jiang N, Hu Y, Wang M, Zhao Z, Li M
Breast Cancer: Targets and Therapy 2022, 14:291-309
The DPY30-H3K4me3 Axis-Mediated PD-L1 Expression in Melanoma
Zhang Z, Han Y, Sun Q, Wang Y, Sun L
Journal of Inflammation Research 2022, 15:5595-5609
Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized Controlled Study)
El Sherif FA, Youssef HA, Fares KM, Mohamed SAB, Ali AR, Thabet AM
Local and Regional Anesthesia 2022, 15:87-96
Self-Management About Adjuvant Therapy in Breast Cancer Survivors: A Qualitative Study
Jia L, Hu Y
Patient Preference and Adherence 2022, 16:2663-2681
The Development of Schematics to Illustrate Women’s Experiences with Adjuvant Hormone Therapy in the Treatment of Breast Cancer
AlOmeir O, Patel N, Donyai P
Patient Preference and Adherence 2022, 16:2639-2647
Knockdown of circRAD18 Mitigates Breast Cancer Progression through the Regulation of miR-613/HK2 Axis [Retraction]
Zang H, Li Y, Zhang X, Huang G
Cancer Management and Research 2022, 14:2859-2860
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity
Domvri K, Petanidis S, Zarogoulidis P, Anestakis D, Charalampidis C, Tsavlis D, Huang H, Freitag L, Hohenforst-Schmidt W, Matthaios D, Katopodi T, Porpodis K
International Journal of Nanomedicine 2022, 17:4449-4468
Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer
Gu F, Hu C, Cao W, Li C, Xia Q, Gao Y, Liu Y, Gao S
International Journal of Nanomedicine 2022, 17:4401-4417
Exploration of Aging-Care Parameters to Predict Mortality of Patients Aged 80-Years and Above with Community-Acquired Pneumonia
Lv C, Shi W, Pan T, Li H, Peng W, Xu J, Deng J
Clinical Interventions in Aging 2022, 17:1379-1391
Is Routine Intraoperative Frozen Section Analysis of Sentinel Lymph Nodes Necessary in Every Early-Stage Breast Cancer?
Lerttiendamrong B, Treeratanapun N, Vacharathit V, Tantiphlachiva K, Vongwattanakit P, Manasnayakorn S, Vongsaisuwon M
Breast Cancer: Targets and Therapy 2022, 14:281-290
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test in Node-Negative Early Breast Cancer
Berdunov V, Millen S, Paramore A, Griffin J, Reynia S, Fryer N, Brown R, Longworth L
ClinicoEconomics and Outcomes Research 2022, 14:619-633
Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
Wang J, Zuo S, Zhang Y, Li S, Shi Y, Du T, Han J, Jin N, Li Y, Li X
Cancer Management and Research 2022, 14:2749-2761
Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma
Li J, Li P, Su H, Feng H, Bai Z, Xi Y
International Journal of General Medicine 2022, 15:7265-7276
Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer [Corrigendum]
Wang N, Gu Y, Li L, Chi J, Liu X, Xiong Y, Zhong C
Journal of Inflammation Research 2022, 15:5157-5159
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series
Cosar R, Sut N, Ozen A, Tastekin E, Topaloglu S, Cicin I, Nurlu D, Ozler T, Demir S, Yıldız G, Şenödeyici E, Uzal MC
Breast Cancer: Targets and Therapy 2022, 14:259-280
Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells
Jing S, Lu Y, Zhang J, Ren Y, Mo Y, Liu D, Duan L, Yuan Z, Wang C, Wang Q
Drug Design, Development and Therapy 2022, 16:2981-2993
Assessment of Subclinical Deterioration of Right Ventricular Function by Three-Dimensional Speckle Tracking Echocardiography in Breast Cancer Patients Undergoing Anthracycline-Based Chemotherapy [Erratum]
Xu H, Mao L, Liu H, Zhang Y, Yang J
International Journal of General Medicine 2022, 15:7063-7064
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic
Schwab R, Droste A, Stewen K, Elger T, Theis S, Heimes AS, Peters K, Schmidt M, Brenner W, Hasenburg A
International Journal of General Medicine 2022, 15:7039-7052
Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
Downton T, Zhou F, Segara D, Jeselsohn R, Lim E
Drug Design, Development and Therapy 2022, 16:2933-2948
Natural Baicalein-Rich Fraction as Radiosensitizer in Combination with Bismuth Oxide Nanoparticles and Cisplatin for Clinical Radiotherapy
Sisin NNT, Mat NFC, Rashid RA, Dollah N, Razak KA, Geso M, Algethami M, Rahman WN
International Journal of Nanomedicine 2022, 17:3853-3874
Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer
Xia J, Wang Q, Ju F, Luo X, Wang F, Zhou Y, Huang H, Wang H, Bao X
Breast Cancer: Targets and Therapy 2022, 14:247-258
Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer
Zhu Q, Wang J, Shi Y, Zha X, Wang S
Cancer Management and Research 2022, 14:2545-2559
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal
Dhakal R, Noula M, Roupa Z, Yamasaki EN
Breast Cancer: Targets and Therapy 2022, 14:229-246
Prevalence and Factors Associated with BRCA1/2 Gene Mutation in Chinese Populations with Breast Cancer
Huang G, Lu H, Chen Q, Huang X
International Journal of General Medicine 2022, 15:6783-6789
Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer
Marie L, Braik D, Abdel-Razeq N, Abu-Fares H, Al-Thunaibat A, Abdel-Razeq H
Cancer Management and Research 2022, 14:2519-2531
Optimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights
Lucas MW, Kelly CM
Cancer Management and Research 2022, 14:2493-2506
Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration
Wu J, Luo D, Li S
Breast Cancer: Targets and Therapy 2022, 14:211-227
Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction]
Talaie F, Azizi E, Dinarvand R, Atyabi F
International Journal of Nanomedicine 2022, 17:3581-3582
A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes
Bari S, Boulware D, Li J, Loftus L, Soyano Muller A, Jameel Z, Khong H, Czerniecki BJ, Costa RLB
Breast Cancer: Targets and Therapy 2022, 14:199-210
Healthcare Inequities Experienced by Patients with Cancer: A Qualitative Study in Medellín, Colombia
Higuita-Gutiérrez LF, Estrada-Mesa DA, Cardona-Arias JA
Patient Preference and Adherence 2022, 16:1983-1997
Design, Synthesis, and Spectroscopic Studies of Some New α-Aminophosphonate Analogues Derived from 4-Hydroxybenzaldehyde with Special Reference to Anticancer Activity
Ali OM, Alotaibi MT, Zaki YH, Amer HH
Drug Design, Development and Therapy 2022, 16:2589-2599
Radiation Recall Pneumonitis COVID-19 Infection Induced After Adjuvant Breast Cancer Radiotherapy. A Known Phenomenon in an Unknown Pandemic Disease: A Case Report
Lazzari G, Giua R, Verdolino E, Solazzo AP, Benevento I, Montagna A, Castaldo G, Rago L, Silvano G
Cancer Management and Research 2022, 14:2299-2304
Oxymatrine Inhibits the Proliferation and Invasion of Breast Cancer Cells via the PI3K Pathway [Retraction]
Guo L, Yang T
Cancer Management and Research 2022, 14:2289-2290
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells
Hammash D, Mahfood M, Khoder G, Ahmed M, Tlili A, Hamoudi R, Harati R
Breast Cancer: Targets and Therapy 2022, 14:187-198
Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
Edaily S, Abdel-Razeq H
OncoTargets and Therapy 2022, 15:815-826
Caffeic Acid Phenethyl Ester as a DHODH Inhibitor and Its Synergistic Anticancer Properties in Combination with 5-Fluorouracil in a Breast Cancer Cell Line
Amalia E, Diantini A, Endang Prabandari E, Waluyo D, Subarnas A
Journal of Experimental Pharmacology 2022, 14:243-253
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold
Stowe HB, Andruska ND, Reynoso F, Thomas M, Bergom C
Breast Cancer: Targets and Therapy 2022, 14:175-186
The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Expression of Concern]
Xia C, Jiang H, Ye F, Zhuang Z
OncoTargets and Therapy 2022, 15:781-782
Coactosin-Like Protein in Breast Carcinoma: Friend or Foe?
Wang B, Zhao L, Chen D
Journal of Inflammation Research 2022, 15:4013-4025
Novel Purine Thioglycoside Analogs: Synthesis, Nanoformulation and Biological Evaluation in in vitro Human Liver and Breast Cancer Models [Retraction]
Abu-Zaied MA, Loutfy SA, Hassan AE, Elgemeie GH
Drug Design, Development and Therapy 2022, 16:2289-2290
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer
Dhabhar B
Breast Cancer: Targets and Therapy 2022, 14:163-173
Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study
Wang L, Zhang YL, Jiang C, Duan FF, Yuan ZY, Huang JJ, Bi XW
Journal of Inflammation Research 2022, 15:3957-3974
Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction]
Hong W, Shi H, Qiao M, Gao X, Yang J, Tian C, Zhang D, Niu S, Liu M
International Journal of Nanomedicine 2022, 17:3055-3056
US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy
Jiang F, Wang L, Tang Y, Wang Y, Li N, Wang D, Zhang Z, Lin L, Du Y, Ou X, Zou J
International Journal of Nanomedicine 2022, 17:2943-2960
Treatment for Triple-Negative Breast Cancer: An Umbrella Review of Meta-Analyses
Yin J, Zhu C, Wang G, Gu J
International Journal of General Medicine 2022, 15:5901-5914
Green Synthesis of Silver Nanoparticles Using Extract of Jasminum officinal L. Leaves and Evaluation of Cytotoxic Activity Towards Bladder (5637) and Breast Cancer (MCF-7) Cell Lines [Retraction]
Elhawary S, EL-Hefnawy H, Alzahraa FA, Sobeh M, Mostafa E, Osman S, El-Raey M
International Journal of Nanomedicine 2022, 17:2805-2806
A Real-World Disproportionality Analysis of Olaparib: Data Mining of the Public Version of FDA Adverse Event Reporting System
Shu Y, He X, Liu Y, Wu P, Zhang Q
Clinical Epidemiology 2022, 14:789-802
Human Growth Hormone Fragment 176–191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells
Habibullah MM, Mohan S, Syed NK, Makeen HA, Jamal QMS, Alothaid H, Bantun F, Alhazmi A, Hakamy A, Kaabi YA, Samlan G, Lohani M, Thangavel N, Al-Kasim MA
Drug Design, Development and Therapy 2022, 16:1963-1974
Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective
Nthontho KC, Ndlovu AK, Sharma K, Kasvosve I, Hertz DL, Paganotti GM
Pharmacogenomics and Personalized Medicine 2022, 15:613-652
CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer
Wang Z, Zhang S, Zheng C, Xia K, Sun L, Tang X, Zhou F, Ouyang Y, Tang F
International Journal of General Medicine 2022, 15:5701-5713
The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study
Belete AM, Aynalem YA, Gemeda BN, Demelew TM, Shiferaw WS
Breast Cancer: Targets and Therapy 2022, 14:153-161
Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer
Wang N, Gu Y, Li L, Chi J, Liu X, Xiong Y, Zhong C
Journal of Inflammation Research 2022, 15:3477-3499
Prognosticating 2-Year Survival Rate of Breast Cancer Patients Through Plasma miRNA-21 and Other Associating Factors
Romadhon PZ, Prayoga AA, Bintoro SUY, Diansyah MN, Amrita PNA, Savitri M, Suryantoro SD, Prahasanti K, Wijaya AY, Hendrata WM, Windradi C, Mahdi BA, Widiyastuti KN, Agustin ED
International Journal of General Medicine 2022, 15:5557-5566
Activation of Polymeric Nanoparticle Intracellular Targeting Overcomes Chemodrug Resistance in Human Primary Patient Breast Cancer Cells [Retraction]
Abou-El-Naga AM, Mutawa G, El-Sherbiny IM, Mousa SA
International Journal of Nanomedicine 2022, 17:2555-2556
Occult Invasive Lobular Carcinoma Presenting as an Axillary Skin Metastatic Lesion Underwent Neoadjuvant Endocrine Therapy and Surgical Resection: A Case Report and Review of Literature
Busbait S, Alkhalifa AM, Aljohani S, Alhaddad H
Breast Cancer: Targets and Therapy 2022, 14:145-152
Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis
Zuo R, Zhang Y, Chen X, Hu S, Song X, Gao X, Gong J, Ji H, Yang F, Peng L, Fang K, Lv Y, Zhang J, Jiang S, Guo D
International Journal of Nanomedicine 2022, 17:2475-2491
A Novel lncRNA Panel for Risk Stratification and Immune Landscape in Breast Cancer Patients
Li C, Wang X, Chen T, Li W, Yang Q
International Journal of General Medicine 2022, 15:5253-5272
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
Zhuang J, Chen S, Hu Y, Yang F, Huo Q, Xie N
International Journal of Nanomedicine 2022, 17:2319-2320
Long Noncoding RNAs in Lung Cancer: From Disease Markers to Treatment Roles
Chen L, Xie Y, Yu M, Gou Q
Cancer Management and Research 2022, 14:1771-1782
Non-Inferiority Study on the Precise Implementation of Multidisciplinary Continuous Nursing Intervention in Patients with Breast Cancer Experiencing Negative Emotions
Shen J, Wang M, Li F, Li Y, Zhou J, Sun W
Cancer Management and Research 2022, 14:1759-1770
Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients
Gion M, Cardinali G, Guzzinati S, Morandi P, Trevisiol C, Fabricio ASC, Rugge M, Zorzi M
Risk Management and Healthcare Policy 2022, 15:1087-1100
“PFH/AGM-CBA/HSV-TK/LIPOSOME-Affibody”: Novel Targeted Nano Ultrasound Contrast Agents for Ultrasound Imaging and Inhibited the Growth of ErbB2-Overexpressing Gastric Cancer Cells
Zhou H, Liu H, Zhang Y, Xin Y, Huang C, Li M, Zhao X, Ding P, Liu Z
Drug Design, Development and Therapy 2022, 16:1515-1530
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Al-Warhi T, El Kerdawy AM, Said MA, Albohy A, Elsayed ZM, Aljaeed N, Elkaeed EB, Eldehna WM, Abdel-Aziz HA, Abdelmoaz MA
Drug Design, Development and Therapy 2022, 16:1457-1471
Using Weighted Gene Co-Expression Network Analysis to Identify Increased MND1 Expression as a Predictor of Poor Breast Cancer Survival
Bao Z, Cheng J, Zhu J, Ji S, Gu K, Zhao Y, Yu S, Meng Y
International Journal of General Medicine 2022, 15:4959-4974
Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell
Kang Z, Yang M, Feng X, Liao H, Zhang Z, Du Y
International Journal of Nanomedicine 2022, 17:2165-2187
Comprehensive Analysis of the Expression and Prognosis for RAD51 Family in Human Breast Cancer
Shi Y, Shen M, Xu M, Tao M, Chen K, Zhu Q
International Journal of General Medicine 2022, 15:4925-4936
The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer
Yang SP, Zhou P, Lian CL, He ZY, Wu SG
Breast Cancer: Targets and Therapy 2022, 14:133-144
Feasibility and Relevance of an Intervention with Systematic Screening as a Base for Individualized Rehabilitation in Breast Cancer Patients: A Pilot Trial of the ReScreen Randomized Controlled Trial
Olsson IM, Malmström M, Rydén L, Olsson Möller U
Journal of Multidisciplinary Healthcare 2022, 15:1057-1068
Opioid-Free Segmental Thoracic Spinal Anesthesia with Intrathecal Sedation for Breast and Axillary Surgery: Report of Four Cases
Vincenzi P, Stronati M, Isidori P, Iuorio S, Gaudenzi D, Boccoli G, Starnari R
Local and Regional Anesthesia 2022, 15:23-29
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
Jeiziner C, Allemann SS, Hersberger KE, Meyer zu Schwabedissen HE
Pharmacogenomics and Personalized Medicine 2022, 15:465-475
Risk of Malignancy in Breast FNAB Categories, Classified According to the Newly Proposed International Academy of Cytology (IAC) Yokohama System
Niaz M, Khan AA, Ahmed S, Rafi R, Salim H, Khalid K, Kazi F, Anjum A, Waheed Y
Cancer Management and Research 2022, 14:1693-1701
Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer Therapy
Liang M, Guo M, Saw PE, Yao Y
International Journal of Nanomedicine 2022, 17:2069-2078
TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer
Liu X, Zhou T, Wang Y, Pei M, Wang G, Chu W, Wang Q, Du S, Wang H, Wang C
OncoTargets and Therapy 2022, 15:509-520
MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36 [Retraction]
Xia W, Liu Y, Du Y, Cheng T, Hu X, Li X
OncoTargets and Therapy 2022, 15:469-470
Breast Cancer in Italy: Stage and Region Distribution
Mangone L, Bisceglia I, Michiara M, Musolino A, Mazzoleni G, Caldarella A, Minerba S, Cascone G, Bella F, Dinaro Y, Pau L, Pinto C
Breast Cancer: Targets and Therapy 2022, 14:125-131
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab
Bagegni NA, Davis AA, Clifton KK, Ademuyiwa FO
Breast Cancer: Targets and Therapy 2022, 14:113-123
Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
Schlam I, Nunes R, Lynce F
OncoTargets and Therapy 2022, 15:471-478
Potential Use of Novel Image and Signal Processing Methods to Develop a Quantitative Assessment of the Severity of Acute Radiation Dermatitis in Breast Cancer Radiotherapy
Kondziołka J, Wilczyński S, Michalecki Ł
Clinical, Cosmetic and Investigational Dermatology 2022, 15:725-733
Treatment Outcomes and Its Associated Factors Among Adult Patients with Selected Solid Malignancies at Kenyatta National Hospital: A Hospital-Based Prospective Cohort Study
Degu A, Terefe EM, Some ES, Tegegne GT
Cancer Management and Research 2022, 14:1525-1540
HBV Infection Status Does Not Influence the Initial Metastatic Pattern and the Prognosis of Breast Cancer Patients with de novo and Relapsed Metastatic Disease
Zhang N, Tao D, Lei H, Shao Q, Liu Y, Long H, Zeng X
Journal of Inflammation Research 2022, 15:2509-2521
Value of Histogram of Gray-Scale Ultrasound Image in Differential Diagnosis of Small Triple Negative Breast Invasive Ductal Carcinoma and Fibroadenoma
Xu M, Li F, Yu S, Zeng S, Weng G, Teng P, Yang H, Li X, Liu G
Cancer Management and Research 2022, 14:1515-1524
Thyroidectomy Using the Lateral Cervical Small Incision Approach for Early Thyroid Cancer
Jin XX, Zhang QY, Gao C, Wei WX, Jiao C, Li L, Ma BL, Dong C
Clinical, Cosmetic and Investigational Dermatology 2022, 15:713-720
The Overexpression and Clinical Significance of AP1S1 in Breast Cancer
Zheng D, Fu W, Jin L, Jiang X, Jiang W, Guan Y, Hao R
Cancer Management and Research 2022, 14:1475-1492
Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer
Zhou R, Zhu X, Peng Y, Zhong L, Peng L, Yang B, Meng Y, Chen X, Lu Y
International Journal of General Medicine 2022, 15:4037-4052
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection
Parati MC, Pedersini R, Perego G, Reduzzi R, Savio T, Cabiddu M, Borgonovo K, Ghilardi M, Luciani A, Petrelli F
Breast Cancer: Targets and Therapy 2022, 14:101-111
Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer
Kok VC, Wang CCN, Liao SH, Chen DL
Breast Cancer: Targets and Therapy 2022, 14:85-99
Hereditary Gynecologic Cancer Syndromes – A Narrative Review
Kostov S, Watrowski R, Kornovski Y, Dzhenkov D, Slavchev S, Ivanova Y, Yordanov A
OncoTargets and Therapy 2022, 15:381-405
Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy
Fahira AI, Amalia R, Barliana MI, Gatera VA, Abdulah R
Breast Cancer: Targets and Therapy 2022, 14:71-83
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily
Stella S, Vitale SR, Martorana F, Massimino M, Pavone G, Lanzafame K, Bianca S, Barone C, Gorgone C, Fichera M, Manzella L
Cancer Management and Research 2022, 14:1341-1352
Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy
Fan Y, Khan NH, Farhan Ali Khan M, Ahammad MF, Zulfiqar T, Virk R, Jiang E
Cancer Management and Research 2022, 14:1323-1329
High-Intensity Focused Ultrasound Enhanced Anti-Tumor Activities of Paclitaxel in Breast Cancer in vitro and in vivo
Chen S, Bian H, Duan J
Cancer Management and Research 2022, 14:1303-1312
Epithelial–Mesenchymal Transition-Based Gene Signature and Distinct Molecular Subtypes for Predicting Clinical Outcomes in Breast Cancer
Hou L, Hou S, Yin L, Zhao S, Li X
International Journal of General Medicine 2022, 15:3497-3515
Long Intergenic Non-Coding RNA 01121 Promotes Breast Cancer Cell Proliferation, Migration, and Invasion via the miR-150-5p/HMGA2 Axis [Corrigendum]
Wang Z, Wang P, Cao L, Li F, Duan S, Yuan G, Xiao L, Guo L, Yin H, Xie D, Zhu J, Chen X, Zhang M
Cancer Management and Research 2022, 14:1283-1284
Comprehensive Analysis of the Expression and Prognostic Significance of the CENP Family in Breast Cancer
Liu X, Liu Y
International Journal of General Medicine 2022, 15:3471-3482
Role of MicroRNA-223 and MicroRNA-182 as Novel Biomarkers in Early Detection of Colorectal Cancer
Mahmoud HA, El Amin HA, Ahmed ESM, Kenawy AG, El-Ebidi AM, ElNakeeb I, Kholef EFM, Elsewify WAE
International Journal of General Medicine 2022, 15:3281-3291
Breast Cancer-Related Lymphedema Risk-Management Behaviors Among Chinese Breast Cancer Survivors and Relationships with Socio-Demographic and Clinical Characteristics: A Longitudinal Study
Zhang Y, Li N, Chen J, Luo X, Li M, Yan J
Patient Preference and Adherence 2022, 16:797-808
pH-Responsive Hyaluronic Acid Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy
Zeng X, Wang H, Zhang Y, Xu X, Yuan X, Li J
International Journal of Nanomedicine 2022, 17:1437-1457
Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer
Yang RQ, Chen M, Zhang Q, Gao YY, Lou KL, Lin TT, Huang WH, Zeng YZ, Zhang YQ, Dang YY, Ren L, Zhang GJ
International Journal of Nanomedicine 2022, 17:1343-1360
Movement Through Chemotherapy Delay to Initiation Among Breast Cancer Patients: A Qualitative Analysis
Housten AJ, Malinowski C, Paredes E, Harris CL, McNeill LH, Chavez-MacGregor M
Patient Preference and Adherence 2022, 16:749-759
Safety in Japanese Advanced Breast Cancer Patients Who Received Abemaciclib in MONARCH 2 and MONARCH 3: Assessment of Treatment-Emergent Neutropenia, Diarrhea, and Increased Alanine Aminotransferase and Aspartate Aminotransferase Levels
Masuda N, Chen Y, Kawaguchi T, Dozono K, Toi M
Cancer Management and Research 2022, 14:1179-1194
Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting
Abdel-Razeq H, Sharaf B
Drug Design, Development and Therapy 2022, 16:727-735
Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis
Landry KK, Lyon JL, Victoria KE, Changizzadeh PN, Cole BF, Pulluri B, Sikov WM, Wood ME
Breast Cancer: Targets and Therapy 2022, 14:63-70
Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL
Li J, Luo H, Liu YY, Chen LX, Zhu MQ, Deng QT, Zhu DM, Wang ZM, Xu JF
Pharmacogenomics and Personalized Medicine 2022, 15:215-225
Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis
Verras GI, Tchabashvili L, Mulita F, Grypari IM, Sourouni S, Panagodimou E, Argentou MI
Breast Cancer: Targets and Therapy 2022, 14:41-61
Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia
Alshamsan B, Suleman K, Agha N, Abdelgawad MI, Alzahrani MJ, Elhassan T, Al-Tweigeri T, Ajarim D, Alsayed A
International Journal of Women's Health 2022, 14:373-384
Effects of Breast-Conserving Surgery Combined with Immediate Autologous Fat Grafting on Oncologic Safety, Satisfaction and Psychology in Patients with Breast Cancer: A Retrospective Cohort Study
Gong F, Zhou X, Niu Z, Mao Y, Wang Y, Lv M, Gao X, Liu W, Wang H
Cancer Management and Research 2022, 14:1113-1124
Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data
Abdel-Razeq H, Sharaf B, AlMasri R, Abdel-Razeq R, Tamimi F, Khader O, Salama O, Abunasser M, Edaily S, Abdulelah H
Cancer Management and Research 2022, 14:1033-1041
Controversial Opinion of “All pCRs are the Same” in St. Gallen International Consensus Guidelines 2021
Cong BB, Wang YS
Cancer Management and Research 2022, 14:1019-1021
Mitochondria-Targeted Mesoporous Titanium Dioxide Nanoplatform for Synergistic Nitric Oxide Gas-Sonodynamic Therapy of Breast Cancer
Zuo S, Zhang Y, Wang Z, Wang J
International Journal of Nanomedicine 2022, 17:989-1002
New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
Abdallah AE, Mabrouk RR, Elnagar MR, Farrag AM, Kalaba MH, Sharaf MH, El-Fakharany EM, Bakhotmah DA, Elkaeed EB, Al Ward MMS
Drug Design, Development and Therapy 2022, 16:587-607
Identification of DTL as Related Biomarker and Immune Infiltration Characteristics of Nasopharyngeal Carcinoma via Comprehensive Strategies
Wang H, Zhang J
International Journal of General Medicine 2022, 15:2329-2345
Development and Validation of a New Multiparametric Random Survival Forest Predictive Model for Breast Cancer Recurrence with a Potential Benefit to Individual Outcomes
Li H, Liu RB, Long CM, Teng Y, Cheng L, Liu Y
Cancer Management and Research 2022, 14:909-923
miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
Normann LS, Haugen MH, Aure MR, Kristensen VN, Mælandsmo GM, Sahlberg KK
Breast Cancer: Targets and Therapy 2022, 14:25-39
Artificial Intelligence-Based Breast Cancer Diagnosis Using Ultrasound Images and Grid-Based Deep Feature Generator
Liu H, Cui G, Luo Y, Guo Y, Zhao L, Wang Y, Subasi A, Dogan S, Tuncer T
International Journal of General Medicine 2022, 15:2271-2282
Eco-Friendly Synthesis of MnO2 Nanorods Using Gmelina arborea Fruit Extract and Its Anticancer Potency Against MCF-7 Breast Cancer Cell Line
Srinivasa C, Kumar SRS, Pradeep S, Prasad SK, Veerapur R, Ansari MA, Alomary MN, Alghamdi S, Almehmadi M, GC K, Daphedar AB, Kakkalameli SB, Shivamallu C, Kollur SP
International Journal of Nanomedicine 2022, 17:901-907
The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
Zhu M, Chen L, Kong X, Wang X, Li X, Fang Y, Wang J
Cancer Management and Research 2022, 14:775-820
Cost-Effectiveness Analysis from a Societal Perspective of Recurrence Index for Distant Recurrence (RecurIndex) in Women with Hormone Receptor-Positive and HER2-Negative Early-Stage Breast Cancer
Pennarun N, Chiu JY, Chang HC, Huang SL, Cheng SHC
Cancer Management and Research 2022, 14:761-773
Insights into the Prognostic Value of Small Nucleolar RNA U81 and SNORA7B in Breast Cancer
Zhou J, Zhu X, Long J
International Journal of General Medicine 2022, 15:2045-2056
Validation of the Prognostic Stage from the American Joint Committee on Cancer 8th Staging Manual in Luminal B-Like Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Ding J, Jiang L, Xu Z, Chen Y, Wu W, Huang J
Cancer Management and Research 2022, 14:719-728
Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review
Zewdie KA, Hailu HG, Ayza MA, Tesfaye BA
Clinical Pharmacology: Advances and Applications 2022, 14:11-17
Investigating the Impact of Optimized Trans-Cinnamic Acid-Loaded PLGA Nanoparticles on Epithelial to Mesenchymal Transition in Breast Cancer
Badawi NM, Attia YM, El-Kersh DM, Hammam OA, Khalifa MKA
International Journal of Nanomedicine 2022, 17:733-750
Clinical Characteristics and Survival Outcomes of Infiltrating Lobular Carcinoma: A Retrospective Study of 365 Cases in China
Han B, Gu Z, Liu Z, Ling H
Cancer Management and Research 2022, 14:647-658
Triple-Negative Breast Cancer with Dermatomyositis: A Case Report and Literature Review
Chen X, Chen A, Liu C, Zhang B
Cancer Management and Research 2022, 14:569-576
Strategy for Avoiding Protein Corona Inhibition of Targeted Drug Delivery by Linking Recombinant Affibody Scaffold to Magnetosomes
Ma S, Gu C, Xu J, He J, Li S, Zheng H, Pang B, Wen Y, Fang Q, Liu W, Tian J
International Journal of Nanomedicine 2022, 17:665-680
Male Breast Carcinoma Metastatic to the Choroid: A Case Report and Opinions of Management
Fu W, Zheng S, Zhou J, Lu K, Lu Y, Guo G
Cancer Management and Research 2022, 14:525-534
iRGD Tumor-Penetrating Peptide-Modified Nano-Delivery System Based on a Marine Sulfated Polysaccharide for Enhanced Anti-Tumor Efficiency Against Breast Cancer
Chen B, Liu X, Li Y, Shan T, Bai L, Li C, Wang Y
International Journal of Nanomedicine 2022, 17:617-633
Fluorophore Localization Determines the Results of Biodistribution of Core-Shell Nanocarriers
Hinz A, Szczęch M, Szczepanowicz K, Bzowska M
International Journal of Nanomedicine 2022, 17:577-588
Peripheral Neuropathic Pain Following Breast Cancer: Effectiveness and Tolerability of High-Concentration Capsaicin Patch
Dupoiron D, Jubier-Hamon S, Seegers V, Bienfait F, Pluchon YM, Lebrec N, Jaoul V, Delorme T
Journal of Pain Research 2022, 15:241-255
The Role of Progesterone Receptors in Breast Cancer
Li Z, Wei H, Li S, Wu P, Mao X
Drug Design, Development and Therapy 2022, 16:305-314
Horseradish Peroxidase-Functionalized Gold Nanoconjugates for Breast Cancer Treatment Based on Enzyme Prodrug Therapy
Vivo-Llorca G, Morellá-Aucejo Á, García-Fernández A, Díez P, Llopis-Lorente A, Orzáez M, Martínez-Máñez R
International Journal of Nanomedicine 2022, 17:409-422
Functionalized Au@Cu-Sb-S Nanoparticles for Spectral CT/Photoacoustic Imaging-Guided Synergetic Photo-Radiotherapy in Breast Cancer
Hu H, Zheng S, Hou M, Zhu K, Chen C, Wu Z, Qi L, Ren Y, Wu B, Xu Y, Yan C, Zhao B
International Journal of Nanomedicine 2022, 17:395-407
Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018)
Piechocki M, Koziołek W, Sroka D, Matrejek A, Miziołek P, Saiuk N, Sledzik M, Jaworska A, Bereza K, Pluta E, Banas T
Clinical Epidemiology 2022, 14:95-114
Clinicopathological Characteristics and Survival Outcomes of Mammary Paget’s Disease: A Retrospective Study Based on a Chinese Population
Han BY, Xu XL, Zhu XZ, Han XC, Hu X, Ling H
Cancer Management and Research 2022, 14:237-247
A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer
Hua X, Duan F, Zhai W, Song C, Jiang C, Wang L, Huang J, Lin H, Yuan Z
Journal of Inflammation Research 2022, 15:381-394
Pyroptosis-Mediated Molecular Subtypes are Characterized by Distinct Tumor Microenvironment Infiltration Characteristics in Breast Cancer
Xu L, Hu Y, Liu W
Journal of Inflammation Research 2022, 15:345-362
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer [Response To Letter]
Wako Z, Mengistu D, Dinegde NG
Patient Preference and Adherence 2022, 16:79-81
Identification of m6A-Associated Gene DST as a Prognostic and Immune-Associated Biomarker in Breast Cancer Patients
Qiu X, Li X, Yan Y, Cai Y, Liang Q, Peng B, Xu Z, Xiao M, Xia F, Peng J
International Journal of General Medicine 2022, 15:523-534
Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review
Maqbool M, Bekele F, Fekadu G
Breast Cancer: Targets and Therapy 2022, 14:15-24
Association Between SNPs in the One-Carbon Metabolism Pathway and the Risk of Female Breast Cancer in a Chinese Population
Wang X, Xiong M, Pan B, Cho WC, Zhou J, Wang S, He B
Antitumor Immunity from Abdominal Flap-Embedded Therapeutic Cancer Vaccine
Liu X, Mai J, Meng C, Spiegel AJ, Wei W, Shen H
International Journal of Nanomedicine 2022, 17:203-212
Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic – A STAT3 Dimerization Blocker
Fong SS, Foo YY, Saw WS, Leo BF, Teo YY, Chung I, Goh BT, Misran M, Imae T, Chang CC, Chung LY, Kiew LV
International Journal of Nanomedicine 2022, 17:137-150
Patient Reported Outcome Measures After Breast Augmentation – Using the BREAST-Q IS
Jayasinghe RT, Ruseckaite R, Gartoulla P, Elder E, Hopper I
Patient Related Outcome Measures 2022, 13:1-8
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective
Kadamkulam Syriac A, Nandu NS, Leone JP
Breast Cancer: Targets and Therapy 2022, 14:1-13
Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer
Berke TP, Slight SH, Hyder SM
OncoTargets and Therapy 2022, 15:23-30
Hypoxic Breast Cancer Cell-Derived Exosomal SNHG1 Promotes Breast Cancer Growth and Angiogenesis via Regulating miR-216b-5p/JAK2 Axis
Dai G, Yang Y, Liu S, Liu H
Cancer Management and Research 2022, 14:123-133
Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review
Sharaf B, AlMasri R, Abdel-Razeq N, Salama O, Hamad I, Abunasser M, Abdel-Razeq H
Clinical, Cosmetic and Investigational Dermatology 2022, 15:5-10
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]
Liu Y, Zhang N, Zhang H, Wang L, Duan Y, Wang X, Chen T, Liang Y, Li Y, Song X, Li C, Han D, Chen B, Zhao W, Yang Q
Development and Validation of Prognostic Nomogram for Elderly Breast Cancer: A Large-Cohort Retrospective Study
Li G, Zhang D
International Journal of General Medicine 2022, 15:87-101
The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
Fan Y, He S
Cancer Management and Research 2022, 14:1-17
Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
Cao J, Sun S, Min R, Li R, Fan X, Han Y, Feng Z, Li N
Cancer Management and Research 2021, 13:9477-9487
Effect of Heparinoid Moisturizer on Quality of Life in Patients with Acute Radiation Skin Damage Following Hypofractionated Radiation Therapy After Breast-Conserving Surgery: A Randomized Controlled Study
Kawamori J, Itazawa T, Fukushima S, Ito R, Yamauchi H, Sekiguchi K
Breast Cancer: Targets and Therapy 2021, 13:743-753
Partial Breast Reconstruction with Lateral Chest Wall Perforator Flap to Facilitate Breast Conservation in Breast Cancer: First 100 Cases with Cancer Outcomes at 8 Years Follow-Up and the Lessons Learned
Roy PG, Mustata L, Hu J, Phillips B, Parulekar V, Bhattacharyya M, Harris A, Oliveros S
Cancer Management and Research 2021, 13:9453-9466
Templated Three-Dimensional Engineered Bone Matrix as a Model for Breast Cancer Osteolytic Bone Metastasis Process
Sun M, Huang K, Luo X, Li H
International Journal of Nanomedicine 2021, 16:8391-8403
Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
Yang X, Zhao Y, Shao Q, Jiang G
International Journal of General Medicine 2021, 14:10447-10464
Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer
Alshamsan B, Alshibany A, Elshenawy MA, Badran A, Elhassan T, Ajarim D, Alsayed A, Suleman K, Al-Tweigeri T
Cancer Management and Research 2021, 13:9411-9420
Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy
Mi X, Hu M, Dong M, Yang Z, Zhan X, Chang X, Lu J, Chen X
International Journal of Nanomedicine 2021, 16:8337-8352
Health-Related Quality of Life in Women with Breast Cancer Undergoing Chemotherapy in Brazil
Marcelo Castro e Silva I, Lúcia Penteado Lancellotti C
International Journal of General Medicine 2021, 14:10265-10270
Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions
Li D, Fan H, Dong J, Sun C, Su Y, Liu J, Gu Y
Breast Cancer: Targets and Therapy 2021, 13:725-742
Low Expression of PLAT in Breast Cancer Infers Poor Prognosis and High Immune Infiltrating Level
Wang X, Xue D, Zhu X, Geng R, Bao X, Chen X, Xia T
International Journal of General Medicine 2021, 14:10213-10224
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer [Letter]
Bekele F
Patient Preference and Adherence 2021, 15:2845-2846
Clinical and Therapeutic Factors Vary by Prognosis in Patients with Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer
Huang Z, Jin S, Zeng M, Shu J, Liu Y, Zhang J, Xu B, Niu M, Sun S, Nanding A, Shan M, Li X, Zhang G
Cancer Management and Research 2021, 13:9235-9246
Efficacy and Safety of Local Radiotherapy to All Oligometastatic Sites in Elderly Patients with Metachronous Oligometastatic Cancers After Initial Treatment for the Primary Tumor
Hu X, Li H, Kang X, Wang X, Pang H, Liu C, Zhang J, Wang Y
Cancer Management and Research 2021, 13:9247-9259
Overall Survival in Patients with Mucinous Carcinoma of Breast: A Population-Based Study
Hu T, Huang J, Fang K
International Journal of General Medicine 2021, 14:9991-10001
Prognostic Model Construction and Immune Microenvironment Analysis of Breast Cancer Based on Ferroptosis-Related lncRNAs
Jia CL, Yang F, Li R
International Journal of General Medicine 2021, 14:9817-9831
Systematic Review of Breast-Q: A Tool to Evaluate Post-Mastectomy Breast Reconstruction
Seth I, Seth N, Bulloch G, Rozen WM, Hunter-Smith DJ
Breast Cancer: Targets and Therapy 2021, 13:711-724
Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors
Fiser C, Crystal JS, Tevis SE, Kesmodel S, Rojas KE
Breast Cancer: Targets and Therapy 2021, 13:701-709
Survival and Predictors of Mortality among Breast Cancer Patients in Northwest Ethiopia: A Retrospective Cohort Study
Tiruneh M, Tesfaw A, Tesfa D
Cancer Management and Research 2021, 13:9225-9234
Facilitating High Quality Cancer Care: A Qualitative Study of Australian Chairpersons’ Perspectives on Multidisciplinary Team Meetings
Fradgley EA, Booth K, Paul C, Zdenkowski N, Rankin NM
Journal of Multidisciplinary Healthcare 2021, 14:3429-3439
Screening of Breast Cancer Methylation Biomarkers Based on the TCGA Database
Wang X, Jia J, Gu X, Zhao W, Chen C, Wu W, Wang J, Xu M
International Journal of General Medicine 2021, 14:9833-9839
Ketogenic Diets and their Therapeutic Potential on Breast Cancer: A Systemic Review
Jemal M, Molla TS, Asmamaw Dejenie T
Cancer Management and Research 2021, 13:9147-9155
Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis
Elakkad YE, Mohamed SNS, Abuelezz NZ
Breast Cancer: Targets and Therapy 2021, 13:675-689
Expression and Clinical Significance of Origin Recognition Complex Subunit 6 in Breast Cancer – A Comprehensive Bioinformatics Analysis
Chen S, Jin Z, Xin L, Lv L, Zhang X, Gong Y, Liu J
International Journal of General Medicine 2021, 14:9733-9745
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
Kaur S, Najm MZ, Khan MA, Akhter N, Shingatgeri VM, Sikenis M, Sadaf, Aloliqi AA
Breast Cancer: Targets and Therapy 2021, 13:691-700
LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3
Wang Y, Xie T, Liu H, Yu X
Cancer Management and Research 2021, 13:9139-9145
Shared Decision-Making in Breast Reconstruction for Breast Cancer Patients: A Scoping Review
Li X, Meng M, Zhao J, Zhang X, Yang D, Fang J, Wang J, Han L, Hao Y
Patient Preference and Adherence 2021, 15:2763-2781
Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma
Tan H, Zuo L, Ma S, Wang D, Li R, Yang Y, Liu W, Chi Y
Cancer Management and Research 2021, 13:9075-9083
Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer
Yang YY, Zhang W, Liu H, Jiang JJ, Wang WJ, Jia ZY
Drug Design, Development and Therapy 2021, 15:4961-4972
Identification of a Lipid Metabolism-Associated Gene Signature Predicting Survival in Breast Cancer
Gong M, Liu X, Yang W, Song H, Zhao X, Ai X, Wang S, Wang H
International Journal of General Medicine 2021, 14:9503-9513
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
Klauser AL, Hirschfeld M, Ritter A, Rücker G, Jäger M, Gundarova J, Weiss D, Juhasz-Böss I, Berner K, Erbes T, Asberger J
Breast Cancer: Targets and Therapy 2021, 13:659-673
Primary Lung Cancer After Treatment for Breast Cancer
Long Q, Wang Y, Che G
International Journal of Women's Health 2021, 13:1217-1225
Fibrinogen/Albumin Ratio (FAR) in Patients with Triple Negative Breast Cancer and Its Relationship with Epidermal Growth Factor Receptor Expression
Gao W, Li M, Zhang Y
OncoTargets and Therapy 2021, 14:5403-5415
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
Castillo C, Camejo N, Rondan M, Savio F, Herrera G, Krygier G, Delgado L
Breast Cancer: Targets and Therapy 2021, 13:651-658
Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study
Rosenberg V, Bareket-Samish A, Chodick G, Siegelmann-Danieli N
International Journal of Women's Health 2021, 13:1207-1216
Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better
Martinez-Cannon BA, Barragan-Carrillo R, Villarreal-Garza C
Breast Cancer: Targets and Therapy 2021, 13:641-650
Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature
Yap KM, Sekar M, Fuloria S, Wu YS, Gan SH, Mat Rani NNI, Subramaniyan V, Kokare C, Lum PT, Begum MY, Mani S, Meenakshi DU, Sathasivam KV, Fuloria NK
International Journal of Nanomedicine 2021, 16:7891-7941
Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery
Hu X, Luo B, Wu Q, Chen Q, Lu P, Huang J, Liang X, Ling C, Li Y
Drug Design, Development and Therapy 2021, 15:4925-4938
Verification of Volume Similarity Between Unilateral Mammary Gland and Autologous Omentum in Adult Women by Measuring Cylinder Method
Shen G, Yu X, Sun T, Hou T, He H, Bai T, Zhang Z, Ding X, Li Q, Liang Y, Ma Y
International Journal of General Medicine 2021, 14:9211-9218
TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
Tang L, Jiang W, Wu L, Yu X, He Z, Shan W, Fu L, Zhang Z, Zhao Y
International Journal of Nanomedicine 2021, 16:7875-7890
Bioinformatic Analysis of Prognostic Value, Genetic Interaction, and Immune Infiltration of Chromobox Family Proteins in Breast Cancer
Mao G, Zheng Y, Lin S, Ma L, Zhou Z, Zhang S
International Journal of General Medicine 2021, 14:9181-9191
Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study
Zheng YZ, Qin HB, Li ZZ, Jiang HS, Zhang G, Yang SW, Wang XM, Xu YC, Deng ZH, Liu GW
Clinical Epidemiology 2021, 13:1095-1108
Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
Butani D, Gupta N, Jyani G, Bahuguna P, Kapoor R, Prinja S
Breast Cancer: Targets and Therapy 2021, 13:625-640
Garlic Extract Alleviates Trastuzumab-Induced Hepatotoxicity in Rats Through Its Antioxidant, Anti-Inflammatory, and Antihyperlipidemic Effects
Mousa AM, Soliman KEA, Alhumaydhi F, Almatroudi A, Al Rugaie O, Allemailem KS, Alrumaihi F, Khan A, Rezk MY, Aljasir M, Alwashmi ASS, Aba Alkhayl FF, Albutti AS, Seleem HS
Journal of Inflammation Research 2021, 14:6305-6316
Construction and Validation of New Nomograms to Predict Risk and Prognostic Factors of Breast Cancer Bone Metastasis in Asian Females: A Population-Based Retrospective Study
Deng J, Zhang D, Zhang W, Li J
International Journal of General Medicine 2021, 14:8881-8902
CD40LG as a Prognostic Molecular Marker Regulates Tumor Microenvironment Through Immune Process in Breast Cancer
Yuan M, Pei J, Li R, Tian L, He X, Li Y
International Journal of General Medicine 2021, 14:8833-8846
Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study
Lin X, Lin X, Li Y, Zhang Y, Lin J, Zhang G
International Journal of General Medicine 2021, 14:8775-8784
Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand
Koonmee S, Somintara O, Intarawichian P, Aphivatanasiri C, Sangkhamanon S, Laohawiriyakamol S, Panawattanakul R, Mahantassanapong P, Rattadilok C, Jeeravongpanich P, Krongyute W, Prachumrasee K, Alaghehbandan R
Cancer Management and Research 2021, 13:8737-8753
Evidence of the Involvement of Spinal EZH2 in the Development of Bone Cancer Pain in Rats
Chen H, Yu J, Hang L, Li S, Lu W, Xu Z
Journal of Pain Research 2021, 14:3593-3600
Impact of the Covid-19 Pandemic on Women’s Health in Brazil
Santos LD, Stevanato KP, Roszkowski I, Pedroso RB, Pelloso FC, Freitas KMS, Carvalho MDB, Pelloso SM
Journal of Multidisciplinary Healthcare 2021, 14:3205-3211
Transcriptome Sequencing Explores the Mechanism of Baicalin on Bone Cancer Pain
Wang A, Guo D, Cheng H, Jiang H, Liu X, Yun Z
Journal of Inflammation Research 2021, 14:5999-6010
Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay
Meijer SE, Klebanov-Akopyn O, Pavlov V, Laks S, Hazzan D, Nissan A, Zippel D
Breast Cancer: Targets and Therapy 2021, 13:617-624
Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study
Ayoub NM, Fares M, Marji R, Al Bashir SM, Yaghan RJ
Breast Cancer: Targets and Therapy 2021, 13:603-615
ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer
Wang X, Li Y, Fu J, Zhou K, Wang T
Pharmacogenomics and Personalized Medicine 2021, 14:1425-1440
Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles
Huang J, Lai W, Wang Q, Tang Q, Hu C, Zhou M, Wang F, Xie D, Zhang Q, Liu W, Zhang Z, Zhang R
International Journal of Nanomedicine 2021, 16:7497-7515
A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198
Zhang Z, Hu H, Li Q, Yi F, Liu Y
Cancer Management and Research 2021, 13:8435-8443
Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4
Zhang JT, Chen J, Ruan HC, Li FX, Pang S, Xu YJ, Huang DL, Wu XH
Cancer Management and Research 2021, 13:8425-8434
AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
Fu L, Jin Q, Dong Q, Li Q
OncoTargets and Therapy 2021, 14:5237-5248
An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer
Yuan J, Duan F, Zhai W, Song C, Wang L, Xia W, Hua X, Yuan Z, Bi X, Huang J
International Journal of Women's Health 2021, 13:1053-1064
Anti-γ-Aminobutyric Acid Type β Receptor Antibody-Associated Encephalitis After 2 Cycles of Durvalumab Therapy in a Patient with Small Cell Lung Cancer: A Case Report
Li J, Jiang J, Lv J, Zhang R, Chen W, Li S, Jin Q, Wang G
OncoTargets and Therapy 2021, 14:5227-5236
Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
Leng W, Pu D, Jiang J, Lei X, Wu Q, Chen B
Diabetes, Metabolic Syndrome and Obesity 2021, 14:4423-4432
The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
Zheng K, Liu X, Ji W, Lu J, Cui J, Li W
Journal of Inflammation Research 2021, 14:5769-5785
Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study
Stephenson JJ, Gable JC, Zincavage R, Price GL, Churchill C, Zhu E, Stenger K, Singhal M, Nepal B, Grabner M, Fisch MJ, Debono D, Geschwender AR, Cuyun Carter G
Patient Preference and Adherence 2021, 15:2417-2429
Prognostic Value and Clinical Significance of LIPH in Breast Cancer
Gao P, Liu Q, Ai B, Fang Y, Wang Z, Wang J
International Journal of General Medicine 2021, 14:7613-7623
Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
Liu Z, Liu F, Chen W, Tao Y, Liu X, Zhang F, Shen J, Guan H, Zhen H, Wang S, Chen Q, Chen Y, Hou X
Cancer Management and Research 2021, 13:8209-8217
Characterization of Treatments and Disease Course for Women with Breast Cancer Brain Metastases: 5-Year Retrospective Single Institution Experience
Chew S, Carroll HK, Darwish W, Boychak O, Higgins M, McCaffrey J, Kelly CM
Cancer Management and Research 2021, 13:8191-8198
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer
Fasching PA, Delea TE, Lu YS, De Boer R, Hurvitz SA, Moynahan A, Chandiwana D, Lanoue B, Hu H, Thuerigen A, O'Shaughnessy J
Cancer Management and Research 2021, 13:8179-8189
Changing Patterns in Clinicopathological Characteristics of Breast Cancer and Prevalence of BRCA Mutations: Analysis in a Rural Area of Southern China
Wang Q, Wu H, Lan Y, Zhang J, Wu J, Zhang Y, Li L, Liu D, Zhang J
International Journal of General Medicine 2021, 14:7371-7380
Analysis of the Effect of Trastuzumab Combined with Docetaxel on Serum Tumor Markers in the Treatment of HER-2 Positive Breast Cancer and Factors Influencing Therapeutic Efficacy
Feng QZ, Chen XZ, Sun J, Lu MM, Wang Y, Wang Q, Zhang C
Cancer Management and Research 2021, 13:8077-8084
How Does Patient Socioeconomic Position Affect Breast Cancer Surgical Treatment and Mortality?: A Rapid Review
Schubbe D, Yen RW, Durand MA
Breast Cancer: Targets and Therapy 2021, 13:595-601
Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity
De Silva S, Tennekoon KH, Karunanayake EH
OncoTargets and Therapy 2021, 14:5115-5129
PER1 as a Tumor Suppressor Attenuated in the Malignant Phenotypes of Breast Cancer Cells
Liu Y, Hao J, Yuan G, Wei M, Bu Y, Jin T, Ma L
International Journal of General Medicine 2021, 14:7077-7087
LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer
Ye T, Feng J, Cui M, Yang J, Wan X, Xie D, Liu J
International Journal of Women's Health 2021, 13:991-1004
LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p [Expression of Concern]
Yu H, Dong L, Wang H, Zhang Y, Wang Z, Wang C, Xia H, Bao H
Cancer Management and Research 2021, 13:7961-7962
Screening Practices, Knowledge and Adherence Among Health Care Professionals at a Tertiary Care Hospital
Shaheen NA, Alaskar A, Almuflih A, Muhanna N, Barrak Alzomia S, Hussein MA
International Journal of General Medicine 2021, 14:6975-6989
Hispanic Ethnicity and Cervical Cancer Precursors Among Low-Income Women in Arizona
Riggs SL, Thomson CA, Jacobs E, Cutshaw CA, Ehiri JE
International Journal of Women's Health 2021, 13:929-937
Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors
Yang X, Wang Y, Chen S, Zhang S, Cui C
International Journal of Nanomedicine 2021, 16:7051-7069
A Narrative Review of Ultrasound Technologies for the Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Wang J, Chu Y, Wang B, Jiang T
Cancer Management and Research 2021, 13:7885-7895
Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics
Lengfeld J, Zhang H, Stoesz S, Murali R, Pass F, Greene MI, Goel PN, Grover P
Breast Cancer: Targets and Therapy 2021, 13:575-593
Mercaptopurine-Loaded Sandwiched Tri-Layered Composed of Electrospun Polycaprolactone/Poly(Methyl Methacrylate) Nanofibrous Scaffolds as Anticancer Carrier with Antimicrobial and Antibiotic Features: Sandwich Configuration Nanofibers, Release Study and in vitro Bioevaluation Tests
Salim SA, Kamoun EA, Evans S, EL-Moslamy SH, El-Fakharany EM, Elmazar MM, Abdel-Aziz AF, Abou-Saleh RH, Salaheldin TA
International Journal of Nanomedicine 2021, 16:6937-6955
A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
Ding T, Liu C, Huang B, Chu L, Wei L, Lin Y, Luo Y, Zhang B, Hong C, Xu Y, Peng Y
Cancer Management and Research 2021, 13:7771-7782
A Practical Predictive Model Based on Ultrasound Imaging and Clinical Indices for Estimation of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Ye P, Duan H, Zhao Z, Fang S
Cancer Management and Research 2021, 13:7783-7793
Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer
Azar I, Alkassis S, Fukui J, Alsawah F, Fedak K, Al Hallak MN, Sukari A, Nagasaka M
Lung Cancer: Targets and Therapy 2021, 12:103-114
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
Al-saraireh YM, Alshammari FOFO, Youssef AM, Al-Tarawneh F, Al-Sarayreh S, Almuhaisen GH, Satari AO, Al-Shuneigat J, Alrawashdeh HM
Breast Cancer: Targets and Therapy 2021, 13:565-574
Novel Anti-Tubulin Compounds from Trigonella foenum-graecum Seeds; Insights into In-vitro and Molecular Docking Studies
Alghamdi SS, Suliman RS, Alsaeed AS, Almutairi KK, Aljammaz NA, Altolayyan A, Ali R, Alhallaj A
Drug Design, Development and Therapy 2021, 15:4195-4211
TCPP-Isoliensinine Nanoparticles for Mild-Temperature Photothermal Therapy
Zhang C, Wang X, Wang J, Qiu Y, Qi Z, Song D, Wang M
International Journal of Nanomedicine 2021, 16:6797-6806
MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction]
Han X, Guo X, Zhang W, Cong Q
OncoTargets and Therapy 2021, 14:4991-4992
Long Intergenic Non-Coding RNA LINC00922 Aggravates the Malignant Phenotype of Breast Cancer by Regulating the microRNA-424-5p/BDNF Axis [Retraction]
Yue X, Wang Z
Cancer Management and Research 2021, 13:7595-7596
Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer
Zhang Z, Qiu X, Yan Y, Liang Q, Cai Y, Peng B, Xu Z, Xia F
International Journal of General Medicine 2021, 14:6189-6200
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
Salkeni MA, Rizvi W, Hein K, Higa GM
Breast Cancer: Targets and Therapy 2021, 13:539-557
In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer
Lawal B, Kuo YC, Sumitra MR, Wu ATH, Huang HS
Journal of Inflammation Research 2021, 14:4901-4913
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration
Wardhani BWK, Louisa M, Watanabe Y, Setiabudy R, Kato M
Breast Cancer: Targets and Therapy 2021, 13:529-538
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
Li D, Zhang J, Wu L, Yang X, Chen Z, Yuan J
Cancer Management and Research 2021, 13:7311-7323
MicroRNA-876 is Sponged by Long Noncoding RNA LINC00707 and Directly Targets Metadherin to Inhibit Breast Cancer Malignancy [Retraction]
Li T, Li Y, Sun H
Cancer Management and Research 2021, 13:7243-7244
Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
Zheng QK, Ma C, ullah I, Hu K, Ma RJ, Zhang N, Sun ZG
OncoTargets and Therapy 2021, 14:4837-4846
Synergistic Theranostics of Magnetic Resonance Imaging and Photothermal Therapy of Breast Cancer Based on the Janus Nanostructures Fe3O4-Aushell-PEG
Kang X, Sun T, Zhang L, Zhou C, Xu Z, Du M, Xiao S, Liu Y, Gong M, Zhang D
International Journal of Nanomedicine 2021, 16:6383-6394
Overexpression of the lncRNA AC012213.3 Promotes Proliferation, Migration and Invasion of Breast Cancer via RAD54B/PI3K/AKT Axis and is Associated with Worse Patient Prognosis
Zhong H, Zeng G, He L
Cancer Management and Research 2021, 13:7213-7223
Radiation Oncologists’ Approach to Internal Mammary Lymph Node Radiotherapy in Breast Cancer: The Turkish Society for Radiation Oncology Breast Cancer Study Group (TROD 06-005 Survey Study)
Ay Eren A, Eren MF
Cancer Management and Research 2021, 13:7203-7212
Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer Through Interactive Analysis
Gao L, Li Q
Cancer Management and Research 2021, 13:7175-7186
Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer
Montagna E, Zagami P, Masiero M, Mazzocco K, Pravettoni G, Munzone E
Patient Preference and Adherence 2021, 15:2051-2061
A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer
Toivonen KI, Carlson LE, Rash JA, Campbell TS
Patient Preference and Adherence 2021, 15:2039-2050
Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
Sun Y, Chen B, Li J, Peng L, Li S, Yu X, Li L
Cancer Management and Research 2021, 13:7165-7174
Quality of Life Assessment and Pain Severity in Breast Cancer Patients Prior to Palliative Oncology Treatment in Indonesia: A Cross-Sectional Study
Gayatri D, Efremov L, Mikolajczyk R, Kantelhardt EJ
Patient Preference and Adherence 2021, 15:2017-2026
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action
Yap KM, Sekar M, Seow LJ, Gan SH, Bonam SR, Mat Rani NNI, Lum PT, Subramaniyan V, Wu YS, Fuloria NK, Fuloria S
Breast Cancer: Targets and Therapy 2021, 13:471-503
A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors
Zeng Y, Li N, Zheng Z, Chen R, Liu W, Zhu J, Zeng M, Cheng J, Peng M, Hong C
International Journal of General Medicine 2021, 14:5415-5429
The Anticancer Potential of Maslinic Acid and Its Derivatives: A Review
Yu L, Xie X, Cao X, Chen J, Chen G, Chen Y, Li G, Qin J, Peng F, Peng C
Drug Design, Development and Therapy 2021, 15:3863-3879
Diagnosis and Individualized Treatment of Three Primary Malignant Tumors: A Case Report
He F, Xia Y, Ling X
Breast Cancer: Targets and Therapy 2021, 13:519-527
The Neutrophil-to-Lymphocyte Ratio (NLR) Predicts the Prognosis of Unresectable Intermediate and Advanced Hepatocellular Carcinoma Treated with Apatinib
Wang H, Wang Z, Hou Z, Yang X, Zhu K, Cao M, Zhu X, Li H, Zhang T
Cancer Management and Research 2021, 13:6989-6998
circTADA2A Retards the Progression of Colorectal Cancer via Regulating miR-1229/BCL2L10 Signal Axis
Hu L, Fang L, Zhang Z, Yan Z
Cancer Management and Research 2021, 13:6811-6821
Elemene Nanoemulsion Inhibits Metastasis of Breast Cancer by ROS Scavenging
Han B, Wang T, Xue Z, Wen T, Lu L, Meng J, Liu J, Wu S, Yu J, Xu H
International Journal of Nanomedicine 2021, 16:6035-6048
Synergistic Therapy Using Doxorubicin-Loading and Nitric Oxide-Generating Hollow Prussian Blue Nanoparticles with Photoacoustic Imaging Potential Against Breast Cancer
Fu J, Wu Q, Dang Y, Lei X, Feng G, Chen M, Yu XY
International Journal of Nanomedicine 2021, 16:6003-6016
Does the Presence of Cytokeratin Positive Individual Tumor Cells (N0(I+)) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation
Smith J, Leonard C, Carter DL, Tole S
Breast Cancer: Targets and Therapy 2021, 13:513-517
A Case Report of Targeted Therapy with Anlotinib in a Patient with Advanced Breast Metaplastic Carcinoma
Zou J, Yang X, Duan J, Wang J, Yang Z, Luo D, Liu L, Chen J, Nie J
OncoTargets and Therapy 2021, 14:4599-4607
Overview of the Active Ingredients in Cosmetic Products for the Care of Skin That Has Been Exposed to Ionizing Radiation – Analysis of Their Effectiveness in Breast Cancer Radiotherapy
Kondziołka J, Wilczyński S
Clinical, Cosmetic and Investigational Dermatology 2021, 14:1065-1076
A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast Cancer
Liu S, Li D, Liu J, Wang H, Horecny I, Shen R, Zhang R, Wu H, Hu Q, Zhao P, Zhang F, Yan Y, Feng J, Zhuang L, Li J, Zhang L, Tao W
OncoTargets and Therapy 2021, 14:4561-4574
Association Between Serum Human Epididymis Protein 4 Levels and Cardiovascular Events in Obese Patients with Breast Cancer
Wang L, Hu N, Jiang Z, Luo P, Yi N, Chen Y, Zhou N, Liu L
Diabetes, Metabolic Syndrome and Obesity 2021, 14:3703-3710
Ultrasound-Guided Thoracic Paravertebral Block Enhances the Quality of Recovery After Modified Radical Mastectomy: A Randomized Controlled Trial
Rao F, Wang Z, Chen X, Liu L, Qian B, Guo Y
Journal of Pain Research 2021, 14:2563-2570
Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review
Cuyún Carter G, Mohanty M, Stenger K, Morato Guimaraes C, Singuru S, Basa P, Singh S, Tongbram V, Kuemmel S, Guarneri V, Tolaney SM
Cancer Management and Research 2021, 13:6537-6566
HOTAIR Facilitates Endocrine Resistance in Breast Cancer Through ESR1/miR-130b-3p Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA Network
Zhang M, Wu K, Zhang P, Qiu Y, Bai F, Chen H
International Journal of General Medicine 2021, 14:4653-4663
Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer
Zhao Y, Liu L, Zhao J, Du X, Yu Q, Wu J, Wang B, Ou R
International Journal of General Medicine 2021, 14:4605-4617
The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer Patients
Liu J, Peng X, Liu Y, Hao R, Zhao R, Zhang L, Zhao F, Liu Q, Liu Y, Qi Y
International Journal of General Medicine 2021, 14:4545-4554
Combined Lifestyle Behaviors and the Incidence of Common Cancer Types in the Norwegian Women and Cancer Study (NOWAC)
Chen SLF, Braaten T, Borch KB, Ferrari P, Sandanger TM, Nøst TH
Clinical Epidemiology 2021, 13:721-734
Elevated mRNA Level of Y-Box Binding Protein 1 Indicates Unfavorable Prognosis Correlated with Macrophage Infiltration and T Cell Exhaustion in Luminal Breast Cancer
Lv Z, Xue C, Zhang L, Sun J, Bo C
Cancer Management and Research 2021, 13:6411-6428
Type C Behavior and Associated Factors in Patients with Breast Cancer During Postoperative Chemotherapy: A Cross-Sectional Study
Shen XY, Lin Y, Miao R, Yao X, Sun H, Yang W
Psychology Research and Behavior Management 2021, 14:1281-1289
Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice
Jin M, Hou Y, Quan X, Chen L, Gao Z, Huang W
International Journal of Nanomedicine 2021, 16:5479-5494
Effectiveness and Anticancer Activity of a Novel Phenolic Compound from Garcinia porrecta Against the MCF-7 Breast Cancer Cell Line in vitro and in silico
Darwati D, Safitri AN, Ambardhani N, Mayanti T, Nurlelasari N, Kurnia D
Drug Design, Development and Therapy 2021, 15:3523-3533
Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort
Kim SJ, Lee JH, Park WJ, Kim S
International Journal of General Medicine 2021, 14:4423-4434
Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis
Lu Y, Tong Y, Huang J, Lin L, Wu J, Fei X, Chen X, Shen K
Cancer Management and Research 2021, 13:6279-6289
Ecust004 Suppresses Breast Cancer Cell Growth, Invasion, and Migration via EMT Regulation
Liu Z, Huang L, Sun L, Nie H, Liang Y, Huang J, Wu F, Hu X
Drug Design, Development and Therapy 2021, 15:3451-3461
Choriocarcinoma Masquerading as Lung Abscess or Lung Cancer: A Case with Atypical Imaging Findings
Gu Q, Yan S, Lin J, Wu X, Chen L, Gan M, Luo H, Lv D, Lin L
OncoTargets and Therapy 2021, 14:4407-4414
RETRACTED ARTICLE: Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis
Zhang M, Zhu W, Haeryfar M, Jiang S, Jiang X, Chen W, Li J
OncoTargets and Therapy 2021, 14:4415-4426
Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus
Duan F, Song C, Ma Y, Jiang K, Xu F, Bi X, Huang J, Hong R, Huang Z, Lu Q, Yuan Z, Wang S, Xia W
Drug Design, Development and Therapy 2021, 15:3463-3473
Construction and Validation of a Nomogram to Predict Overall Survival in Very Young Female Patients with Curatively Resected Breast Cancer
Li N, Feng LW, Li ZN, Wang J, Yang L
Cancer Management and Research 2021, 13:6181-6190
The Co-Expression of Melanoma-Antigen Family a Proteins and New York Esophageal Squamous Cell Carcinoma-1 in Breast Cancer: A Pilot Study
Wang YX, Li FL, Du LX, Liu JF, Huo LG, Li SQ, Tian B
Cancer Management and Research 2021, 13:6123-6128
RETRACTED ARTICLE: miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer
Wang J, Wang L, Zhang C
OncoTargets and Therapy 2021, 14:4335-4343
Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption
Zahran AM, El-Badawy O, Kamel LM, Rayan A, Rezk K, Abdel-Rahim MH
Cancer Management and Research 2021, 13:6019-6029
Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles
Chen R, Ni S, Chen W, Liu M, Feng J, Hu K
International Journal of Nanomedicine 2021, 16:5265-5279
Glypican-1 Overexpression in Different Types of Breast Cancers
Alshammari FO, Al-Saraireh YM, Youssef AM, AL-sarayra YM, Alrawashdeh HM
OncoTargets and Therapy 2021, 14:4309-4318
Long Non-Coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis [Retraction]
Qu R, Hu C, Tang Y, Yu Q, Shi G
Cancer Management and Research 2021, 13:5873-5874
Delayed Breast Cancer Detection in an Asian Country (Taiwan) with Low COVID-19 Incidence
Chou CP, Lin HS
Cancer Management and Research 2021, 13:5899-5906
Predictive Value of Pretreatment Peripheral Neutrophil-to-Lymphocyte Ratio for Response to Neoadjuvant Chemotherapy and Breast Cancer Prognosis
Li X, Tan Q, Li H, Yang X
Cancer Management and Research 2021, 13:5889-5898
Interpectoral Lymph Node Dissection Can Be Spared in pN0/N1 Invasive Breast Cancer Undergoing Modified Radical Mastectomy: Single-Institution Experience from Mainland China
Yan Y, Jiang L, Fang J, Dai Y, Chenyu X, Ding J
Cancer Management and Research 2021, 13:5855-5863
Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer
Ahmed KS, Liu S, Mao J, Zhang J, Qiu L
Drug Design, Development and Therapy 2021, 15:3223-3239
Assessing Techniques for Quantifying the Impact of Bias Due to an Unmeasured Confounder: An Applied Example
Barberio J, Ahern TP, MacLehose RF, Collin LJ, Cronin-Fenton DP, Damkier P, Sørensen HT, Lash TL
Clinical Epidemiology 2021, 13:627-635
Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia
Urga Workineh M, Alem Lake E, Asmare Adella G
Breast Cancer: Targets and Therapy 2021, 13:459-469
Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of OVOLs in Breast Cancer
Chen J, Tang H, Li T, Jiang K, Zhong H, Wu Y, He J, Li D, Li M, Cai X
International Journal of General Medicine 2021, 14:3951-3960
Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis
Li H, Xia Z, Liu L, Pan G, Ding J, Liu J, Kang J, Li J, Jiang D, Liu W
Cancer Management and Research 2021, 13:5821-5833
Cardiovascular and Other Competing Causes of Death in Male Breast Cancer Patients: A Population-Based Epidemiologic Study
Zhang H, Lin W, Chen D, Wang K, Tu W, Lin H, Li K, Ye S, Guan T, Chen Y
Clinical Interventions in Aging 2021, 16:1393-1401
The Biological Function of TUSC7/miR-1224-3p Axis in Triple-Negative Breast Cancer
Zheng BH, He ZX, Zhang J, Ma JJ, Zhang HW, Zhu W, Shao ZM, Ni XJ
Cancer Management and Research 2021, 13:5763-5774
Comparison of Outcomes After Breast Cancer Surgery Between Inhalational and Propofol-Based Intravenous Anaesthesia: A Systematic Review and Meta-Analysis
Pang QY, Duan LP, Jiang Y, Liu HL
Journal of Pain Research 2021, 14:2165-2177
Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells
Hadisaputri YE, Habibah U, Abdullah FF, Halimah E, Mutakin M, Megantara S, Abdulah R, Diantini A
Breast Cancer: Targets and Therapy 2021, 13:447-457
Key Role of MCUR1 in Malignant Progression of Breast Cancer
Gao P, Peng T, Lin S, Zhi W, Cao C, Wu P, Xi L, Wu P, Yang Q, Ding W
OncoTargets and Therapy 2021, 14:4163-4175
The Impact of Different Simulation Modalities on Target Volume Delineation in Breast-Conserving Radiotherapy
Jin M, Liu X, Ma J, Sun X, Zhen H, Shen J, Liu Z, Lian X, Miao Z, Hu K, Hou X, Zhang F
Cancer Management and Research 2021, 13:5633-5640
Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286
Ni J, Xi X, Xiao S, Xiao X
Cancer Management and Research 2021, 13:5573-5585
Preoperative Serum Hypersensitive-c-Reactive-Protein (Hs-CRP) to Albumin Ratio Predicts Survival in Patients with Luminal B Subtype Breast Cancer
Liu X, Guo X, Zhang Z
OncoTargets and Therapy 2021, 14:4137-4148
Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies – State of the Art
Mleko M, Pitynski K, Pluta E, Czerw A, Sygit K, Karakiewicz B, Banas T
Cancer Management and Research 2021, 13:5491-5508
Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries
El-Beltagy AEFBM, Elsyyad HIH, Abdelaziz KK, Madany AS, Elghazaly MM
Breast Cancer: Targets and Therapy 2021, 13:431-445
Bifidobacterium bifidum-Mediated Specific Delivery of Nanoparticles for Tumor Therapy
Tang Y, Chen C, Jiang B, Wang L, Jiang F, Wang D, Wang Y, Yang H, Ou X, Du Y, Wang Q, Zou J
International Journal of Nanomedicine 2021, 16:4643-4659
Prognostic Characteristics of Operated Breast Cancer Patients with Second Primary Lung Cancer: A Retrospective Study
Wang Y, Li J, Chang S, Dong Y, Che G
Cancer Management and Research 2021, 13:5309-5316
Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth
Kanzaki H, Chatterjee A, Hossein Nejad Ariani H, Zhang X, Chung S, Deng N, Ramanujan VK, Cui X, Greene MI, Murali R
Breast Cancer: Targets and Therapy 2021, 13:419-430
Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p
Hou T, Ye L, Wu S
OncoTargets and Therapy 2021, 14:3991-4003
Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer
Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki A, Hemminki K
Clinical Epidemiology 2021, 13:515-525
The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells
Stepankova H, Swiatkowski M, Kruszynski R, Svec P, Michalkova H, Smolikova V, Ridoskova A, Splichal Z, Michalek P, Richtera L, Kopel P, Adam V, Heger Z, Rex S
International Journal of Nanomedicine 2021, 16:4431-4449
Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience
Boér K, Rubovszky G, Rokszin G, Abonyi-Tóth Z, Földesi C, Dank M
OncoTargets and Therapy 2021, 14:3971-3981
Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer
Hu Y, Gao J, Wang M, Li M
Cancer Management and Research 2021, 13:5223-5237
Value of Machine Learning with Multiphases CE-MRI Radiomics for Early Prediction of Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Invasive Breast Cancer
Li Q, Xiao Q, Li J, Wang Z, Wang H, Gu Y
Cancer Management and Research 2021, 13:5053-5062
An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy
Jonasson AF, Åstrom M
Medical Devices: Evidence and Research 2021, 14:193-200
Presence of HPV, EBV and HMTV Viruses Among Egyptian Breast Cancer Women: Molecular Detection and Clinical Relevance
Metwally SA, Abo-Shadi MA, Abdel Fattah NF, Barakat AB, Rabee OA, Osman AM, Helal AM, Hashem T, Moneer MM, Chehadeh W, Loutfy SA
Infection and Drug Resistance 2021, 14:2327-2339
Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
Tailaiti G, Maimaiti G, Aikeremu Y, Tuerdi B
International Journal of General Medicine 2021, 14:2777-2783
The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer
Chilà G, Guarini V, Galizia D, Geuna E, Montemurro F
Drug Design, Development and Therapy 2021, 15:2711-2720
Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital
Sá RS, Logullo AF, Elias S, Facina G, Sanvido VM, Nazário ACP
Breast Cancer: Targets and Therapy 2021, 13:409-417
The Guiding Significance of the Number of Positive Sentinel Lymph Nodes in Frozen Section for Intraoperative Axillary Dissection in Early Breast Cancer
Liang C, Li L, Zhu M, Hu J, Yu Y
Cancer Management and Research 2021, 13:4803-4810
Molecular Examination of Differentially Expressed Genes in the Brains of Experimental Autoimmune Encephalomyelitis Mice Post Herceptin Treatment
Al-Ani M, Elemam NM, Hachim IY, Raju TK, Muhammad JS, Hachim MY, Bendardaf R, Maghazachi AA
Journal of Inflammation Research 2021, 14:2601-2617
Clinical Analysis of Severe Radiation Pneumonia
Li FJ, Yuan X, Chen C, Zhu ML, Bai CQ, Wang RJ
International Journal of General Medicine 2021, 14:2581-2588
A Grateful Disposition Promotes the Well-Being of Women with Breast Cancer Through Adaptive Coping
Tomczyk J, Krejtz I, Kornacka M, Nezlek JB
International Journal of Women's Health 2021, 13:579-590
Sleep Quality and Related Factors in Patients with Breast Cancer: A Cross-Sectional Study in Taiwan
Weng YP, Hong RM, Chen VCH, Tsai CJ, Yeh DC, Fang YH
Cancer Management and Research 2021, 13:4725-4733
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
Jagosky M, Tan AR
Breast Cancer: Targets and Therapy 2021, 13:393-407
Multiple Administrations of Itraconazole Increase Plasma Exposure to Pyrotinib in Chinese Healthy Adults
Liu Y, Zhang Q, Lu C, Hu W
Drug Design, Development and Therapy 2021, 15:2485-2493
Deep Learning-Based Multi-Class Classification of Breast Digital Pathology Images
Mi W, Li J, Guo Y, Ren X, Liang Z, Zhang T, Zou H
Cancer Management and Research 2021, 13:4605-4617
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study
Wako Z, Mengistu D, Dinegde NG, Asefa T, Wassie M
Breast Cancer: Targets and Therapy 2021, 13:383-392
circHIPK3 (hsa_circ_0000284) Promotes Proliferation, Migration and Invasion of Breast Cancer Cells via miR-326
Qi L, Sun B, Yang B, Lu S
OncoTargets and Therapy 2021, 14:3671-3685
Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
Zhao X, Yang X, Fu L, Yu K
Cancer Management and Research 2021, 13:4579-4586
Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
Abdel-Razeq H, Tamimi F, Abujamous L, Edaily S, Abunasser M, Bater R, Salama O
Cancer Management and Research 2021, 13:4597-4604
Erythrocyte-Camouflaged Mesoporous Titanium Dioxide Nanoplatform for an Ultrasound-Mediated Sequential Therapies of Breast Cancer
Li Q, Lin B, Li Y, Lu N
International Journal of Nanomedicine 2021, 16:3875-3887
Dietary Pattern at 18-Month Post-Diagnosis and Outcomes of Breast Cancer Among Chinese Women with Early-Stage Breast Cancer
Lei Y, Ho SC, Kwok C, Cheng AC, Cheung KL, Lee R, Yeo W
Cancer Management and Research 2021, 13:4553-4565
Volumetric Absorptive Microsampling as a New Biosampling Tool for Monitoring of Tamoxifen, Endoxifen, 4-OH Tamoxifen and N-Desmethyltamoxifen in Breast Cancer Patients
Maggadani BP, Harmita, Haryono SJ, Rinaldi MR, Harahap Y
Drug Design, Development and Therapy 2021, 15:2417-2430
Can Breast Cancer Survivors Benefit from Speed of Processing Training? A Perspective Article on Treatment and Research
Triebel K, Anderson J, Nakkina SR, Vance DE
Nursing: Research and Reviews 2021, 11:9-20
Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer
Sun X, Ding S, Lu S, Wang Z, Chen X, Shen K
OncoTargets and Therapy 2021, 14:3611-3624
Tumor-to-Gland Volume Ratio versus Tumor-to-Breast Ratio as Measured on CBBCT: Possible Predictors of Breast-Conserving Surgery
Li J, Zhong G, Wang K, Kang W, Wei W
Cancer Management and Research 2021, 13:4463-4471
Decision-Making in Multidisciplinary Tumor Boards in Breast Cancer Care – An Observational Study
Schellenberger B, Diekmann A, Heuser C, Gambashidze N, Ernstmann N, Ansmann L
Journal of Multidisciplinary Healthcare 2021, 14:1275-1284
RETRACTED ARTICLE: LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p
Han X, Liu J, Liu Y, Mou L, Li C
Cancer Management and Research 2021, 13:4393-4401
Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights
Abdelgawad MA, Musa A, Almalki AH, Alzarea SI, Mostafa EM, Hegazy MM, Mostafa-Hedeab G, Ghoneim MM, Parambi DGT, Bakr RB, Al-Muaikel NS, Alanazi AS, Alharbi M, Ahmad W, Bukhari SNA, Al-Sanea MM
Drug Design, Development and Therapy 2021, 15:2325-2337
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib
Ulrich L, Okines AF
Breast Cancer: Targets and Therapy 2021, 13:361-381
In vitro Anticancer Effects of Vernonia amygdalina Leaf Extract and Green-Synthesised Silver Nanoparticles
Joseph J, Khor KZ, Moses EJ, Lim V, Aziz MY, Abdul Samad N
International Journal of Nanomedicine 2021, 16:3599-3612
Preparation, Biocompatibility and Antitumor Activity of Nanodelivery System Targeting Breast Cancer Base on a Silica Nanoparticle
Liu J, Ren S, Zhang X, Feng Y, Qiu Z, Ma L, Huang J
OncoTargets and Therapy 2021, 14:3429-3442
Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer
Savioli F, Seth S, Morrow E, Doughty J, Stallard S, Malyon A, Romics L
Breast Cancer: Targets and Therapy 2021, 13:353-359
RETRACTED ARTICLE: LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression
Meng D, Shao H, Feng C
OncoTargets and Therapy 2021, 14:3395-3407
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women
Martelli V, Latocca MM, Ruelle T, Perachino M, Arecco L, Beshiri K, Razeti MG, Tagliamento M, Cosso M, Fregatti P, Lambertini M
Breast Cancer: Targets and Therapy 2021, 13:341-351
Analysis of Increased EGFR and IGF-1R Signaling and Its Correlation with Socio-Epidemiological Features and Biological Profile in Breast Cancer Patients: A Study in Northern Brazil
Silva Rocha F, da Silva Maués JH, Brito Lins Pereira CM, Moreira-Nunes CA, Rodriguez Burbano RM
Breast Cancer: Targets and Therapy 2021, 13:325-339
Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience
Calvo V, Fernandez-Cruz A, Nuñez B, Blanco M, Morito A, Martínez M, Traseira C, Garitaonaindía Y, Aguado R, Ramos A, Royuela A, Franco FF, Provencio M
Clinical Epidemiology 2021, 13:317-324
Identification of Serotonin as a Predictive Marker for Breast Cancer Patients
Xie QE, Du X, Wang M, Xie F, Zhang Z, Cao Y, Liu Y
International Journal of General Medicine 2021, 14:1939-1948
Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer
Martinez-Cannon BA, Castro-Sanchez A, Barragan-Carrillo R, de la Rosa Pacheco S, Platas A, Fonseca A, Vega Y, Bojorquez-Velazquez K, Bargallo-Rocha JE, Mohar A, Villarreal-Garza C
Patient Preference and Adherence 2021, 15:1039-1049
High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer
Siraj AK, Parvathareddy SK, Annaiyappanaidu P, Ahmed SO, Siraj N, Tulbah A, Al-Dayel F, Ajarim D, Al-Kuraya KS
OncoTargets and Therapy 2021, 14:3309-3318
Development of Japanese Versions of the Control Preferences Scale and Information Needs Questionnaire: Role of Decision-Making and Information Needs for Japanese Breast Cancer Patients
Azuma K, Kawaguchi T, Yamaguchi T, Motegi S, Yamada K, Onda K, Iwase S, Unezaki S, Takeuchi H
Patient Preference and Adherence 2021, 15:1017-1026
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
Chen MY, Gillanders WE
Breast Cancer: Targets and Therapy 2021, 13:311-323
Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
Li C, Wang J, Mo M, Yuan J, Luo J, Jin K, Wang X, Yang Y, Ma J, Mei X, Yang Z, Yu X, Chen X, Guo X
Cancer Management and Research 2021, 13:3889-3899
Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells
Abdellatif AAH, Alsharidah M, Al Rugaie O, Tawfeek HM, Tolba NS
Drug Design, Development and Therapy 2021, 15:2035-2046
Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?
Lazzari G, Buono G, Zannino B, Silvano G
Breast Cancer: Targets and Therapy 2021, 13:299-310
Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer
Li Y, Liu C, Wang B, Hu X, Gong C, Zhao Y, Xie Y, Zhang Y, Song S, Yang Z, Wang B
International Journal of General Medicine 2021, 14:1797-1809
Effectiveness of Psycho-Education Intervention Programme on Coping Strategies Among Jordanian Women Diagnosed with Breast Cancer: A Randomised Controlled Trial
Younis M, Norsa'adah B, Othman A
Breast Cancer: Targets and Therapy 2021, 13:285-297
A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer
Zhai L, Luo C, Gao H, Du S, Shi J, Wang F
International Journal of Nanomedicine 2021, 16:3185-3199
Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients
Tsegaye S, Mehdi M, Lako WL, Melka DS
Breast Cancer: Targets and Therapy 2021, 13:271-283
A Case of Phyllodes Tumor of the Breast with Mixed Liposarcoma: Case Report and Literature Review
Tu He Ta Mi Shi ME, Wang N, Yao Q, Dong SS, Feng X, Zhao J, Zou H, Pang LJ, Qi Y
OncoTargets and Therapy 2021, 14:3003-3011
Advances in Therapy for Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer Patients Who Have Experienced Progression After Treatment with CDK4/6 Inhibitors
Li C, Li X
OncoTargets and Therapy 2021, 14:2929-2939
Amelioration of Pterostilbene Antiproliferative, Proapoptotic, and Oxidant Potentials in Human Breast Cancer MCF7 Cells Using Zein Nanocomposites
Kutbi HI, Kammoun AK, Farag El-Telbany D
International Journal of Nanomedicine 2021, 16:3059-3071
Assessment of Bone Health Education in US Multiple Myeloma and Solid Tumor Patients at Risk for Skeletal-Related Events
Flora DR, Carlson KB, Fuehrer DC, Cadieux B, Boike G, Schenfeld J, Lowe KA
Cancer Management and Research 2021, 13:3529-3537
Established and Validated Novel Nomogram for Predicting Prognosis of Post-Mastectomy pN0-1 Breast Cancer without Adjuvant Radiotherapy
Qi WX, Cao L, Xu C, Zhao S, Chen J
Cancer Management and Research 2021, 13:3517-3527
Olaparib Treatment in a Patient with Advanced Gallbladder Cancer Harboring BRCA1 Mutation
Li X, Gao L, Qiu M, Cao D
OncoTargets and Therapy 2021, 14:2815-2819
lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
Zhang J, Du C, Zhang L, Wang Y, Zhang Y, Li J
OncoTargets and Therapy 2021, 14:2747-2759
Effectiveness of Image-Guided Radiotherapy in Adjuvant Radiotherapy on Survival for Localized Breast Cancer: A Population-Based Analysis
Liang JA, Lee PC, Ku CP, Chen WTL, Chung CY, Kuo YC, Chou SH, Li CC, Chien CR
Cancer Management and Research 2021, 13:3465-3472
Methanolic Fenugreek Seed Extract Induces p53-Dependent Mitotic Catastrophe in Breast Cancer Cells, Leading to Apoptosis
Alrumaihi FA, Khan MA, Allemailem KS, Alsahli MA, Almatroudi A, Younus H, Alsuhaibani SA, Algahtani M, Khan A
Journal of Inflammation Research 2021, 14:1511-1535
Expression and Prognosis of Sperm-Associated Antigen 1 in Human Breast Cancer
Lin S, Lv Y, Zheng L, Mao G, Peng F
OncoTargets and Therapy 2021, 14:2689-2698
Machine Learning Models to Improve the Differentiation Between Benign and Malignant Breast Lesions on Ultrasound: A Multicenter External Validation Study
Huo L, Tan Y, Wang S, Geng C, Li Y, Ma X, Wang B, He Y, Yao C, Ouyang T
Cancer Management and Research 2021, 13:3367-3379
Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy
Lin BX, Xu CS
International Journal of General Medicine 2021, 14:1337-1341
Prognostic Value of the TP53 Mutation Location in Metastatic Breast Cancer as Detected by Next-Generation Sequencing
Bai H, Yu J, Jia S, Liu X, Liang X, Li H
Cancer Management and Research 2021, 13:3303-3316
Role of G Protein-Coupled Estrogen Receptor in Digestive System Carcinomas: A Minireview
Qiu YA, Xiong J, Yu T
OncoTargets and Therapy 2021, 14:2611-2622
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer
Daly AA, Rolph R, Cutress RI, Copson ER
Breast Cancer: Targets and Therapy 2021, 13:241-257
Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis
Vyas A, Gabriel M, Kurian S
Breast Cancer: Targets and Therapy 2021, 13:259-269
RETRACTED ARTICLE: Solasodine, Isolated from Solanum sisymbriifolium Fruits, Has a Potent Anti-Tumor Activity Against Pancreatic Cancer
Fan Y, Li Z, Wu L, Lin F, Shao J, Ma X, Yao Y, Zhuang W, Wang Y
Drug Design, Development and Therapy 2021, 15:1509-1519
Quality of Life After Bilateral Risk-Reducing Mastectomy and Simultaneous Reconstruction Using Pre-Pectoral Silicone Implants
Spindler N, Ebel F, Briest S, Wallochny S, Langer S
Patient Preference and Adherence 2021, 15:741-750
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway
Fan S, Yan S, Yang Y, Shang J, Hao M
OncoTargets and Therapy 2021, 14:2463-2473
Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer
Lechner J, Schulz T, Lejeune B, von Baehr V
Breast Cancer: Targets and Therapy 2021, 13:225-240
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer
Wang Y, Zhong Q, Li Z, Lin Z, Chen H, Wang P
OncoTargets and Therapy 2021, 14:2433-2448
Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women [Corrigendum]
Nikpour M, Hajian-Tilaki K, Bakhtiari A
Cancer Management and Research 2021, 13:3079-3080
The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up
Lombardi A, Lazzeroni R, Bersigotti L, Vitale V, Amanti C
Breast Cancer: Targets and Therapy 2021, 13:213-217
Association of Endocrine Therapy and Dementia in Women with Breast Cancer
Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, Nead KT
Breast Cancer: Targets and Therapy 2021, 13:219-224
Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients
Wen L, Zhang G, Ren C, Li X, Mok H, Jia M, Wang Y, Chen B, Li K, Cao L, Li C, Xiao W, Lai J, Lin J, Wei G, Li Y, Zhang Y, Chen X, Liao N
Cancer Management and Research 2021, 13:3055-3065
LncRNA SNHG8 Serves as an Oncogene in Breast Cancer Through miR-634/ZBTB20 Axis
Xu X, Xie Q, Xie M, Zeng Y, Liu Q
Cancer Management and Research 2021, 13:3017-3028
Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma
Cui Y, Han B, Zhang H, Liu H, Zhang F, Niu R
OncoTargets and Therapy 2021, 14:2259-2277
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
Hyder T, Bhattacharya S, Gade K, Nasrazadani A, Brufsky AM
Breast Cancer: Targets and Therapy 2021, 13:199-211
Remodels the Immunosuppressive Tumor Microenvironment by Combination of Bacillus Calmette–Guérin and Anti-PD-L1 in an Orthotopic Triple-Negative Breast Cancer Mouse Model
Lu Y, Huang X, Liu X, He Y, Hu Z, Xu JW, Cao G, He W
OncoTargets and Therapy 2021, 14:2247-2258
Evaluation of Antitumor Efficacy of Chitosan-Tamarind Gum Polysaccharide Polyelectrolyte Complex Stabilized Nanoparticles of Simvastatin
Malviya R, Raj S, Fuloria S, Subramaniyan V, Sathasivam K, Kumari U, Unnikrishnan Meenakshi D, Porwal O, Hari Kumar D, Singh A, Chakravarthi S, Kumar Fuloria N
International Journal of Nanomedicine 2021, 16:2533-2553
Prevalence of MMTV-Like env Sequences and Its Association with BRCA1/2 Genes Mutations Among Egyptian Breast Cancer Patients
Loutfy SA, Abdallah ZF, Shaalan M, Moneer M, Karam A, Moneer MM, Sayed IM, Abd El-Hafeez AA, Ghosh P, Zekri ARN
Cancer Management and Research 2021, 13:2835-2848
A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy
Wang H, Zhang Y, Zeng X, Pei W, Fan R, Wang Y, Wang X, Li J
International Journal of Nanomedicine 2021, 16:2373-2388
ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining
Chen Y, Tian D, Chen X, Tang Z, Li K, Huang Z, Fu Y, Feng Y, Yang Z
International Journal of General Medicine 2021, 14:967-981
Factors Associated with Delay in Breast Cancer Presentation at the Only Oncology Center in North East Ethiopia: A Cross-Sectional Study
Hassen AM, Hussien FM, Asfaw ZA, Assen HE
Journal of Multidisciplinary Healthcare 2021, 14:681-694
Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
Beusterien K, Maculaitis MC, Hallissey B, Gaschler MM, Smith ML, Law EH
Patient Preference and Adherence 2021, 15:611-623
DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer
Deng Z, Xiao M, Du D, Luo N, Liu D, Liu T, Lian D, Peng J
OncoTargets and Therapy 2021, 14:2003-2017
Role and Therapeutic Potential of Melatonin in Various Type of Cancers
Gurunathan S, Qasim M, Kang MH, Kim JH
OncoTargets and Therapy 2021, 14:2019-2052
Assessment of Subclinical Deterioration of Right Ventricular Function by Three-Dimensional Speckle Tracking Echocardiography in Breast Cancer Patients Undergoing Anthracycline-Based Chemotherapy
Xu H, Mao L, Liu H, Zhang Y, Yang J
International Journal of General Medicine 2021, 14:885-893
Identifying Risk Factors of Breast Cancer Among Women Attending Selected Hospitals of Addis Ababa City: Hospital-Based Unmatched Case-Control Study
Duche H, Tsegay AT, Tamirat KS
Breast Cancer: Targets and Therapy 2021, 13:189-197
MiR-129-5p Suppresses Cell Proliferation of Human Osteosarcoma Cancer by Down-Regulating LncRNA Lnc712
Yu Y, Zuo W, Cai W, Xu Y, Liu W, Zhao Z
Cancer Management and Research 2021, 13:2259-2264
Remarkable Response of Toripalimab Combined with Chemotherapy in Sarcomatoid Carcinoma of Palatine Tonsil: A Case Report
Huang J, Lei L, Chen B, Pan G, Fang M, Wang X
Journal of Multidisciplinary Healthcare 2021, 14:599-604
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
Zhuang J, Chen S, Hu Y, Yang F, Huo Q, Xie N
International Journal of Nanomedicine 2021, 16:1961-1976
99mTc-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer
Rainone P, De Palma A, Sudati F, Roffia V, Rigamonti V, Salvioni L, Colombo M, Ripamonti M, Spinelli AE, Mazza D, Mauri P, Moresco RM, Prosperi D, Belloli S
International Journal of Nanomedicine 2021, 16:1943-1960
Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer
Si Y, Yue J, Liu Z, Li M, Du F, Wang X, Dai Z, Hu N, Ju J, Gao S, Wang X, Yuan P
International Journal of Nanomedicine 2021, 16:1913-1926
Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
Chang DY, Ma WL, Lu YS
Therapeutics and Clinical Risk Management 2021, 17:193-207
Better Reporting and Awareness Campaigns Needed for Breast Cancer in Pakistani Women
Khan NH, Duan SF, Wu DD, Ji XY
Cancer Management and Research 2021, 13:2125-2129
LncRNA AGAP2-AS1 Promotes Cancer Cell Proliferation, Migration and Invasion in Colon Cancer by Forming a Negative Feedback Loop with LINC-PINT
Ji L, Chen S, Gu L, Wang J, Zhang X
Cancer Management and Research 2021, 13:2153-2161
Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review
Qu Y, Liu Y, Ding K, Li Y, Hong X, Zhang H
OncoTargets and Therapy 2021, 14:1581-1588
Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin
Gallo E, Diaferia C, Rosa E, Smaldone G, Morelli G, Accardo A
International Journal of Nanomedicine 2021, 16:1617-1630
FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival
Elian FA, Are U, Ghosh S, Nuin P, Footz T, McMullen TPW, Brindley DN, Walter MA
Breast Cancer: Targets and Therapy 2021, 13:171-188
Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis
Li L, Huang H, Zhu M, Wu J
Cancer Management and Research 2021, 13:2095-2104
Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells
Zuo R, Zhang J, Song X, Hu S, Gao X, Wang J, Ji H, Ji C, Peng L, Si H, Li G, Fang K, Zhang J, Jiang S, Guo D
International Journal of Nanomedicine 2021, 16:1587-1600
Dissection of Level III Axillary Lymph Nodes in Breast Cancer
Hu J, Xia X, Yang H, Yu Y
Cancer Management and Research 2021, 13:2041-2046
An Update on the Molecular Pathology of Metaplastic Breast Cancer
McCart Reed AE, Kalaw EM, Lakhani SR
Breast Cancer: Targets and Therapy 2021, 13:161-170
MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway
Cai M, Li H, Chen R, Zhou X
Cancer Management and Research 2021, 13:2009-2024
Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
Epstein RS, Basu Roy UK, Aapro M, Salimi T, Moran D, Krenitsky J, Leone-Perkins ML, Girman C, Schlusser C, Crawford J
Patient Preference and Adherence 2021, 15:453-465
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review
Linehan AS, Fitzpatrick OM, Morris PG
Breast Cancer: Targets and Therapy 2021, 13:151-159
Preoperative Contrast-Enhanced Ultrasound (CEUS) Combined with 125I Seeds Localization in Sentinel Lymph Node Biopsy for Breast Cancer
Zhou P, Zheng W, Liu Y, Wang Y
Cancer Management and Research 2021, 13:1853-1860
The Impact of AC and AC-T Chemotherapy’s Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study
Gadisa DA, Wang SH, Yimer G
Breast Cancer: Targets and Therapy 2021, 13:107-132
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective
Yuan P, Xu B
Breast Cancer: Targets and Therapy 2021, 13:135-150
Imbalance of Molecular Module of TINCR-miR-761 Promotes the Metastatic Potential of Early Triple Negative Breast Cancer and Partially Offsets the Anti-Tumor Activity of Luteolin
Zhang ML, Liu WW, Li WD
Cancer Management and Research 2021, 13:1877-1886
Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
Lv L, Shi Y, Wu J, Li G
International Journal of Nanomedicine 2021, 16:1487-1508
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia [Corrigendum]
Assefa AA, Abera G, Geta M
Breast Cancer: Targets and Therapy 2021, 13:133-134
RETRACTED ARTICLE: LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p
Yu H, Dong L, Wang H, Zhang Y, Wang Z, Wang C, Xia H, Bao H
Cancer Management and Research 2021, 13:1803-1815
Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
Jeiziner C, Stäuble CK, Lampert ML, Hersberger KE, Meyer zu Schwabedissen HE
Pharmacogenomics and Personalized Medicine 2021, 14:279-286
In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach
Fleisher B, Lezeau J, Werkman C, Jacobs B, Ait-Oudhia S
Breast Cancer: Targets and Therapy 2021, 13:87-105
Degrees of Multidisciplinarity Underpinning Care Planning for Patients with Cancer in Weekly Multidisciplinary Team Meetings: Conversation Analysis
Soukup T, Murtagh G, Lamb BW, Green JSA, Sevdalis N
Journal of Multidisciplinary Healthcare 2021, 14:411-424
Clinicopathological Characteristics and Prognosis of Breast Cancer in Young Women – A Single Center Study in a Developing Country
Sun X, Liu J, Ji H, Yang M, Lu Y
Cancer Management and Research 2021, 13:1601-1607
High Prevalence of Triple-Negative Breast Cancer in Southern Shaanxi Province, China
Xing X, Fan Z, Gao Y, Liu Z
Cancer Management and Research 2021, 13:1609-1615
Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide
Suehiro M, Kojima Y, Takahashi M, Ito Y, Keira T, Ikegawa K, Minatogawa H, Tsugawa K, Tanaka T
Cancer Management and Research 2021, 13:1617-1624
Association Between Single-Nucleotide Polymorphisms in Breast Cancer Susceptibility Genes and Clinicopathological Characteristics
Wang S, Zhang K, Tang L, Yang Y, Wang H, Zhou Z, Pang J, Chen F
Clinical Epidemiology 2021, 13:103-112
Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Ma Y, Zhang J, Chen X
Cancer Management and Research 2021, 13:1571-1580
The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients
Wu X, Ye C, Wang X, Cai R, Yang J, Yu X, Zhou Y, Shen L, Zhu Y, Liu X
Cancer Management and Research 2021, 13:1517-1527
The Effect of Subsequent Pregnancy on Prognosis in Young Breast Cancer Patients (≤35 Years Old) According to Hormone Receptor Status
Li Y, Zhang Y, Wang S, Lu S, Song Y, Liu H
Cancer Management and Research 2021, 13:1505-1515
The Inhibitive Effect of sh-HIF1A-AS2 on the Proliferation, Invasion, and Pathological Damage of Breast Cancer via Targeting miR-548c-3p Through Regulating HIF-1α/VEGF Pathway in vitro and vivo [Retraction]
Guo X, Lee S, Cao P
OncoTargets and Therapy 2021, 14:1003-1004
GATA1-Activated HNF1A-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-32-5p to Upregulate RNF38
Yang J, Niu H, Chen X
Cancer Management and Research 2021, 13:1357-1369
Large Tumor Size is an Indicator for the Timely Administration of Adjuvant Radiotherapy in Luminal Breast Cancer with Positive Lymph Node
You KY, Zou WL, Ding L, Bi ZF, Yao HR
Cancer Management and Research 2021, 13:1325-1332
Development and Validation of a Nomogram for the Estimation of Response to Platinum-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer
Chen W, Wang B, Zeng R, Wang T
Cancer Management and Research 2021, 13:1279-1289
LncRNA SLC16A1-AS1 Suppresses Cell Proliferation in Cervical Squamous Cell Carcinoma (CSCC) Through the miR-194/SOCS2 Axis
Zhang H, Jin S, Ji A, Ma Y, Zhang C, Wang A, Wang R
Cancer Management and Research 2021, 13:1299-1306
Successful Use of Nivolumab in a Patient with Head and Neck Cancer After Allogeneic Bone Marrow Transplantation
Dong X, Lu N, Tong Z, Shi Y
OncoTargets and Therapy 2021, 14:929-936
Perceived Quality of Nursing Care Among Cancer Patients Attending Hawassa University Comprehensive Specialized Hospital Cancer Treatment Center; Hawassa Southern Ethiopia: Cross-Sectional Study
Deribe B, Ayalew M, Geleta D, Gemechu L, Bogale N, Mengistu K, Gadissa A, Dula D, Ababi G, Gebretsadik A
Cancer Management and Research 2021, 13:1225-1231
CircRNA circYY1 (hsa_circ_0101187) Modulates Cell Glycolysis and Malignancy Through Regulating YY1 Expression by Sponging miR-769-3p in Breast Cancer
Zhang X, Li J, Feng Q
Cancer Management and Research 2021, 13:1145-1158
Genetic Influences in Breast Cancer Drug Resistance
Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R
Breast Cancer: Targets and Therapy 2021, 13:59-85
Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer
Li XM, Li MT, Jiang N, Si YC, Zhu MM, Wu QY, Shi DC, Shi H, Luo Q, Yu B
Cancer Management and Research 2021, 13:1189-1204
siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line
Savukaitytė A, Gudoitytė G, Bartnykaitė A, Ugenskienė R, Juozaitytė E
Cancer Management and Research 2021, 13:1123-1133
LINC00665 Stimulates Breast Cancer Progression via Regulating miR-551b-5p
Qi L, Sun B, Yang B, Lu S
Cancer Management and Research 2021, 13:1113-1121
Knowledge Mapping of Acupuncture for Cancer Pain: A Scientometric Analysis (2000–2019)
Huang L, Zhao Y, Xiang M
Journal of Pain Research 2021, 14:343-358
Combined Photothermal and Ionizing Radiation Sensitization of Triple-Negative Breast Cancer Using Triangular Silver Nanoparticles
Sears J, Swanner J, Fahrenholtz CD, Snyder C, Rohde M, Levi-Polyachenko N, Singh R
International Journal of Nanomedicine 2021, 16:851-865
MALT Lymphoma of the Urinary Bladder Shows a Dramatic Female Predominance, Uneven Geographic Distribution, and Possible Infectious Etiology
Lyapichev KA, Ivashkevich Y, Chernov Y, Chinenov D, Shpot E, Bessonov AA, Dabaja BS, Konoplev S
Research and Reports in Urology 2021, 13:49-62
tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel
Ma Y, Li R, Dong Y, You C, Huang S, Li X, Wang F, Zhang Y
International Journal of Nanomedicine 2021, 16:789-802
A New Procedure to Assess When Estimates from the Cumulative Link Model Can Be Interpreted as Differences for Ordinal Scales in Quality of Life Studies
Ning Y, Ho PJ, Støer NC, Lim KK, Wee HL, Hartman M, Reilly M, Tan CS
Clinical Epidemiology 2021, 13:53-65
Triple Discordances in Receptor Status During Breast Cancer Local Progression and Metastases: Case Report and Literature Review [Erratum]
Martuszewski A, Paluszkiewicz P, Nowak M, Szewczyk K, Staszek-Szewczyk U
OncoTargets and Therapy 2021, 14:807-808
Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia
Saiful Bahri A, Tuan Mahmood TM, Abdul-Aziz SA, Makmor-Bakry M, Mohamed Shah N
Patient Preference and Adherence 2021, 15:227-235
How Long is It Safe to Wait for Breast Surgery After Completion of Neoadjuvant Chemotherapy?
Ma T, Mao Y, Wang H
Cancer Management and Research 2021, 13:989-998
Enophthalmos as the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma
El-Khazen Dupuis J, Marchand M, Javidi S, Nguyen TQT
Bibliometric Analysis of Research on the Comorbidity of Cancer and Pain
Wu CC, Wang YZ, Hu HY, Wang XQ
Journal of Pain Research 2021, 14:213-228
MiR-183-5p Promotes Tumor Progression of Osteosarcoma and Predicts Poor Prognosis in Patients
Jin L, Luo Y, Zhao YC, Tao H
Cancer Management and Research 2021, 13:805-814
LINC01224 Promotes Colorectal Cancer Progression by Sponging miR-2467
Chen L, Chen W, Zhao C, Jiang Q
Cancer Management and Research 2021, 13:733-742
Cytotoxicity Effects of Curcumin Loaded on Chitosan Alginate Nanospheres on the KMBC-10 Spheroids Cell Line
Afzali E, Eslaminejad T, Yazdi Rouholamini SE, Shahrokhi-Farjah M, Ansari M
International Journal of Nanomedicine 2021, 16:579-589
Significance of Oncotype DX 21-Gene Test and Expression of Long Non-Coding RNA MALAT1 in Early and Estrogen Receptor-Positive Breast Cancer Patients
Huang Z, Qin Q, Xia L, Lian B, Tan Q, Yu Y, Mo Q
Cancer Management and Research 2021, 13:587-593
Giant Fungated Locally Advanced Breast Carcinoma Responded to Hypofractionated Radiotherapy Combined with Apatinib: A Case Report and Literature Review
Liu H, Liu B, Ma Y, Guo L, Wu D, Shi A, Liu M
Cancer Management and Research 2021, 13:605-611
Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
Lv Y, Ma X, Du Y, Feng J
OncoTargets and Therapy 2021, 14:589-607
Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
Chen B, Dong C, Wang F, Wu J
OncoTargets and Therapy 2021, 14:637-651
Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis
Wang Y, Wang Q, Li X, Luo G, Shen M, Shi J, Wang X, Tang L
Drug Design, Development and Therapy 2021, 15:245-257
Primary Cancer Sites and Clinical Features of Choroidal Metastasis in Mexican Patients
Salcedo-Villanueva G, Medina-Andrade AA, Moreno-Paramo D, Golzarri MF, Moreno-Paramo E, Ortiz-Ramirez GY, Martinez-Aguilar U, De Dios-Cuadras U, Jimenez-Rodriguez M, Espinosa-Soto I, Mira-Lorenzo X, Guzman-Cerda J, Orozco-Moguel A, Becerra-Revollo C, Orozco-Gomez LP, Fulda E
Clinical Ophthalmology 2021, 15:201-209
CircSKA3 Downregulates miR-1 Through Methylation in Glioblastoma to Promote Cancer Cell Proliferation
Zhou M, Li H, Chen K, Ding W, Yang C, Wang X
Cancer Management and Research 2021, 13:509-514
Risk Factors Associated with Breast Cancer among Women in Addis Ababa, Ethiopia: Unmatched Case–Control Study
Tolessa L, Sendo EG, Dinegde NG, Desalew A
International Journal of Women's Health 2021, 13:101-110
RETRACTED ARTICLE: Regulatory Effect of miR497-5p–CCNE1 Axis in Triple-Negative Breast Cancer Cells and Its Predictive Value for Early Diagnosis
Liu WW, Li WD, Zhang YJ, Zhang ML
Cancer Management and Research 2021, 13:439-447
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?
Fleury E, Nimir C, D'Alessandro GS
Breast Cancer: Targets and Therapy 2021, 13:45-58
MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway
Guo J, Luo C, Yang Y, Dong J, Guo Z, Yang J, Lian H, Ye C, Liu M
Cancer Management and Research 2021, 13:403-413
Anatomic Landmark Technique Thoracic Paravertebral Nerve Block as a Sole Anesthesia for Modified Radical Mastectomy in a Resource-Poor Setting: A Clinical Case Report
Zemedkun A, Destaw B, Milkias M
Local and Regional Anesthesia 2021, 14:1-5
Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer
Liu F, Wu H
Journal of Inflammation Research 2021, 14:97-114
Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers
McAlarnen L, Stearns K, Uyar D
Patients’ Responses to the Sudden Interruption of Chemotherapy During the Outbreak of the Novel Coronavirus: A Cross-Sectional Study
Zhang H, Yin J, Wang X, Yuan D, Zhu K, Li K, Xu G, Dang C, Jia R, Zhang Y
Cancer Management and Research 2021, 13:351-358
Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum]
Lv Y, Jun Y, Tang Z, Li X, Tao M, Zhang Z, Liu L, Sun S, Wang Q, Luo C, Zhang L
International Journal of Nanomedicine 2021, 16:237-238
Malignancy Risk Stratification Prediction of Amorphous Calcifications Based on Clinical and Mammographic Features
Shen L, Ma X, Jiang T, Shen X, Yang W, You C, Peng W
Cancer Management and Research 2021, 13:235-245
Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer
Huang Z, Tan Q, Qin Q, Mo Q, Wei C
Cancer Management and Research 2021, 13:319-327
Capsaicin Inhibits Proliferation and Induces Apoptosis in Breast Cancer by Down-Regulating FBI-1-Mediated NF-κB Pathway
Chen M, Xiao C, Jiang W, Yang W, Qin Q, Tan Q, Lian B, Liang Z, Wei C
Drug Design, Development and Therapy 2021, 15:125-140
Information Needs of Breast Cancer Patients Attending Care at Tikur Anbessa Specialized Hospital: A Descriptive Study
Legese B, Addissie A, Gizaw M, Tigneh W, Yilma T
Cancer Management and Research 2021, 13:277-286
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
da Silva JL, Rodrigues FR, de Mesquita GG, Fernandes PV, Thuler LCS, de Melo AC
Breast Cancer: Targets and Therapy 2021, 13:31-44
Predictive Factors Among Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in T1-T2 Breast Cancer
Minami S, Sakimura C, Irie J, Tokai Y, Okubo H, Ohno T
Cancer Management and Research 2021, 13:215-223
Distance Between the Tumour and Nipple as a Predictor of Axillary Lymph Node Involvement in Breast Cancer
Yang J, Yang Q, Mukherjee A, Lv Q
Cancer Management and Research 2021, 13:193-199
miR-1298-5p Influences the Malignancy Phenotypes of Breast Cancer Cells by Inhibiting CXCL11
Zhang J, Hu D
Cancer Management and Research 2021, 13:133-145
Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
Yang H, Jiang F, Ji X, Wang L, Wang Y, Zhang L, Tang Y, Wang D, Luo Y, Li N, Wang Q, Zou J
International Journal of Nanomedicine 2021, 16:105-117
The Association Between Smartphone Use and Breast Cancer Risk Among Taiwanese Women: A Case–Control Study [Response to Letter]
Shih YW, Tsai HT
Cancer Management and Research 2021, 13:89-90
Breast Cancer Screening Practices in a Tertiary Care Center in the State of Qatar: A Cross-Sectional Survey
Parambil JV, Najim M, Mahmoud M, Abubeker IY, Kartha A, Calaud F, Al-Mohamed A, Al-Mohannadi D, Chandra P, A Yassin M
Breast Cancer: Targets and Therapy 2021, 13:21-30
SnO2-Doped ZnO/Reduced Graphene Oxide Nanocomposites: Synthesis, Characterization, and Improved Anticancer Activity via Oxidative Stress Pathway
Ahamed M, Akhtar MJ, Khan MAM, Alhadlaq HA
International Journal of Nanomedicine 2021, 16:89-104
Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia
Assefa AA, Abera G, Geta M
Breast Cancer: Targets and Therapy 2021, 13:9-19
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients
Purwanto I, Heriyanto DS, Widodo I, Hakimi M, Hardianti MS, Aryandono T, Haryana SM
Circ_0004771 Accelerates Cell Carcinogenic Phenotypes via Suppressing miR-1253-Mediated DDAH1 Inhibition in Breast Cancer
Ding X, Zheng J, Cao M
Cancer Management and Research 2021, 13:1-11
Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
Skubalova Z, Rex S, Sukupova M, Zahalka M, Skladal P, Pribyl J, Michalkova H, Weerasekera A, Adam V, Heger Z
BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells
Alhoshani A, Alatawi FO, Al-Anazi FE, Attafi IM, Zeidan A, Agouni A, El Gamal HM, Shamoon LS, Khalaf S, Korashy HM
OncoTargets and Therapy 2020, 13:13357-13370
Comparison of Diagnostic Efficacy Between Contrast-Enhanced Ultrasound and DCE-MRI for Mass- and Non-Mass-Like Enhancement Types in Breast Lesions
Liu W, Zong M, Gong HY, Ling LJ, Ye XH, Wang S, Li CY
Cancer Management and Research 2020, 12:13567-13578
Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer
Yin Y, Yang H, Liu Z, Tan J, Zhu C, Chen M, Zhou R, Wang L, Qian J
Cancer Management and Research 2020, 12:13479-13487
Comparisons of Therapeutic and Aesthetic Effects of One-Stage Implant-Based Breast Reconstruction with and without Biological Matrix
Gao P, Wang Z, Kong X, Wang X, Fang Y, Wang J
Cancer Management and Research 2020, 12:13381-13392
Comparative Study of Lipophilic Statin Activity in 2D and 3D in vitro Models of Human Breast Cancer Cell Lines MDA-MB-231 and MCF-7
Bytautaite M, Petrikaite V
OncoTargets and Therapy 2020, 13:13201-13209
Interactions Between lncRNA TUG1 and miR-9-5p Modulate the Resistance of Breast Cancer Cells to Doxorubicin by Regulating eIF5A2
Wang S, Cheng M, Zheng X, Zheng L, Liu H, Lu J, Liu Y, Chen W
OncoTargets and Therapy 2020, 13:13159-13170
The Detection of Plasma Soluble Podoplanin of Patients with Breast Cancer and Its Clinical Signification
Zhu X, Xu M, Zhao X, Shen F, Ruan C, Zhao Y
Cancer Management and Research 2020, 12:13207-13214
MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression
Ma H, Liu T, Xu Y, Wang X, Wang J, Liu X
OncoTargets and Therapy 2020, 13:12987-12997
Resatorvid Relieves Breast Cancer Complicated with Depression by Inactivating Hippocampal Microglia Through TLR4/NF-κB/NLRP3 Signaling Pathway
Luo W, Han Y, Meng P, Yang Q, Zhao H, Ling J, Wang Y
Cancer Management and Research 2020, 12:13003-13014
Metastasis of Ovarian Cancer to Breast: A Case Report and Review of Imaging Manifestations
Wang J, Wang B
Cancer Management and Research 2020, 12:13015-13021
Niraparib as Maintenance Therapy in Germline ATM-mutated and Somatic BRCA2-mutated Ovarian Cancer with Brain Metastases: A Case Report and Literature Review
Tao M, Cheng J, Wu X
OncoTargets and Therapy 2020, 13:12979-12986
Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis
Dong K, Zhao ZZ, Kang J, Lin LR, Chen WT, Liu JX, Wu XL, Lu TL
International Journal of Nanomedicine 2020, 15:10285-10304
Effect of Ect2 Expression on the Growth of Triple-Negative Breast Cancer Cells with Paclitaxel Intervention
Wang H, Liu H, Li J, Wei S, Liu X, Wan H, Zheng P, Zheng H
OncoTargets and Therapy 2020, 13:12905-12918
Case Report: Metachronous Quadruple Cancers Including Breast Cancer and Triple Genital Cancer
Bai J, Xie Z, Sun L
International Journal of General Medicine 2020, 13:1575-1580
Expression and Importance of TMED2 in Multiple Myeloma Cells
Ge X, Jiang W, Jiang Y, Lv X, Liu X, Wang X
Cancer Management and Research 2020, 12:12895-12903
Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
Yang J, Han J, Tian M, Tian K, Liao W, Yan X
Cancer Management and Research 2020, 12:12905-12913
Long Noncoding RNA SNHG22 Induces Cell Migration, Invasion, and Angiogenesis of Gastric Cancer Cells via microRNA-361-3p/HMGA1/Wnt/β-Catenin Axis
Cui X, Zhang H, Chen T, Yu W, Shen K
Cancer Management and Research 2020, 12:12867-12883
The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia
Kumie G, Melak T, Wondifraw Baynes H
Breast Cancer: Targets and Therapy 2020, 12:279-287
Platelet-Mimicking Drug Delivery Nanoparticles for Enhanced Chemo-Photothermal Therapy of Breast Cancer
Pei W, Huang B, Chen S, Wang L, Xu Y, Niu C
International Journal of Nanomedicine 2020, 15:10151-10167
A Fibroblast-Derived Human Growth Factor Preparation for the Management of Acute Radiodermatitis: A Case Report
Vadarli G, Angelo-Khattar M
International Medical Case Reports Journal 2020, 13:691-696
Reliability and Validity of the Arabic Version of the EORTC QLQ-C30 and QLQ-BR23 Questionnaires
Jassim G, AlAnsari A
Neuropsychiatric Disease and Treatment 2020, 16:3045-3052
Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
Yan H, Xiao H, Zhu J, Zhang J, Liu Z
Cancer Management and Research 2020, 12:12715-12722
Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer
Lv Y, Jun Y, Tang Z, Li X, Tao M, Zhang Z, Liu L, Sun S, Wang Q, Luo C, Zhang L
International Journal of Nanomedicine 2020, 15:10075-10084
Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment
Zheng D, Wan C, Yang H, Xu L, Dong Q, Du C, Du J, Li F
International Journal of Nanomedicine 2020, 15:10007-10028
Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer
Ren S, Wu J, Yin W, Liao Q, Gong S, Xuan B, Mu X
Cancer Management and Research 2020, 12:12635-12647
Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer
Wu J, Luo D, Li S
Breast Cancer: Targets and Therapy 2020, 12:267-277
The Role of Exosomes in the Female Reproductive System and Breast Cancers
Bai Y, Guo J, Liu Z, Li Y, Jin S, Wang T
OncoTargets and Therapy 2020, 13:12567-12586
Research Progress on the Anti-Cancer Molecular Mechanisms of Huaier
Qi T, Dong Y, Gao Z, Xu J
OncoTargets and Therapy 2020, 13:12587-12599
miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
Liu C, Jiang Y, Han B
Cancer Management and Research 2020, 12:12623-12633
Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer
Zheng D, Jiang C, Yan N, Miao Y, Wang K, Gao G, Jiao Y, Zhang X, He M, Yang Z
OncoTargets and Therapy 2020, 13:12649-12659
LncRNA NLIPMT Inhibits Tumorigenesis in Esophageal Squamous-Cell Carcinomas by Regulating miR-320/Survivin Axis
Li D, Li D, Meng L, Liu J, Huang C, Sun H
Cancer Management and Research 2020, 12:12603-12612
Regarding: “The Association Between Smartphone Use and Breast Cancer Risk Among Taiwanese Women: A Case-Control Study” [Letter]
Mortazavi SMJ, Abbasi S, Mortazavi SA
Cancer Management and Research 2020, 12:12535-12536
Xanthohumol Inhibits TGF-β1-Induced Cardiac Fibroblasts Activation via Mediating PTEN/Akt/mTOR Signaling Pathway
Jiang C, Xie N, Sun T, Ma W, Zhang B, Li W
Drug Design, Development and Therapy 2020, 14:5431-5439
H19 Knockdown Suppresses Proliferation and Induces Apoptosis by Regulating miR-130a-3p/SATB1 in Breast Cancer Cells
Zhong G, Lin Y, Wang X, Wang K, Liu J, Wei W
OncoTargets and Therapy 2020, 13:12501-12513
Green Synthesis of Silver Nanoparticles Using Extract of Jasminum officinal L. Leaves and Evaluation of Cytotoxic Activity Towards Bladder (5637) and Breast Cancer (MCF-7) Cell Lines
Elhawary S, EL-Hefnawy H, Alzahraa FA, Sobeh M, Mostafa E, Osman S, El-Raey M
International Journal of Nanomedicine 2020, 15:9771-9781
Effects of Annona muricata Extract on Triple-Negative Breast Cancer Cells Mediated Through EGFR Signaling
Alshaeri HK, Alasmari MM, Natto ZS, Pino-Figueroa A
Cancer Management and Research 2020, 12:12519-12526
α-MSH-PE38KDEL Kills Melanoma Cells via Modulating Erk1/2/MITF/TYR Signaling in an MC1R-Dependent Manner
Liu X, Li H, Cong X, Huo D, Cong L, Wu G
OncoTargets and Therapy 2020, 13:12457-12469
The Effect of Low and High Vacuum Drainage on the Postoperative Drainage of Breast Cancer: Insights from a Prospective, Non-Inferiority, Randomized Clinical Trial
Lin W, Yang Y, Zhong W, Lin Q, Rao N, Liang G, Ling Y, Liu Z, Luo Q, Tian Z, Gong C
Cancer Management and Research 2020, 12:12487-12496
Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer
Lyu L, Wang M, Zheng Y, Tian T, Deng Y, Xu P, Lin S, Yang S, Zhou L, Hao Q, Wu Y, Dai Z, Kang H
Cancer Management and Research 2020, 12:12457-12471
Survival Analysis of Patients with Inflammatory Breast Cancer in Relation to Clinical and Histopathological Characteristics
Preda M, Ilina R, Potre O, Potre C, Mazilu O
Cancer Management and Research 2020, 12:12447-12455
Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization
Mehanna MM, Sarieddine R, Alwattar JK, Chouaib R, Gali-Muhtasib H
International Journal of Nanomedicine 2020, 15:9557-9570
Identification by Comprehensive Bioinformatics Analysis of KIF15 as a Candidate Risk Gene for Triple-Negative Breast Cancer
Sheng J, Li C, Dong M, Jiang K
Cancer Management and Research 2020, 12:12337-12348
Genetic Variability in the microRNA Binding Sites of BMPR1B, TGFBR1, IQGAP1, KRAS, SETD8 and RYR3 and Risk of Breast Cancer in Colombian Women
Garcia Mesa K, Bermejo JL, Torres D, Gilbert M, Plass C, Hamann U
OncoTargets and Therapy 2020, 13:12281-12287
Patient Participation in Multidisciplinary Tumor Conferences from the Providers’ Perspective: Is It Feasible in Routine Cancer Care?
Heuser C, Diekmann A, Schellenberger B, Bohmeier B, Kuhn W, Karbach U, Ernstmann N, Ansmann L
Journal of Multidisciplinary Healthcare 2020, 13:1729-1739
Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
Mlole AT, Yahaya JJ, Othieno E, Kalungi S, Okwi AL
International Journal of Women's Health 2020, 12:1109-1123
The Prevalence of Sarcopenic Obesity in Postmenopausal Women with a History of Breast Cancer Depending on Adopted Methodology – A Case–Control Study
Kałędkiewicz E, Milewska M, Panczyk M, Szostak-Węgierek D
Journal of Multidisciplinary Healthcare 2020, 13:1749-1758
Long Non-Coding RNA A2M-AS1 Promotes Breast Cancer Progression by Sponging microRNA-146b to Upregulate MUC19
Liu Y, Zhang Q, Wu J, Zhang H, Li X, Zheng Z, Luo M, Li L, Xiang Y, Yang F, Wu L
International Journal of General Medicine 2020, 13:1305-1316
MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer
Tao Z, Suo H, Zhang L, Jin Z, Wang Z, Wang D, Wu M, Peng N, Zhao Y, Chen B
OncoTargets and Therapy 2020, 13:12255-12268
Psychological Resilience and Health-Related Quality of Life in Swedish Women with Newly Diagnosed Breast Cancer
Mohlin Å, Axelsson U, Bendahl PO, Borrebaeck C, Hegardt C, Johnsson P, Rahm Hallberg I, Rydén L
Cancer Management and Research 2020, 12:12041-12051
Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer
Wang Y, Shan BJ, Shen XB, Zheng CC, Wang JQ, Li GL, Pan YY
Cancer Management and Research 2020, 12:12021-12028
A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
Kunnuru SKR, Thiyagarajan M, Martin Daniel J, Singh K B
Breast Cancer: Targets and Therapy 2020, 12:259-266
Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer
Bacinschi XE, Zgura A, Safta I, Anghel R
Cancer Management and Research 2020, 12:11965-11971
A Descriptive Cross-Sectional Study on Awareness and Belief of People About Cancer in Southern Ethiopia: Special Focus on Breast and Cervical Cancers
Labisso WL, Leka Y, Leka Y, Haileselassie W
Risk Management and Healthcare Policy 2020, 13:2655-2668
Combined Therapy Can Improve the Outcomes of Breast Cancer with Isolated Supraclavicular Lymph Node Involvement
Ma T, Mao Y, Wang H
Cancer Management and Research 2020, 12:11857-11869
RETRACTED ARTICLE: Histone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis
Liu J, Li D, Zhang X, Li Y, Ou J
OncoTargets and Therapy 2020, 13:11957-11973
Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data
Armaghani AJ, Han HS
Breast Cancer: Targets and Therapy 2020, 12:251-258
ATAS Acupuncture Reduces Chemotherapy Induced Fatigue in Breast Cancer Through Regulating ADROA1 Expression: A Randomized Sham-Controlled Pilot Trial
Li YF, Liu DQ, Nie JY, Chen DD, Yan M, Zuo Z, Liu LX, Wang WY, Zhu MS, Li WH
OncoTargets and Therapy 2020, 13:11743-11754
89Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem Cell Targeted Therapy
Yang R, Lu M, Ming L, Chen Y, Cheng K, Zhou J, Jiang S, Lin Z, Chen D
International Journal of Nanomedicine 2020, 15:9061-9074
FOXN4 Inhibits Breast Cancer Progression by Direct Activation of P53 [Retraction]
Ye H, Duan M
OncoTargets and Therapy 2020, 13:11741-11742
18F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model
Li X, Yin G, Ji W, Liu J, Zhang Y, Wang J, Zhu X, Zhu L, Dai D, Ma W, Xu W
OncoTargets and Therapy 2020, 13:11659-11668
Perioperative Analgesic Modalities for Breast Cancer Surgeries: A Prospective Randomized Controlled Trial
Elsabeeny WY, Shehab NN, Wadod MA, Elkady MA
Journal of Pain Research 2020, 13:2885-2894
Metastases to the Breast from Extramammary Nonhematological Malignancies: Case Series
Wan X, Zhang H, Zhang Y, Peng Y
International Journal of General Medicine 2020, 13:1105-1114
Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial
Macchia G, Cilla S, Buwenge M, Zamagni A, Ammendolia I, Zamagni C, Frezza GP, Valentini V, Deodato F, Morganti AG
Breast Cancer: Targets and Therapy 2020, 12:243-249
CircPVT1 Promoted the Progression of Breast Cancer by Regulating MiR-29a-3p-Mediated AGR2-HIF-1α Pathway
Wang J, Huang K, Shi L, Zhang Q, Zhang S
Cancer Management and Research 2020, 12:11477-11490
Resistance and Overcoming Resistance in Breast Cancer
Luque-Bolivar A, Pérez-Mora E, Villegas VE, Rondón-Lagos M
Breast Cancer: Targets and Therapy 2020, 12:211-229
Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women
Al-Mousa DS, Alakhras M, Hossain SZ, Al-Sa’di AG, Al Hasan M, Al-Hayek Y, Brennan PC
Breast Cancer: Targets and Therapy 2020, 12:231-242
Prognostic Significance of a Novel Score Model Based on Preoperative Indicators in Patients with Breast Cancer Spine Metastases (BCSM)
Zhao C, Wang Y, Cai X, Xu W, Wang D, Wang T, Jia Q, Gong H, Sun H, Wu Z, Xiao J
Cancer Management and Research 2020, 12:11501-11513
Prognostic Significance of Inflammatory Biomarkers in Patients with Breast Cancer Skeletal Metastases
Wang Y, Huang G, Li Z
Cancer Management and Research 2020, 12:11463-11475
Overexpression of lncRNA TATDN1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Regulating miR-26b Methylation
Long Q, Li H, Fan Y, Zhang J
Cancer Management and Research 2020, 12:11403-11410
Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Experiment and Best–Worst Scaling
Maculaitis MC, Liu X, Will O, Hanson M, McRoy L, Berk A, Crastnopol M
Patient Preference and Adherence 2020, 14:2201-2214
LncRNA Lnc712 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting miR-142-3p/Bach-1 Axis
Cui D, Ni C
Cancer Management and Research 2020, 12:11285-11294
Circ_0061825 Acts as a miR-593-3p Sponge to Promote Breast Cancer Progression by Regulating FGFR3 Expression
Xie J, Wan Y, Zhang M, Jin Z, Yao Y
Cancer Management and Research 2020, 12:11243-11255
Knowledge and Practice of Breast Self-Examination Among Young Women in Tertiary Education in Addis Ababa, Ethiopia
Dinegde NG, Demie TG, Diriba AB
Breast Cancer: Targets and Therapy 2020, 12:201-210
Prevalence of Depression and the Quality-of-Life of Breast Cancer Patients in Jordan
Alquraan L, Alzoubi KH, Rababa’h S, Karasneh R, Al-azzam S, Al-Azayzih A
Journal of Multidisciplinary Healthcare 2020, 13:1455-1462
Circ_0072995 Promotes Cell Carcinogenesis via Up-Regulating miR-149-5p-Mediated SHMT2 in Breast Cancer
Qi C, Qin X, Zhou Z, Wang Y, Yang Q, Liao T
Cancer Management and Research 2020, 12:11169-11181
Patient Delay and Contributing Factors Among Breast Cancer Patients at Two Cancer Referral Centres in Ethiopia: A Cross-Sectional Study
Tesfaw A, Demis S, Munye T, Ashuro Z
Journal of Multidisciplinary Healthcare 2020, 13:1391-1401
Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy
Guimei M, Alrouh S, Saber-Ayad M, Hafezi SA, Vinod A, Rawat S, Wardeh Y, Bakkour TM, El-Serafi AT
Breast Cancer: Targets and Therapy 2020, 12:189-199
Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
Lu W, Zang R, Du Y, Li X, Li H, Liu C, Song Y, Li Y, Wang Y
Cancer Management and Research 2020, 12:11095-11102
Long-Chain Non-Coding SOX21-AS1 Promotes Proliferation and Migration of Breast Cancer Cells Through the PI3K/AKT Signaling Pathway
Sheng XY, Wang CH, Wang CF, Xu HY
Cancer Management and Research 2020, 12:11005-11014
Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7
Abdellatif AAH, Rasheed Z, Alhowail AH, Alqasoumi A, Alsharidah M, Khan RA, Aljohani ASM, Aldubayan MA, Faisal W
International Journal of Nanomedicine 2020, 15:8479-8493
pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer
Cao Z, Li W, Liu R, Li C, Song Y, Liu G, Chen Y, Lu C, Lu A, Liu Y
International Journal of Nanomedicine 2020, 15:8369-8382
Upregulated Long Non-Coding RNA LL22NC03-N64E9.1 Promotes the Proliferation and Migration of Human Breast Cancer Cells by Silencing Kruppel-Like Factor 2 Expression
Lian W, Jiang X, Li L, Wang Q, Hong C, Yang P, Chen D
Cancer Management and Research 2020, 12:10763-10770
The Association Between Smartphone Use and Breast Cancer Risk Among Taiwanese Women: A Case-Control Study
Shih YW, Hung CS, Huang CC, Chou KR, Niu SF, Chan S, Tsai HT
Cancer Management and Research 2020, 12:10799-10807
LncRNA ADAMTS9-AS1 Restrains the Aggressive Traits of Breast Carcinoma Cells via Sponging miR-513a-5p
Fang SQ, Zhao Y, Hu XZ
Cancer Management and Research 2020, 12:10693-10703
Anti-Breast Cancer Effect of 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione in vivo and in vitro Through MAPK Signaling Pathway [Corrigendum]
Zhou X, Wu X, Qin L, Lu S, Zhang H, Wei J, Chen L, Jiang L, Wu Y, Chen C, Huang R
Drug Design, Development and Therapy 2020, 14:4575-4577
Breast Self-Examination Practice Among Women in Jimma, Southwest Ethiopia: A Community-Based Cross-Sectional Study
Biratu Terfa Y, Bayana Kebede E, Olani Akuma A
Breast Cancer: Targets and Therapy 2020, 12:181-188
MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC
Li Q, Xiao Q, Li J, Duan S, Wang H, Gu Y
Cancer Management and Research 2020, 12:10603-10613
A Validation of Methods for the Evaluation of Observational Studies of Screening Mammography: An Exploratory Analysis Based on Simulating Screening Cohorts
Giannakeas V, Sopik V, Narod S
Clinical Epidemiology 2020, 12:1161-1169
Incidence and Clinicopathological Features of Breast Cancer in the Northern Emirates: Experience from Sharjah Breast Care Center
Bendardaf R, Saheb Sharif-Askari F, Saheb Sharif-Askari N, Guraya SY, A AlMadhi Sawsan, Abusnana S
International Journal of Women's Health 2020, 12:893-899
Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options
Gampenrieder SP, Castagnaviz V, Rinnerthaler G, Greil R
Cancer Management and Research 2020, 12:10615-10629
Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions
Farcas CG, Dehelean C, Pinzaru IA, Mioc M, Socoliuc V, Moaca EA, Avram S, Ghiulai R, Coricovac D, Pavel I, Alla PK, Cretu OM, Soica C, Loghin F
International Journal of Nanomedicine 2020, 15:8175-8200
Synthesis, Cytotoxic Analysis, and Molecular Docking Studies of Tetrazole Derivatives via N-Mannich Base Condensation as Potential Antimicrobials
Atef Hatamleh A, Al Farraj D, Salah Al-Saif S, Chidambaram S, Radhakrishnan S, Akbar I
Drug Design, Development and Therapy 2020, 14:4477-4492
Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy
Dorjsuren B, Chaurasiya B, Ye Z, Liu Y, Li W, Wang C, Shi D, Evans CE, Webster TJ, Shen Y
International Journal of Nanomedicine 2020, 15:8201-8215
A Model to Predict the Risk of Lymph Node Metastasis in Breast Cancer Based on Clinicopathological Characteristics
Chen W, Wang C, Fu F, Yang B, Chen C, Sun Y
Cancer Management and Research 2020, 12:10439-10447
ATP6AP2 is Overexpressed in Breast Cancer and Promotes Breast Cancer Progression
Zhao K, Wang M, Wu A
Cancer Management and Research 2020, 12:10449-10459
Polysaccharides Derived from Saposhnikovia divaricata May Suppress Breast Cancer Through Activating Macrophages
Ding J, Guo Y, Jiang X, Li Q, Li K, Liu M, Fu W, Cao Y
OncoTargets and Therapy 2020, 13:10749-10757
SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
Rattanacheeworn P, Chamnanphon M, Thongthip S, Kittanamongkolchai W, Townamchai N, Avihingsanon Y, Udomnilobol U, Prueksaritanont T, Jianmongkol S, Chariyavilaskul P
Pharmacogenomics and Personalized Medicine 2020, 13:521-530
Gold Nanoparticles Mediated Drug-Gene Combinational Therapy for Breast Cancer Treatment
Shrestha B, Wang L, Zhang H, Hung CY, Tang L
International Journal of Nanomedicine 2020, 15:8109-8119
Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer
Shibabaw T, Teferi B, Molla MD, Ayelign B
Breast Cancer: Targets and Therapy 2020, 12:165-180
Genetic Liability to Smoking and Breast Cancer Risk
Xu Z, Xu H, Lu Y
Clinical Epidemiology 2020, 12:1145-1148
Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development
Kok VC, Yu CC
International Journal of Nanomedicine 2020, 15:8019-8036
Blood Transfusion and the Risk of Cancer in the US Population: Is There an Association?
El-Qushayri AE, Ghozy S, Morsy S, Ali F, Islam SMS
Clinical Epidemiology 2020, 12:1121-1127
Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer
Kase AM, Copland III JA, Tan W
OncoTargets and Therapy 2020, 13:10499-10513
Dynamic Changes of Blood Lipids in Breast Cancer Patients After (Neo)adjuvant Chemotherapy: A Retrospective Observational Study
Xu L, Dong Q, Long Y, Tang X, Zhang N, Lu K
International Journal of General Medicine 2020, 13:817-823
The Evolving Role of Disulfiram in Radiobiology and the Treatment of Breast Cancer
Wang R, Shen J, Yan H, Gao X, Dong T, Wang P, Zhou J
OncoTargets and Therapy 2020, 13:10441-10446
Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries
Pedersen RN, Öztürk B, Mellemkjær L, Friis S, Tramm T, Nørgaard M, Cronin-Fenton DP
Clinical Epidemiology 2020, 12:1083-1093
LncRNA-SNHG7 Enhances Chemotherapy Resistance and Cell Viability of Breast Cancer Cells by Regulating miR-186
Zhang H, Zhang XY, Kang XN, Jin LJ, Wang ZY
Cancer Management and Research 2020, 12:10163-10172
Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility
Dobiasova B, Mego M
Breast Cancer: Targets and Therapy 2020, 12:153-163
Triple Discordances in Receptor Status During Breast Cancer Local Progression and Metastases: Case Report and Literature Review
Martuszewski A, Paluszkiewicz P, Nowak M, Szewczyk K, Staszek-Szewczyk U
OncoTargets and Therapy 2020, 13:10343-10349
Hsa_circ_0003645 Promotes Breast Cancer Progression by Regulating miR-139-3p/HMGB1 Axis
Zhang J, Ke S, Zheng W, Zhu Z, Wu Y
OncoTargets and Therapy 2020, 13:10361-10372
Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications
Hadjipanteli A, Doolan P, Kyriacou E, Constantinidou A
Cancer Management and Research 2020, 12:9953-9964
Synergetic Influence of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-Rich Fraction on Reactive Oxygen Species Generation and Radiosensitization Effects for Clinical Radiotherapy Beams
Talik Sisin NN, Abdul Razak K, Zainal Abidin S, Che Mat NF, Abdullah R, Ab Rashid R, Khairil Anuar MA, Rahman WN
International Journal of Nanomedicine 2020, 15:7805-7823
The Novel Circular RNA Circ-PGAP3 Promotes the Proliferation and Invasion of Triple Negative Breast Cancer by Regulating the miR-330-3p/Myc Axis
He D, Yang X, Kuang W, Huang G, Liu X, Zhang Y
OncoTargets and Therapy 2020, 13:10149-10159
A Novel Imidazopyridine Derivative Exhibits Anticancer Activity in Breast Cancer by Inhibiting Wnt/β‑catenin Signaling
He LJ, Yang DL, Chen HY, Huang JH, Zhang YJ, Qin HX, Wang JL, Tang DY, Chen ZZ
OncoTargets and Therapy 2020, 13:10111-10121
Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity
Saif MW
OncoTargets and Therapy 2020, 13:10197-10206
Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
Sales ACV, Gomes da Silva IIF, Leite MCB, Coutinho LL, Reis RBAC, Castoldi A, B. G. Martins D, Lima-Filho JL, Souto FO
Breast Cancer: Targets and Therapy 2020, 12:141-151
Do Men and Women in Saudi Arabia Have the Same Level of Awareness and Knowledge of Breast Cancer? A Cross-Sectional Study
Farsi NJ, Al-Wassia R, Merdad L
Breast Cancer: Targets and Therapy 2020, 12:131-139
Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam
Phung HT, Thi Nguyen H, Nguyen TV, Nguyen TV, Dinh LAT, Nguyen CV
Breast Cancer: Targets and Therapy 2020, 12:117-122
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
Adehin A, Kennedy MA, Soyinka JO, Alatise OI, Olasehinde O, Bolaji OO
Breast Cancer: Targets and Therapy 2020, 12:123-130
ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells
Wang F, Xiang Z, Huang T, Zhang M, Zhou WB
Cancer Management and Research 2020, 12:9725-9734
Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study
Fianu Jonasson A, Bixo M, Sundström Poromaa I, Åstrom M
Medical Devices: Evidence and Research 2020, 13:339-347
A Review on the Role of Denosumab in Fracture Prevention
Pang KL, Low NY, Chin KY
Drug Design, Development and Therapy 2020, 14:4029-4051
Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
Shi J, Liu F, Song Y
Cancer Management and Research 2020, 12:9375-9387
MicroRNA-139 Suppresses the Tumorigenicity of Triple Negative Breast Cancer Cells by Targeting SOX8
Dong L, Zhou D, Xin C, Liu B, Sun P
Cancer Management and Research 2020, 12:9417-9428
LINC01087 is Highly Expressed in Breast Cancer and Regulates the Malignant Behavior of Cancer Cells Through miR-335-5p/Rock1
She JK, Fu DN, Zhen D, Gong GH, Zhang B
OncoTargets and Therapy 2020, 13:9771-9783
A Staphylococcus aureus Coinfection on a COVID-19 Pneumonia in a Breast Cancer Patient
Spoto S, Valeriani E, Riva E, De Cesaris M, Tonini G, Vincenzi B, Locorriere L, Beretta Anguissola G, Lauria Pantano A, Brando E, Costantino S, Ciccozzi M, Angeletti S
International Journal of General Medicine 2020, 13:729-733
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial
Cho AR, Choi WJ, Kwon YJ, Lee HS, Ahn SG, Lee JW
Diabetes, Metabolic Syndrome and Obesity 2020, 13:3325-3335
A Retrospective Analysis of Dose Distribution and Toxicity in Patients with Left Breast Cancer Treated with Adjuvant Intensity-Modulated Radiotherapy: Comparison with Three-Dimensional Conformal Radiotherapy
Chen CH, Hsieh CC, Chang CS, Chen MF
Cancer Management and Research 2020, 12:9173-9182
Cancer Incidence and Distribution at a Tertiary Care Hospital in Somalia from 2017 to 2020: An Initial Report of 1306 Cases
Tahtabasi M, Mohamud Abdullahi I, Kalayci M, Gedi Ibrahim I, Er S
Cancer Management and Research 2020, 12:8599-8611
MiR-101-3p and Syn-Cal14.1a Synergy in Suppressing EZH2-Induced Progression of Breast Cancer
Jiang H, Li L, Zhang J, Wan Z, Wang Y, Hou J, Yu Y
OncoTargets and Therapy 2020, 13:9599-9609
Identifying Risk Factors for Regional Recurrence in Early-Stage Breast Cancer with pT1-2 and Negative Sentinel Lymph Node Biopsy
You K, Bi Z, Ding L, Ma Y, Liu Y, Yao H
Cancer Management and Research 2020, 12:9211-9219
Long Non-Coding RNA H19 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Breast Cancer Cells by Targeting miR-491-5p/ZNF703 Axis
Wang Y, Wu Z, Li Y, Zheng Z, Yan J, Tian S, Han L
Cancer Management and Research 2020, 12:9247-9258
RETRACTED ARTICLE: Long-Noncoding RNA CASC9 Promotes Progression of Non-Small Cell Lung Cancer by Promoting the Expression of CDC6 Through Binding to HuR
Zhang X, Lian T, Fan W, Zhang G, Chen Z, Gou X, Jha RK
Cancer Management and Research 2020, 12:9033-9043
Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis
Liu G, Zhang Z, Song Q, Guo Y, Bao P, Shui H
OncoTargets and Therapy 2020, 13:9497-9511
The Prognostic Value of Combination of Plasma Fibrinogen and CA19-9 in Non-Distant Metastatic Breast Cancer Patients Undergoing Surgery
Hu W, Zheng C, Quan R, Dai X, Zhang X
Cancer Management and Research 2020, 12:8875-8886
RETRACTED ARTICLE: Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells
Ren F, Shrestha C, Shi H, Sun F, Zhang M, Cao Y, Li G
OncoTargets and Therapy 2020, 13:9419-9428
Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling
Jia Z, Zhu H, Sun H, Hua Y, Zhang G, Jiang J, Wang X
Cancer Management and Research 2020, 12:8733-8744
Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy
Ye JH, Shi JJ, Yin X, Wu HY, Xu XY, Yao YZ, Zhang WJ
Cancer Management and Research 2020, 12:8887-8892
Association of Silicone Breast Implants, Breast Cancer and Anti-RNA Polymerase III Autoantibodies in Systemic Sclerosis: Case-Based Review
De Angelis R, Di Battista J, Smerilli G, Cipolletta E, Di Carlo M, Salaffi F
Open Access Rheumatology: Research and Reviews 2020, 12:207-213
Breast Cancer Detection Using Low-Frequency Bioimpedance Device
Mansouri S, Alhadidi T, Ben Azouz M
Breast Cancer: Targets and Therapy 2020, 12:109-116
Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial–Mesenchymal Transition
Wen J, Lin L, Lin B, Xia E, Qu J, Wang O
Cancer Management and Research 2020, 12:8631-8642
Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
Zeleke Alem A, Gebeye Zeleke E, Akalu TY
Breast Cancer: Targets and Therapy 2020, 12:97-108
Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab
Che YQ, Zhang Y, Ou KP, Wang D, Shen D, Liu HY, Luo Y
Cancer Management and Research 2020, 12:8527-8534
RETRACTED ARTICLE: Long Non-Coding RNA LINC01089 Enhances the Development of Gastric Cancer by Sponging miR-145-5p to Mediate SOX9 Expression
Wang F, Yang Q
OncoTargets and Therapy 2020, 13:9213-9224
The Association Between Illness Acceptance and Quality of Life in Women with Breast Cancer
Jankowska-Polańska B, Świątoniowska-Lonc N, Ośmiałowska E, Gałka A, Chabowski M
Cancer Management and Research 2020, 12:8451-8464
Cancer Cell-Erythrocyte Hybrid Membrane Coated Gold Nanocages for Near Infrared Light-Activated Photothermal/Radio/Chemotherapy of Breast Cancer
Sun M, Duan Y, Ma Y, Zhang Q
International Journal of Nanomedicine 2020, 15:6749-6760
Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer
Li X, Zou Q, Zhang J, Zhang P, Zhou X, Yalamarty SSK, Liang X, Liu Y, Zheng Q, Gao J
International Journal of Nanomedicine 2020, 15:6791-6811
Effects of Chemotherapy on Serum Lipids in Chinese Postoperative Breast Cancer Patients
Lu Q, Wu X, Zhu Y, Yang J, Wang X, Ye C, Cai R, Zhang K, Xu T, Wang B, Veeramootoo JS, Xia T, Liu X
Cancer Management and Research 2020, 12:8397-8408
Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer
Yan S, Wang W, Zhu B, Pan X, Wu X, Tao W
Cancer Management and Research 2020, 12:8313-8323
Synthesis, Characterization and Anti-Cancer Therapeutic Potential of Withanolide-A with 20nm sAuNPs Conjugates Against SKBR3 Breast Cancer Cell Line
Tabassam Q, Mehmood T, Raza AR, Ullah A, Saeed F, Anjum FM
International Journal of Nanomedicine 2020, 15:6649-6658
Down-Regulation of CCL17 in Cancer-Associated Fibroblasts Inhibits Cell Migration and Invasion of Breast Cancer Through ERK1/2 Pathway [Retraction]
Li J, Yang C, Yang J, Zou L
Cancer Management and Research 2020, 12:8115-8116
Can Anti-Müllerian Hormone Be a Reliable Biomarker for Assessing Ovarian Function in Women Postchemotherapy?
Li X, Liu S, Ma L, Chen X, Weng H, Huang R, Yu Y, Zong X
Cancer Management and Research 2020, 12:8171-8181
RETRACTED ARTICLE: MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK
Zhang W, Liao K, Liu D
Cancer Management and Research 2020, 12:8137-8147
Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer
Ye S, Xu Y, Wang L, Zhou K, He J, Lu J, Huang Q, Sun P, Wang T
OncoTargets and Therapy 2020, 13:8887-8899
PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date
Nizialek E, Antonarakis ES
Cancer Management and Research 2020, 12:8105-8114
LncRNA PVT1 Regulates TRPS1 Expression in Breast Cancer by Sponging miR-543
Wang H, Huang Y, Yang Y
Cancer Management and Research 2020, 12:7993-8004
Moxibustion Enhances Chemotherapy of Breast Cancer by Affecting Tumor Microenvironment
Xue N, Fu X, Zhu Y, Da N, Zhang J
Cancer Management and Research 2020, 12:8015-8022
Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases
Chen K, Zhang F, Fan Y, Cheng G
OncoTargets and Therapy 2020, 13:8837-8844
Sodium Butyrate Combined with Docetaxel for the Treatment of Lung Adenocarcinoma A549 Cells by Targeting Gli1
Chen M, Jiang W, Xiao C, Yang W, Qin Q, Mao A, Tan Q, Lian B, Wei C
OncoTargets and Therapy 2020, 13:8861-8875
Clinical Practice Status of Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer Patients in China: A Multicenter Study
Zhang J, Wang T, Yan C, Huang M, Fan Z, Ling R
Clinical Epidemiology 2020, 12:917-924
You searched for "breast cancer". We found 60 video(s).
Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer
Liu WL, Zhang YQ, Luo XJ, Zhu YY, Song L, Ming ZH, Zhang LX, Li MJ, Lv RC, Zhang GJ, Chen M
International Journal of Nanomedicine 2023, 18:5141-5157
A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases
Shen F, Huang J, Yang K, Sun C
OncoTargets and Therapy 2023, 16:485-495
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
Klauser AL, Hirschfeld M, Ritter A, Rücker G, Jäger M, Gundarova J, Weiss D, Juhasz-Böss I, Berner K, Erbes T, Asberger J
Breast Cancer: Targets and Therapy 2021, 13:659-673
Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand
Koonmee S, Somintara O, Intarawichian P, Aphivatanasiri C, Sangkhamanon S, Laohawiriyakamol S, Panawattanakul R, Mahantassanapong P, Rattadilok C, Jeeravongpanich P, Krongyute W, Prachumrasee K, Alaghehbandan R
Cancer Management and Research 2021, 13:8737-8753
The Effect of Subsequent Pregnancy on Prognosis in Young Breast Cancer Patients (≤35 Years Old) According to Hormone Receptor Status
Li Y, Zhang Y, Wang S, Lu S, Song Y, Liu H
Cancer Management and Research 2021, 13:1505-1515
Successful Use of Nivolumab in a Patient with Head and Neck Cancer After Allogeneic Bone Marrow Transplantation
Dong X, Lu N, Tong Z, Shi Y
OncoTargets and Therapy 2021, 14:929-936
Triple Discordances in Receptor Status During Breast Cancer Local Progression and Metastases: Case Report and Literature Review
Martuszewski A, Paluszkiewicz P, Nowak M, Szewczyk K, Staszek-Szewczyk U
OncoTargets and Therapy 2020, 13:10343-10349
Polymorphism of XRCC3 in Egyptian Breast Cancer Patients
Alkasaby MK, Abd El-Fattah AI, Ibrahim IH, Abd El-Samie HS
Pharmacogenomics and Personalized Medicine 2020, 13:273-282
Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery
Tsolou A, Angelou E, Didaskalou S, Bikiaris D, Avgoustakis K, Agianian B, Koffa MD
International Journal of Nanomedicine 2020, 15:4899-4918
The Anti-Tumor Effect of Nab-Paclitaxel Proven by Patient-Derived Organoids
Xiao X, Chen W, Wei ZW, Chu WW, Lu XF, Li B, Chen H, Meng SJ, Hao TF, Wei JT, He YL, Zhang CH
OncoTargets and Therapy 2020, 13:6017-6025
Proteomics of Sentinel Lymph Nodes in Early Breast Cancer for Identification of Thymidylate Synthase as a Potential Biomarker to Flag Metastasis: A Preliminary Study
Pathania S, Khan MI, Kumar A, Gupta AK, Rani K, Ramesh Parashar T, Jayaram J, Ranjan Mishra P, Srivastava A, Mathur S, Hari S, Hariprasad G
Cancer Management and Research 2020, 12:4841-4854
New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine – Pre-Clinical and Pilot Human Clinical Investigations
Khoobchandani M, Katti KK, Karikachery AR, Thipe VC, Srisrimal D, Dhurvas Mohandoss DK, Darshakumar RD, Joshi CM, Katti KV
International Journal of Nanomedicine 2020, 15:181-197
The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route
Jiang Y, Liu C, Zhai W, Zhuang N, Han T, Ding Z
International Journal of Nanomedicine 2019, 14:9217-9234
Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model
Mubarik S, Malik SS, Wang Z, Li C, Fawad M, Yu C
Cancer Management and Research 2019, 11:8145-8155
Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis
He L, Wu Q, Xiong J, Su Z, Zhang B, Song Y
Cancer Management and Research 2019, 11:8043-8054
Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line
Kamel AE, Fadel M, Louis D
International Journal of Nanomedicine 2019, 14:5073-5085
The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity
He L, Lv Y, Song Y, Zhang B
Cancer Management and Research 2019, 11:5765-5775
Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer
Yuan H, Qin Y, Zeng B, Feng Y, Li Y, Xiang T, Ren G
OncoTargets and Therapy 2019, 12:4883-4895
Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells
Tambe P, Kumar P, Paknikar KM, Gajbhiye V
International Journal of Nanomedicine 2018, 13:7669-7680
Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer
Yildiz T, Gu R, Zauscher S, Betancourt T
International Journal of Nanomedicine 2018, 13:6961-6986
Physical activity and sociodemographic variables related to global health, quality of life, and psychological factors in breast cancer survivors
Patsou ED, Alexias GT, Anagnostopoulos FG, Karamouzis MV
Psychology Research and Behavior Management 2018, 11:371-381
“Breaking breast cancer news” with ethnic minority: a UK experience
Naseem S
Journal of Multidisciplinary Healthcare 2018, 11:317-322
The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2–) subtype breast cancer by quantum-dot-based molecular imaging
Zhu YY, Chen C, Li JJ, Sun SR
International Journal of Nanomedicine 2018, 13:3795-3803
Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
Rodallec A, Brunel JM, Giacometti S, Maccario H, Correard F, Mas E, Orneto C, Savina A, Bouquet F, Lacarelle B, Ciccolini J, Fanciullino R
International Journal of Nanomedicine 2018, 13:3451-3465
Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers
Patra A, Satpathy S, Shenoy AK, Bush JA, Kazi M, Hussain MD
International Journal of Nanomedicine 2018, 13:2869-2881
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine
De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N
OncoTargets and Therapy 2018, 11:2241-2250
Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma
Lapin NA, Vergara LA, Mackeyev Y, Newton JM, Dilliard SA, Wilson LJ, Curley SA, Serda RE
International Journal of Nanomedicine 2017, 12:8289-8307
Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant
Zhao Z, Song ZJ, Wang XW, Sun HF, Yang XM, Yuan Y, Yu P
OncoTargets and Therapy 2017, 10:4129-4133
Thyroid cancer in a patient with Lynch syndrome – case report and literature review
Fazekas-Lavu M, Parker A, Spigelman AD, Scott RJ, Epstein RJ, Jensen M, Samaras K
Therapeutics and Clinical Risk Management 2017, 13:915-918
Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
Wu PH, Onodera Y, Ichikawa Y, Rankin EB, Giaccia AJ, Watanabe Y, Qian W, Hashimoto T, Shirato H, Nam JM
International Journal of Nanomedicine 2017, 12:5069-5085
SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer
Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG
Breast Cancer: Targets and Therapy 2017, 9:383-392
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
Lazzari P, Spiga M, Sani M, Zanda M, Fleming IN
CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study
Wickramage I, Tennekoon KH, Ariyaratne MAY, Hewage AS, Sundralingam T
Breast Cancer: Targets and Therapy 2017, 9:111-120
Ulva lactuca polysaccharides prevent Wistar rat breast carcinogenesis through the augmentation of apoptosis, enhancement of antioxidant defense system, and suppression of inflammation
Abd-Ellatef GF, Ahmed OM, Abdel-Reheim ES, Abdel-Hamid AZ
Breast Cancer: Targets and Therapy 2017, 9:67-83
Conductive polymer-based nanoparticles for laser-mediated photothermal ablation of cancer: synthesis, characterization, and in vitro evaluation
Cantu T, Walsh K, Pattani VP, Moy AJ, Tunnell JW, Irvin JA, Betancourt T
International Journal of Nanomedicine 2017, 12:615-632
Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
Boér K
OncoTargets and Therapy 2016, 9:6119-6125
Increasing roughness of the human breast cancer cell membrane through incorporation of gold nanoparticles
Lara-Cruz C, Jiménez-Salazar JE, Ramón-Gallegos E, Damian-Matsumura P, Batina N
International Journal of Nanomedicine 2016, 11:5149-5161
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
Ghidini M, Hahne JC, Trevisani F, Panni S, Ratti M, Toppo L, Tomasello G
Therapeutics and Clinical Risk Management 2016, 12:1009-1015
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
Kagan R, Goldstein SR, Pickar JH, Komm BS
Therapeutics and Clinical Risk Management 2016, 12:549-562
Temporal tuning of daily rhythms helps advanced cancer patients and cancer survivors feel better, live better, and live longer
Hrushesky W, Grutsch JF, Huff DF, Tavolacci L, Kazlausky T
ChronoPhysiology and Therapy 2016, 6:1-13
Recent perspectives on the anticancer properties of aqueous extracts of Nigerian Vernonia amygdalina
Howard CB, Johnson WK, Pervin S, Izevbigie EB
Botanics: Targets and Therapy 2015, 5:65-76
Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway
Cai Y, He J, Zhang D
OncoTargets and Therapy 2015, 8:2657-2664
Triple negative breast cancer: an Indian perspective
Akhtar M, Dasgupta S, Rangwala M
Breast Cancer: Targets and Therapy 2015, 7:239-243
Factors that influence patient preferences for prostate cancer management options: a systematic review
Showalter TN, Mishra MV, Bridges JFP
Patient Preference and Adherence 2015, 9:899-911
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
Sandoo A, Kitas GD, Carmichael AR
Vascular Health and Risk Management 2015, 11:223-228
Critical analysis of the potential for microRNA biomarkers in breast cancer management
Graveel CR, Calderone HM, Westerhuis JJ, Winn ME, Sempere LF
Breast Cancer: Targets and Therapy 2015, 7:59-79
Management of patients with hormone receptor–positive breast cancer with visceral disease: challenges and treatment options
Harb WA
Cancer Management and Research 2015, 7:37-46
Molecular photoacoustic imaging of breast cancer using an actively targeted conjugated polymer
Balasundaram G, Ho CJH, Li K, Driessen WH, Dinish US, Wong CL, Ntziachristos V, Liu B, Olivo M
International Journal of Nanomedicine 2015, 10:387-397
Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
Wurz GT, Kao CJ, DeGregorio MW
Clinical Interventions in Aging 2014, 9:1939-1950
Whole exome sequencing for cancer – is there evidence of clinical utility?
Malhotra A, Levine S, Allingham-Hawkins D
Advances in Genomics and Genetics 2014, 4:115-128
Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
Cadoo KA, Gucalp A, Traina TA
Breast Cancer: Targets and Therapy 2014, 6:123-133
Current strategies for the prevention of breast cancer
Advani P, Moreno-Aspitia A
Breast Cancer: Targets and Therapy 2014, 6:59-71
Precision medicine and personalized breast cancer: combination pertuzumab therapy
Reynolds K, Sarangi S, Bardia A, Dizon DS
Synthesis and characterization of surface-enhanced Raman-scattered gold nanoparticles
Kalmodia S, Harjwani J, Rajeswari R, Yang W, Barrow CJ, Ramaprabhu S, Krishnakumar S, Elchuri SV
International Journal of Nanomedicine 2013, 8:4327-4338
Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast
Soe LH, Wurz GT, Kao CJ, DeGregorio MW
International Journal of Women's Health 2013, 5:605-611
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?
Lechner J, von Baehr V
International Journal of General Medicine 2013, 6:277-290
Sonomammographic characteristics of invasive lobular carcinoma
Kombar OR, Fahmy DM, Brown MV, Farouk O, El-Damshety O
Breast Cancer: Targets and Therapy 2012, 4:115-124
Children and young adults with parents with cancer: a population-based study
Syse A, Aas GB, Loge JH
Clinical Epidemiology 2012, 4:41-52
Functionalization of single-walled carbon nanotubes and their binding to cancer cells
Madani SY, Tan A, Dwek M, Seifalian AM
International Journal of Nanomedicine 2012, 7:905-914
The Automated Breast Volume Scanner (ABVS): initial experiences in lesion detection compared with conventional handheld B-mode ultrasound: a pilot study of 50 cases
Wojcinski S, Farrokh A, Hille U, Wiskirchen J, Gyapong S, Soliman AA, Degenhardt F, Hillemanns P
International Journal of Women's Health 2011, 3:337-346